<SEC-DOCUMENT>0001140361-22-007581.txt : 20220303
<SEC-HEADER>0001140361-22-007581.hdr.sgml : 20220303
<ACCEPTANCE-DATETIME>20220303073212
ACCESSION NUMBER:		0001140361-22-007581
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20220303
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20220303
DATE AS OF CHANGE:		20220303

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Tilray Brands, Inc.
		CENTRAL INDEX KEY:			0001731348
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				824310622
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38594
		FILM NUMBER:		22706751

	BUSINESS ADDRESS:	
		STREET 1:		655 MADISON AVENUE
		STREET 2:		19TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10065
		BUSINESS PHONE:		519.322.8800

	MAIL ADDRESS:	
		STREET 1:		655 MADISON AVENUE
		STREET 2:		19TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10065

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Tilray, Inc.
		DATE OF NAME CHANGE:	20180213
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>ny20002883x2_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:us-gaap="http://fasb.org/us-gaap/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:country="http://xbrl.sec.gov/country/2021" xmlns:currency="http://xbrl.sec.gov/currency/2021" xmlns:naics="http://xbrl.sec.gov/naics/2021" xmlns:sic="http://xbrl.sec.gov/sic/2021" xmlns:stpr="http://xbrl.sec.gov/stpr/2021" xmlns:exch="http://xbrl.sec.gov/exch/2021" xmlns:srt="http://fasb.org/srt/2021-01-31" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:tlry="http://tilray.com/20220303" xmlns="http://www.w3.org/1999/xhtml">
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
    <meta http-equiv="Content-Type" content="text/html" />
</head>

<body style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000; background-color: #ffffff;">
<div id="DSPFiXBRLHidden" style="display: none;"><ix:header><ix:hidden><ix:nonNumeric name="dei:AmendmentFlag" id="Fact_6ffd309601274ab8aa155eb1733b495e" contextRef="c20220303to20220303" format="ixt:booleanfalse">false</ix:nonNumeric><ix:nonNumeric name="dei:EntityCentralIndexKey" id="Fact_a6a6767e2b8e4fb98948294112de7cb7" contextRef="c20220303to20220303">0001731348</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:href="tlry-20220303.xsd" xlink:type="simple"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c20220303to20220303"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001731348</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-03</xbrli:startDate><xbrli:endDate>2022-03-03</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001731348</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2022-03-03</xbrli:startDate><xbrli:endDate>2022-03-03</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div>

  <div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">
      <hr style="border: none; border-bottom: 1px solid black; border-top: 4px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" />
<div><span style="font-size: 14pt;">UNITED






        STATES</span></div>
</div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 14pt; font-weight: bold;">SECURITIES AND EXCHANGE COMMISSION</div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 12pt; font-weight: bold;">WASHINGTON, D.C. 20549</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 18pt; font-weight: bold;">FORM <ix:nonNumeric name="dei:DocumentType" id="Fact_b169bdf0e346499483436fc6861b4b6a" contextRef="c20220303to20220303">8-K</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CURRENT REPORT</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" id="Fact_bc67854aa40a4b23842b4757ef6e7863" contextRef="c20220303to20220303" format="ixt:datemonthdayyearen">March 3, 2022</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 24pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityRegistrantName" id="Fact_3c4309d60a1a496f83eee87fafc49f83" contextRef="c20220303to20220303">Tilray Brands, Inc.</ix:nonNumeric><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Exact name of Registrant as Specified in Its Charter)</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" id="Fact_4ee961c296974272a4f1fc6f45882f99" contextRef="c20220303to20220303" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityFileNumber" id="Fact_edebf49b778d4c908cc0eac28c37c0c8" contextRef="c20220303to20220303">001-38594</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" id="Fact_28a4c3f3ce05415fb835c65efb75eef7" contextRef="c20220303to20220303">82-4310622</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(State or Other Jurisdiction</div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">of Incorporation)</div>
          </td>

    <td style="width: 34%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Commission File Number)</div>
          </td>

    <td style="width: 33%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(IRS Employer</div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Identification No.)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_f9c0b47103794d508d3dc4c4100deaa2" contextRef="c20220303to20220303">265 Talbot Street West</ix:nonNumeric>,
              <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_3574e43cd2924ac68ac0ef71c93f3b11" contextRef="c20220303to20220303">Leamington</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_6dfa9db41b1247e980e4c4a659848890" contextRef="c20220303to20220303">Ontario</ix:nonNumeric>,
              <ix:nonNumeric name="dei:EntityAddressCountry" id="Fact_100b5cdfc7354e429d0be4f24b39f3ac" contextRef="c20220303to20220303" format="ixt-sec:countrynameen">Canada</ix:nonNumeric></div>
          </td>

    <td style="width: 50%; vertical-align: bottom;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_41b8a960db14480fa905d4cf0648005f" contextRef="c20220303to20220303">N8H 4H3</ix:nonNumeric><br />
            </div>
          </td>

  </tr>

  <tr>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Address of Principal Executive Offices)</div>
          </td>

    <td style="width: 50%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Zip Code)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Registrant&#8217;s Telephone Number, Including Area Code: (<ix:nonNumeric name="dei:CityAreaCode" id="Fact_f106d235470244f399f30ce5ddc2b521" contextRef="c20220303to20220303">844</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" id="Fact_9c4e207dbe914d1fb2163c3e56745c06" contextRef="c20220303to20220303">845-7291</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:EntityAddressAddressLine1" id="Fact_ac1e538e40fd40c5b7baa7137f934d2f" contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember">655 Madison Avenue</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressAddressLine2" id="Fact_a6a87fe1f7634e4babbc933a30515bb0" contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember">Suite 1900</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" id="Fact_908df462bd194fb583da432c1eb5a413" contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember">New York</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" id="Fact_190b4e48729549cc96d4f36fd4871c37" contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember">NY</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" id="Fact_ccc9ab7784d94e5b92471a2fe69aac10" contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember">10065</ix:nonNumeric></div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">(Former Name or Former Address, if Changed Since Last Report)</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the
      following provisions:</div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 4%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:WrittenCommunications" id="Fact_f7e0bc5180b54fc4bdf5508604ba23db" contextRef="c20220303to20220303" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 4%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:SolicitingMaterial" id="Fact_9527d22fd06840d1ae777da73eaf9685" contextRef="c20220303to20220303" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 4%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" id="Fact_f94a94d822fa47969cfa1078ef13a106" contextRef="c20220303to20220303" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</div>
          </td>

  </tr>

  <tr>

    <td style="width: 4%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Segoe UI Symbol', sans-serif; font-size: 10pt;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" id="Fact_1dd3e074d4ef4a25a6465a035460a6a3" contextRef="c20220303to20220303" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 96%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Securities registered pursuant to Section 12(b) of the Exchange Act:</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 40%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0); white-space: nowrap;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Title of each class</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 16%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Trading</div>
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Symbol(s)</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 40%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Name of each exchange on which registered</div>
          </td>

  </tr>

  <tr>

    <td style="width: 40%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:Security12bTitle" id="Fact_3e1fdb5d042b4036947adb7d3829f485" contextRef="c20220303to20220303">Class 2 Common Stock, $0.0001 par value per share</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 16%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:TradingSymbol" id="Fact_fdee6b91c9284a3b974e57d000c3ace2" contextRef="c20220303to20220303">TLRY</ix:nonNumeric><br />
            </div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 40%; vertical-align: top;">
            <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><ix:nonNumeric name="dei:SecurityExchangeName" id="Fact_6ffabf326396417b8069dfef8428d6ea" contextRef="c20220303to20220303" format="ixt-sec:exchnameen">The NASDAQ Global Select Market</ix:nonNumeric><br />
            </div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (Sec. 230.405 of this
      chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (Sec. 240.12b-2 of this chapter).</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" id="Fact_1106681606044242854e5153c4e1d5fe" contextRef="c20220303to20220303" format="ixt-sec:boolballotbox">&#x2610;</ix:nonNumeric></div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or
      revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. <span style="font-size: 10pt; font-family: 'Segoe UI Symbol', sans-serif;">&#9744;</span></div>

    <div>
      <hr style="border: none; border-bottom: 4px solid black; border-top: 1px solid black; height: 10px; color: #ffffff; background-color: #ffffff; text-align: center; margin-left: auto; margin-right: auto;" /></div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 1.01 Entry into a Material Definitive Agreement.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">On March 3, 2022, Tilray Brands, Inc. (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><span style="text-decoration: underline;">Company</span></span>&#8221; or &#8220;<span style="text-decoration: underline;">Tilray</span>&#8221;)


      entered into a sales agreement (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><span style="text-decoration: underline;">Sales Agreement</span></span>&#8221;) with Jefferies LLC and Canaccord Genuity LLC (each, an &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><span style="text-decoration: underline;">Agent</span></span>&#8221; and together, the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><span style="text-decoration: underline;">Agents</span></span>&#8221;), pursuant to which the Company may offer and sell shares of the Company&#8217;s
      Class 2 common stock, par value US$0.0001 per share (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><span style="text-decoration: underline;">Common Stock</span></span>&#8221;), having an aggregate offering price of up to $400,000,000 from time to time through
      the Agents, acting as sales agents, or directly to the Agents, acting as principals.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Sales of the Common Stock, if any, under the Sales Agreement will be made by any method that is deemed to be an &#8220;at the market offering&#8221; as defined in Rule
      415(a)(4) under the Securities Act of 1933, as amended, including, but not limited to, sales made directly on or through The Nasdaq Global Select Market or any other existing trading market for the Common Stock. The Company has no obligation to sell
      any of the Common Stock and may at any time suspend offers under the Sales Agreement or terminate the Sales Agreement. The offering of shares of Common Stock pursuant to the Sales Agreement will terminate upon the earlier of (i) the sale of all
      Common Stock subject to the Sales Agreement or (ii) termination of the Sales Agreement in accordance with its terms.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Subject to the terms and conditions of the Sales Agreement, the Agents will use their commercially reasonable efforts to sell the Common Stock from time to
      time, as the sales agents, based upon the Company&#8217;s instructions. The Company may sell shares of its Common Stock through only one Agent on any particular trading day. No sales of the Common Stock under the Sales Agreement will be made in Canada, to
      anyone known by the selling Agent to be a resident of Canada or over or through the facilities of the Toronto Stock Exchange.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company has provided customary representations, warranties and covenants, and the parties have agreed to indemnification rights. Each Agent will be
      entitled to a commission of up to 3.0% of the gross proceeds for each sale of the Common Stock made through or to such Agent from time to time under the Sales Agreement.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">This description of the Sales Agreement does not purport to be complete and is qualified in its entirety by reference to the terms of the Sales Agreement,
      which is attached as Exhibit 1.1 to this Current Report on Form 8-K and is incorporated by reference herein.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Common Stock to be sold under the Sales Agreement, if any, will be offered and sold pursuant to the Company&#8217;s shelf registration statement on Form S-3ASR
      (File No. 333-233703), filed with the Securities and Exchange Commission (the &#8220;<span style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><span style="text-decoration: underline;">SEC</span></span>&#8221;) on September 11, 2019, which became effective immediately upon filing. On
      March 3, 2022, the Company filed a prospectus supplement with the SEC in connection with the offer and sale of the Common Stock pursuant to the Sales Agreement. This Current Report on Form 8-K shall not constitute an offer to sell or the solicitation
      of an offer to buy the Common Stock nor shall there be any sale of the Common Stock in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such
      state or other jurisdiction.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The legal opinion of DLA Piper LLP (US) relating to the Common Stock being offered pursuant to the Sales Agreement is filed as Exhibit 5.1 to this Current
      Report on Form 8-K.</div>

    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after: always;" class="DSPFPageBreak">
        <hr style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;" /></div>

    </div>

    <div>
      <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold; background-color: rgb(255, 255, 255); color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Item 8.01 Other
        Events.</div>

      <div>&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">On March 2,
        2022, the Company entered into a term sheet (the &#8220;Holder Term Sheet&#8221;) to acquire all of the outstanding principal balance (along with accrued and unpaid interest) of the secured convertible notes (the &#8220;Notes&#8221;) issued by Hexo Corp. (&#8220;Hexo&#8221;) and
        maturing on May 1, 2023 from the current holder. The total purchase price for the Notes would be in an amount equal to 95% of the current outstanding principal balance (approximately $211 million) plus the accrued and unpaid interest on the Notes
        (which would be converted into principal prior to closing), together with costs incurred by the Company in connection with the acquisition of the Notes. The purchase price would be payable in cash consideration, Class 2 Common Stock of Tilray or
        any combination thereof, at the option of Tilray.</div>

      <div>&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">The Company
        simultaneously entered into a second term sheet (the &#8220;Hexo Term Sheet&#8221;) to amend certain terms of the Notes upon acquisition by Tilray. The amendment terms include extending the maturity date by three years to May 1, 2026 and adjusting the initial
        conversion price of the Notes to Canadian $0.90. The Hexo Term Sheet further provides Tilray with Hexo board governance rights to appoint one director and one board observer.</div>

      <div>&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt; background-color: rgb(255, 255, 255); font-weight: normal; color: rgb(0, 0, 0); font-style: normal; font-variant: normal; text-transform: none;">Tilray would
        be granted &#8220;top-up&#8221; and preemptive rights enabling it to maintain its percentage ownership (on an &#8220;as-converted&#8221; basis) in the event that Hexo issues equity or debt securities following acquisition of the Notes by Tilray.</div>

      <div>&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">The Hexo Term Sheet also provides that Tilray and Hexo would work in good faith to evaluate and implement production efficiencies and cost-saving synergies
        pursuant to commercial production arrangements to be negotiated by the parties.</div>

      <div>&#160;</div>

      <div style="text-align: left; font-family: 'Times New Roman',Times,serif; font-size: 10pt;">Each of the transactions described above is subject to negotiation and execution of definitive agreements, satisfactory completion of financial due diligence,
        receipt of the requisite stock exchange approval by Hexo, board approvals, Hexo shareholder approval and other customary conditions.</div>

      <div>&#160;</div>

    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Item 9.01 Financial Statements and Exhibits.</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(d) Exhibits.</div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br />
    </div>

    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 7.71%; vertical-align: bottom; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Exhibit</div>
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Number</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: bottom; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Description of Exhibit</div>
          </td>

  </tr>

  <tr>

    <td style="width: 7.71%; vertical-align: middle;">&#160;</td>

    <td style="vertical-align: middle;" colspan="2">&#160;</td>

  </tr>

  <tr>

    <td style="width: 7.71%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20002883x2_ex1-1.htm">1.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Sales Agreement, dated as of March 3, 2022, by and between Tilray Brands, Inc. and Jefferies LLC and Canaccord Genuity LLC</div>
          </td>

  </tr>

  <tr>

    <td style="width: 7.71%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20002883x2_ex5-1.htm">5.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Opinion of DLA Piper LLP (US)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 7.71%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><a href="ny20002883x2_ex5-1.htm">23.1</a></div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Consent of DLA Piper LLP (US) (included in Exhibit 5.1)</div>
          </td>

  </tr>

  <tr>

    <td style="width: 7.71%; vertical-align: top; white-space: nowrap;" rowspan="1"><a href="ny20002883x2_ex99-1.htm">99.1</a><br />
          </td>

    <td style="width: 2%; vertical-align: bottom;" rowspan="1">&#160;</td>

    <td style="width: 90%; vertical-align: top;" rowspan="1">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Press Release of Tilray Brands, Inc., dated March 3, 2022</div>
          </td>

  </tr>

  <tr>

    <td style="width: 7.71%; vertical-align: top; white-space: nowrap;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">104</div>
          </td>

    <td style="width: 2%; vertical-align: bottom;">&#160;</td>

    <td style="width: 90%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cover Page Interactive Data File (formatted in Inline XBRL document)</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" class="DSPFPageBreakArea">
      <div style="page-break-after:always;" class="DSPFPageBreak">
        <hr style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;" /></div>

    </div>

    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">SIGNATURES</div>

    <div><br />
    </div>

    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
      thereunto duly authorized.</div>

    <div><br />
    </div>

    <table cellspacing="0" cellpadding="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">


  <tr>

    <td style="width: 48.04%; vertical-align: top;">&#160;</td>

    <td style="width: 51.96%; vertical-align: top;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Brands, Inc.</div>
          </td>

  </tr>

  <tr>

    <td style="width: 48.04%; vertical-align: top;">&#160;</td>

    <td style="width: 51.96%; vertical-align: top;" colspan="2">&#160;</td>

  </tr>

  <tr>

    <td style="width: 48.04%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date: March 3, 2022</div>
          </td>

    <td style="width: 4.48%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
          </td>

    <td style="width: 47.48%; vertical-align: top; border-bottom: #000000 2px solid;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">/s/ Mitchell Gendel</div>
          </td>

  </tr>

  <tr>

    <td style="width: 48.04%; vertical-align: top;">&#160;</td>

    <td style="width: 4.48%; vertical-align: top;">&#160;</td>

    <td style="width: 47.48%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mitchell Gendel</div>
          </td>

  </tr>

  <tr>

    <td style="width: 48.04%; vertical-align: top;">&#160;</td>

    <td style="width: 4.48%; vertical-align: top;">&#160;</td>

    <td style="width: 47.48%; vertical-align: bottom;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Global General Counsel</div>
          </td>

  </tr>


</table>
    <div><br />
    </div>

    <div>
      <hr style="height: 4px; color: #000000; background-color: #000000; text-align: center; border: none; margin-left: auto; margin-right: auto;" /></div>

  </div>

</body>
</html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>ny20002883x2_ex1-1.htm
<DESCRIPTION>EXHIBIT 1.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">Exhibit 1.1</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><u>SALES AGREEMENT</u></div>
    <div><br>
    </div>
    <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">March 3, 2022</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">JEFFERIES LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">520 Madison Avenue</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">New York, New York 10022</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">CANACCORD GENUITY LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">99 High Street, 12<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Boston, Massachusetts 02110</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Tilray Brands, Inc., a Delaware corporation (the &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Company</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221;), proposes, subject to the terms and conditions stated herein, to
        issue and sell from time to time through Jefferies LLC and Canaccord Genuity LLC, as sales agents and/or principals (each, an &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Agent</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221; and collectively, the &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Agents</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221;), shares of the Company&#8217;s Class 2 common stock, par value $0.0001 per share (the &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Common Shares</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221;), having an aggregate offering price of up to $400,000,000 on the terms set forth in this agreement (this &#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Agreement</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221;)</font>.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Section 1.&#160; DEFINITIONS</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Certain Definitions</u></font>.&#160; For purposes of this Agreement, capitalized terms used herein and not otherwise defined shall have the following respective meanings:</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Affiliate</font>&#8221; of a Person means
      another Person that directly or indirectly, through one or more intermediaries, controls, is controlled by, or is under common control with, such first- mentioned Person. The term &#8220;control&#8221; (including the terms &#8220;controlling,&#8221; &#8220;controlled by&#8221; and
      &#8220;under common control with&#8221;) means the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person, whether through the ownership of voting securities, by contract or otherwise.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Agency Period</font>&#8221; means the period
      commencing on the date of this Agreement and expiring on the earliest to occur of (x) the date on which the Agents shall have placed the Maximum Program Amount pursuant to this Agreement and (y) the date this Agreement is terminated pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 7</u></font>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Commission</font>&#8221; means the U.S.
      Securities and Exchange Commission.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Exchange Act</font>&#8221; means the
      Securities Exchange Act of 1934, as amended, and the rules and regulations of the Commission thereunder.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Floor Price</font>&#8221; means the minimum
      price set by the Company in the Issuance Notice below which the Designated Agent (as defined below) shall not sell Shares during the applicable <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">period set forth in the
        Issuance Notice</font>, which may be adjusted by the Company at any time <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">during the period set forth in the Issuance Notice</font> by delivering written notice of such
      change to the Designated Agent and which in no event shall be less than $1.00 without the prior written consent of the Designated Agent, which may be withheld in the Designated Agent&#8217;s sole discretion.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <!--PROfilePageNumberReset%Num%2%%%-->
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Issuance Amount</font>&#8221; means the
      aggregate Sales Price of the Shares to be sold by the Designated Agent pursuant to any Issuance Notice.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Issuance Notice</font>&#8221; means a written
      notice delivered to the Designated Agent by the Company in accordance with this Agreement in the form attached hereto as <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Exhibit A</u></font> that is executed by its
      Chief Executive Officer<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, President or Chief Financial Officer</font>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Issuance Notice Date</font>&#8221; means any
      Trading Day during the Agency Period that an Issuance Notice is <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">delivered </font>pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section




          3(b)(i)</u></font>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#160;&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Issuance Price</font>&#8221; means <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">the Sales Price less the Selling Commission</font>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Maximum Program Amount</font>&#8221; means
      Common Shares with an aggregate Sales Price of the lesser of (a) the number or dollar amount of Common Shares registered under the effective Registration Statement (defined below) pursuant to which the offering is being made, (b) the number of
      authorized but unissued Common Shares (less Common Shares issuable upon exercise, conversion or exchange of any outstanding securities of the Company or otherwise reserved from the Company&#8217;s authorized capital stock), (c) the number or dollar amount
      of Common Shares permitted to be sold under Form S-3 (including General Instruction I.B.6 thereof, if applicable), or (d) the number or dollar amount of Common Shares for which the Company has filed a Prospectus (defined below).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Person</font>&#8221; means an individual or a
      corporation, partnership, limited liability company, trust, incorporated or unincorporated association, joint venture, joint stock company, governmental authority or other entity of any kind.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Principal Market</font>&#8221; means the
      NASDAQ Global Select Market or such other national securities exchange on which the Common Shares, including any Shares, are then listed.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Sales Price</font>&#8221; means the actual
      sale execution price of each Share placed by the Designated Agent pursuant to this Agreement.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Securities Act</font>&#8221; means the
      Securities Act of 1933, as amended, and the rules and regulations of the Commission thereunder.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Selling Commission</font>&#8221; means three
      percent (3.0%) of the gross proceeds of Shares sold pursuant to this Agreement, or as otherwise agreed between the Company and the Agents with respect to any Shares sold pursuant to this Agreement.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;&#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Settlement Date</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221; </font>means the second business day following each Trading Day during the <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">period set forth in the Issuance Notice</font> on which Shares are sold pursuant to this Agreement, when the Company shall deliver to the Designated Agent the amount of Shares sold on such
      Trading Day and the Designated Agent shall deliver to the Company the Issuance Price received on such sales<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">2</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Shares</font>&#8221; shall mean the Company&#8217;s
      Common Shares issued or issuable pursuant to this Agreement.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Trading Day</font>&#8221; means any day on
      which the Principal Market is open for trading.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Section 2.&#160; REPRESENTATIONS AND WARRANTIES OF THE COMPANY</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company represents and warrants to, and agrees with, the Agents that as of (1) the date of this Agreement, (2) each Issuance Notice
      Date, (3) each Settlement Date, (4) each Triggering Event Date and (5) as of each Time of Sale (each of the times referenced above is referred to herein as a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Representation Date</font>&#8221;), except as may be disclosed in the Prospectus (including any documents incorporated by reference therein and any supplements thereto) on or before a Representation Date:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Registration Statement</u></font>.&#160; The Company has prepared and filed with the Commission a shelf registration statement on Form S-3 (File No. 333-233703) that contains a base prospectus
        (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Base Prospectus</font>&#8221;).&#160; Such registration statement registers the issuance and sale by the Company of the Shares under the Securities Act.&#160; The
        Company may file one or more additional registration statements from time to time that will contain a base prospectus and related prospectus or prospectus supplement, if applicable, with respect to the Shares. Except where the context otherwise
        requires, such registration statement(s), including any information deemed to be a part thereof pursuant to Rule 430B under the Securities Act, including all financial statements, exhibits and schedules thereto and all documents incorporated or
        deemed to be incorporated therein by reference pursuant to Item 12 of Form S-3 under the Securities Act as from time to time amended or supplemented, is herein referred to as the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Registration Statement</font>,&#8221; and the prospectus constituting a part of such registration statement(s), together with any prospectus supplement filed with the Commission pursuant to Rule 424(b) under the Securities
        Act relating to a particular issuance of the Shares, including all documents incorporated or deemed to be incorporated therein by reference pursuant to Item 12 of Form S-3 under the Securities Act, in each case, as from time to time amended or
        supplemented, is referred to herein as the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Prospectus</font>,&#8221; except that if any revised prospectus is provided to the Agents by the Company for use
        in connection with the offering of the Shares that is not required to be filed by the Company pursuant to Rule 424(b) under the Securities Act, the term &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Prospectus</font>&#8221; shall refer to such revised prospectus from and after the time it is first provided to the Agents for such use.&#160; The Registration Statement at the time it originally became effective is herein called the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Original Registration Statement</font>.&#8221;&#160; As used in this Agreement, the terms &#8220;amendment&#8221; or &#8220;supplement&#8221; when applied to the Registration Statement or the
        Prospectus shall be deemed to include the filing by the Company with the Commission of any document under the Exchange Act after the date hereof that is or is deemed to be incorporated therein by reference.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">All references in this Agreement to financial statements and schedules and other information which is &#8220;contained,&#8221; &#8220;included&#8221; or
      &#8220;stated&#8221; in the Registration Statement or the Prospectus (and all other references of like import) shall be deemed to mean and include all such financial statements and schedules and other information which is or is deemed to be incorporated by
      reference in or otherwise deemed under the Securities Act to be a part of or included in the Registration Statement or the Prospectus, as the case may be, as of any specified date; and all references in this Agreement to amendments or supplements to
      the Registration Statement or the Prospectus shall be deemed to mean and include, without limitation, the filing of any document under the Exchange Act which is or is deemed to be incorporated by reference in or otherwise deemed under the Securities
      Act to be a part of or included in the Registration Statement or the Prospectus, as the case may be, as of any specified date. The Company&#8217;s obligations under this Agreement to furnish, provide, deliver or make available (and all other references of
      like import) copies of any report or statement shall be deemed satisfied if the same is filed with the Commission through its Electronic Data Gathering, Analysis and Retrieval system (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">EDGAR</font>&#8221;).</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">3</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">At the time the Registration Statement was or will be originally declared effective and at the time the Company&#8217;s most recent annual
      report on Form 10-K was filed with the Commission, if later, the Company met the then-applicable requirements for use of Form S-3 under the Securities Act.&#160; During the Agency Period, each time the Company files an annual report on Form 10-K the
      Company will meet the then-applicable requirements for use of Form S-3 under the Securities Act.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Compliance with Registration Requirements</u></font>.&#160; The Original Registration Statement and any Rule 462(b) Registration Statement have been declared effective by the Commission under the
        Securities Act.&#160; The Company has complied to the Commission&#8217;s satisfaction with all requests of the Commission for additional or supplemental information.&#160; No stop order suspending the effectiveness of the Registration Statement or any Rule 462(b)
        Registration Statement is in effect and no proceedings for such purpose have been instituted or are pending or, to the best knowledge of the Company, are contemplated or threatened by the Commission.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Prospectus when filed complied in all material respects with the Securities Act and, if filed with through EDGAR (except as may be
      permitted by Regulation S&#8209;T under the Securities Act), was identical to the copy thereof delivered to the Agents for use in connection with the issuance and sale of the Shares.&#160; Each of the Registration Statement, any Rule 462(b) Registration
      Statement and any post-effective amendment thereto, at the time it became effective and at all subsequent times, complied and will comply in all material respects with the Securities Act and did not and will not contain any untrue statement of a
      material fact or omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading.&#160; As of the date of this Agreement, the Prospectus and any Free Writing Prospectus (as defined below) considered
      together (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Time of Sale Information</font>&#8221;) did not contain any untrue statement of a material fact or omit to state a material fact
      necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.&#160; The Prospectus, as amended or supplemented, as of its date and at all subsequent times, did not and will not contain any untrue
      statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading.&#160; The representations and warranties set forth in the three
      immediately preceding sentences do not apply to statements in or omissions from the Registration Statement, any Rule 462(b) Registration Statement, or any post-effective amendment thereto, or the Prospectus, or any amendments or supplements thereto,
      made in reliance upon and in conformity with information relating to the Agents furnished to the Company in writing by the Agents expressly for use therein, it being understood and agreed that the only such information furnished by the Agents to the
      Company consists of the information described in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font>&#160; below.&#160; There are no contracts or other documents required to be described in the Prospectus or to
      be filed as exhibits to the Registration Statement which have not been described or filed as required. The Registration Statement and the offer and sale of the Shares as contemplated hereby meet the requirements of Rule 415 under the Securities Act
      and comply in all material respects with said rule.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">4</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Ineligible Issuer Status</u></font>. The Company is not an &#8220;ineligible issuer&#8221; in connection with the offering of the Shares pursuant to Rules 164, 405 and 433 under the Securities Act.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Incorporated Documents</u></font>. The documents incorporated or deemed to be incorporated by reference in the Registration Statement and the Prospectus, at the time they were filed with the
        Commission, complied in all material respects with the requirements of the Exchange Act, as applicable, and, when read together with the other information in the Prospectus, do not contain an untrue statement of a material fact or omit to state a
        material fact required to be stated therein or necessary to make the statements therein, in light of the circumstances under which they were made, not misleading.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Exchange Act Compliance</u></font>.&#160; The documents incorporated or deemed to be incorporated by reference in the Prospectus, at the time they were or hereafter are filed with the Commission,
        and any Free Writing Prospectus or amendment or supplement thereto complied and will comply in all material respects with the requirements of the Exchange Act, and, when read together with the other information in the Prospectus, at the time the
        Registration Statement and any amendments thereto become effective and at each Time of Sale (as defined below), as the case may be, will not contain an untrue statement of a material fact or omit to state a material fact required to be stated
        therein or necessary to make the fact required to be stated therein or necessary to make the statements therein, in the light of the circumstances under which they were made, not misleading.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Statistical and Market-Related Data</u></font>.&#160; The statistical, demographic and market-related data included in the Registration Statement and the Prospectus are based on or derived from
        sources that the Company believes to be reliable and accurate in all material respects or represent the Company&#8217;s good faith estimates that are made on the basis of data derived from such sources.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Disclosure Controls and Procedures; Deficiencies in or Changes to Internal Control Over Financial Reporting</u></font>.&#160; Except as otherwise disclosed in the Registration Statement and the
        Prospectus, the Company has established and maintains disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Exchange Act), which (i) are designed to ensure that material information relating to the Company, including
        its consolidated Subsidiaries, is made known to the Company&#8217;s principal executive officer and its principal financial officer by others within those entities, particularly during the periods in which the periodic reports required under the Exchange
        Act are being prepared; (ii) have been evaluated by management of the Company for effectiveness as of the end of the Company&#8217;s most recent fiscal quarter; and (iii) are effective in all material respects to perform the functions for which they were
        established.&#160; Since the end of the Company&#8217;s most recent audited fiscal year, there have been no significant deficiencies or material weaknesses in the Company&#8217;s internal control over financial reporting (whether or not remediated) and no change in
        the Company&#8217;s internal control over financial reporting that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.&#160; The Company is not aware of any change in its internal
        control over financial reporting that has occurred during its most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the Company&#8217;s internal control over financial reporting.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">5</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>This Agreement</u></font>. This Agreement has been duly authorized, executed and delivered by the Company.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Authorization of the Shares</u></font>. The Shares have been duly authorized for issuance and sale pursuant to this Agreement and, when issued and delivered by the Company against payment
        therefor pursuant to this Agreement, will be validly issued, fully paid and nonassessable, and the issuance and sale of the Shares is not subject to any preemptive rights, rights of first refusal or other similar rights to subscribe for or purchase
        the Shares.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Applicable Registration or Other Similar Rights</u></font>.&#160; There are no persons with registration or other similar rights to have any equity or debt securities registered for sale under
        the Registration Statement or included in the offering contemplated by this Agreement, except for such rights as have been duly waived.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Material Adverse Change</u></font>.&#160; Subsequent to the respective dates as of which information is contained in the Registration Statement and the Prospectus, except as disclosed in the
        Registration Statement and the Prospectus, (i) neither the Company nor any of the Subsidiaries has incurred any liabilities, direct or contingent, including without limitation any losses or interference with its business from fire, explosion,
        flood, earthquakes, accident or other calamity, whether or not covered by insurance, or from any strike, labor dispute or court or governmental action, order or decree, that are material, individually or in the aggregate, to the Company and the
        Subsidiaries, taken as a whole, or has entered into any transactions material, individually or in the aggregate, to the Company&#8217;s business and operations on a consolidated basis, not in the ordinary course of business, (ii) there has not been any
        material decrease in the capital stock or any material increase in any short-term or long-term indebtedness of the Company or the Subsidiaries, or any payment of or declaration to pay any dividends or any other distribution with respect to the
        Company, and (iii) there has not been any material adverse change, or any development that could reasonably be expected to result in a material adverse change, in the properties, business, operations, earnings, assets, liabilities or condition
        (financial or otherwise) of the Company and the Subsidiaries, taken as a whole (each of clauses (i), (ii) and (iii), a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Material Adverse Change</font>&#8221;).</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Independent Accountants</u></font>. PricewaterhouseCoopers LLP, which has expressed its opinion with respect to the financial statements (which term as used in this Agreement includes the
        related notes thereto) filed with the Commission as a part of the Registration Statement and the Prospectus, is (i) an independent registered public accounting firm as required by the Securities Act, the Exchange Act, and the rules of the Public
        Company Accounting Oversight Board (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">PCAOB</font>&#8221;), (ii) in compliance with the applicable requirements relating to the qualification of accountants
        under Rule 2-01 of Regulation S-X under the Securities Act and (iii) a registered public accounting firm as defined by the PCAOB whose registration has not been suspended or revoked and who has not requested such registration to be withdrawn.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">6</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Financial Statements</u></font>.&#160; The financial statements filed with the Commission as a part of the Registration Statement and the Prospectus present fairly, in all material respects, the
        consolidated financial position of the Company and its Subsidiaries as of the dates indicated and the results of their operations, changes in stockholders&#8217; equity and cash flows for the periods specified.&#160; The supporting schedules included in the
        Registration Statement present fairly the information required to be stated therein.&#160; Such financial statements have been prepared in conformity with generally accepted accounting principles as applied in the United States applied on a consistent
        basis throughout the periods involved, except as may be expressly stated in the related notes thereto and except in the case of unaudited, interim financial statements, normal year-end adjustments and the omission of certain footnotes as permitted
        by applicable rules of the Commission and any supporting schedules included in the Registration Statement.&#160; The interactive data in eXtensible Business Reporting Language included or incorporated by reference in the Registration Statement fairly
        presents the information called for in all material respects and has been prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.&#160; No other financial statements or supporting schedules are required to be included in
        the Registration Statement or the Prospectus.&#160; The financial data set forth in each of the Registration Statement and the Prospectus fairly present, in all material respects, the information set forth therein on a basis consistent with that of the
        audited financial statements contained in the Registration Statement and the Prospectus thereto and except in the case of unaudited, interim financial statements, normal year-end adjustment and the omission of certain footnotes as permitted by
        applicable rules of the Commission and any supporting schedules included in the Registration Statement.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Company&#8217;s Accounting System</u></font>.&#160; The Company and each of its Subsidiaries make and keep accurate books and records and maintain a system of internal accounting controls sufficient to
        provide reasonable assurance that:&#160; (i) transactions are executed in accordance with management&#8217;s general or specific authorization; (ii) transactions are recorded as necessary to permit preparation of financial statements in conformity with
        generally accepted accounting principles as applied in the United States and to maintain accountability for assets; (iii) access to assets is permitted only in accordance with management&#8217;s general or specific authorization; (iv) the recorded
        accountability for assets is compared with existing assets at reasonable intervals and appropriate action is taken with respect to any differences; and (v) the interactive data in eXtensible Business Reporting Language included or incorporated by
        reference in the Registration Statement and the Prospectus fairly presents the information called for in all material respects and is prepared in accordance with the Commission&#8217;s rules and guidelines applicable thereto.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(o)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Incorporation and Good Standing of the Company</u></font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">.</font>&#160; The Company and each of
        the Subsidiaries (i) has been duly organized or formed, as the case may be, is validly existing and is in good standing under the laws of its jurisdiction of organization, (ii) has all requisite power and authority to carry on its business and to
        own, lease and operate its properties and assets as described in the Registration Statement and the Prospectus and (iii) is duly qualified or licensed to do business and is in good standing as a foreign corporation, partnership or other entity as
        the case may be, authorized to do business in each jurisdiction in which the nature of such businesses or the ownership or leasing of such properties requires such qualification, except, in each instance, where the failure to do so or to be so
        would not, individually or in the aggregate, have a material adverse effect on (A) the properties, business, operations, earnings, assets, liabilities or condition (financial or otherwise) of the Company and the Subsidiaries, taken as a whole, (B)
        the ability of the Company or any Subsidiary to perform its obligations in all material respects under this Agreement, (C) the validity or enforceability of this Agreement, or (D) the consummation of the issuance and sale of the Shares (each
        material adverse effect described in clauses (A) &#8211; (D), a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Material Adverse Effect</font>&#8221;).</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">7</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(p)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Subsidiaries.</u></font>&#160; Each material corporation, partnership or other entity in which the Company, directly or indirectly through any of its subsidiaries, owns more than fifty percent
        (50%) of any class of equity securities or interests is listed on <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Schedule B</u></font> attached hereto (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Subsidiaries</font>&#8221;). Other than the Subsidiaries, the Company has no direct or indirect subsidiary nor any investment in any person which is material to the business and affairs of the Company or which
        otherwise is required to be disclosed in the Registration Statement and the Prospectus.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Capitalization and Other Capital Stock Matters</u></font>.&#160; The authorized, issued and outstanding capital stock of the Company is as set forth in the Registration Statement and the
        Prospectus (other than for subsequent issuances, if any, pursuant to employee benefit plans described in the Prospectus or upon the exercise of outstanding options or warrants, in each case described in the Registration Statement and the
        Prospectus).&#160; The Common Shares (including the Shares) conform in all material respects to the description thereof contained in the Prospectus.&#160; All of the issued and outstanding Common Shares have been duly authorized and validly issued, are fully
        paid and nonassessable and have been issued in compliance with all federal and state securities laws.&#160; None of the outstanding Common Shares was issued in violation of any preemptive rights, rights of first refusal or other similar rights to
        subscribe for or purchase securities of the Company.&#160; There are no authorized or outstanding options, warrants, preemptive rights, rights of first refusal or other rights to purchase, or equity or debt securities convertible into or exchangeable or
        exercisable for, any capital stock of the Company or any of its Subsidiaries other than those described in the Registration Statement and the Prospectus.&#160; The descriptions of the Company&#8217;s stock option, stock bonus and other stock plans or
        arrangements, and the options or other rights granted thereunder, set forth in the Registration Statement and the Prospectus accurately and fairly presents the information required to be shown with respect to such plans, arrangements, options and
        rights.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(r)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Stock Exchange Listing</u></font>. The Common Shares are registered pursuant to Section 12(b) or 12(g) of the Exchange Act and are listed on the Principal Market, and the Company has taken
        no action designed to, or likely to have the effect of, terminating the registration of the Common Shares under the Exchange Act or delisting the Common Shares from the Principal market, nor has the Company received any notification that the
        Commission or the Principal Market is contemplating terminating such registration or listing.&#160; To the Company&#8217;s knowledge, it is in compliance with all applicable listing requirements of the Principal Market.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">8</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(s)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Non-Contravention of Existing Instruments; No Further Authorizations or Approvals Required</u></font>.&#160; Neither the Company nor any of the Subsidiaries is (i) in violation of its articles of
        incorporation, by-laws or other organizational documents (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Charter Documents</font>&#8221;); (ii) in violation of any U.S., Canadian or foreign federal,
        state, provincial, or local statute, law (including, without limitation, common law) or ordinance, or any judgment, decree, rule, regulation, order or injunction (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Applicable Law</font>&#8221;) of any U.S. or non-U.S. federal, state, provincial, local or other governmental or regulatory authority, governmental or regulatory agency or body, court, arbitrator or self-regulatory
        organization (including Health Canada or any comparable federal, provincial, state, municipal, local or foreign governmental bodies in Canada or any other country, in each case with jurisdiction over the Company or the Subsidiaries) (each, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Governmental Authority</font>&#8221;), applicable to any of them or any of their respective properties; or (iii) in breach of or default under any bond,
        debenture, note, loan or other evidence of indebtedness, indenture, mortgage, deed of trust, lease or any other agreement or instrument to which any of them is a party or by which any of them or their respective property is bound (collectively, the
        &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Existing Instruments</font>&#8221;), except, in the case of clauses (ii) and (iii) for such violations, breaches or defaults that would not, individually or
        in the aggregate, reasonably be expected to have a Material Adverse Effect. All Existing Instruments are in full force and effect and are legal, valid and binding obligations, other than as disclosed in the Registration Statement and the
        Prospectus. There exists no condition that, with the passage of time or otherwise, would constitute (a) a violation of such Charter Documents or Applicable Law, (b) a breach of or default or a &#8220;Debt Repayment Triggering Event&#8221; (as defined below)
        under any Existing Instruments. As used herein, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Debt Repayment Triggering Event</font>&#8221; means any event or condition that gives, or with the giving
        of notice or lapse of time would give, the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#8217;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such
        indebtedness by the Company or any of the Subsidiaries or any of their respective properties. Neither the execution, delivery or performance of this Agreement nor the consummation of the sales of the Shares hereunder (including the use of proceeds
        from the sale of the Shares as described in the Prospectus under the caption &#8220;Use of Proceeds&#8221;) will conflict with, violate, constitute a breach of or a default (with the passage of time or otherwise) or a Debt Repayment Triggering Event under, or
        result in the imposition of a lien on any assets of the Company or any of the Subsidiaries, the imposition of any penalty or a Debt Repayment Triggering Event under or pursuant to (i) the Charter Documents, (ii) any Existing Instrument, (iii) any
        Applicable Law or (iv) any order, writ, judgment, injunction, decree, determination or award binding upon or affecting the Company. No consent, approval, authorization, order, filing, qualification or registration of or with any Governmental
        Authority or third party is required for execution, delivery or performance of this Agreement or the consummation of the sale of the Shares hereunder, except such (i) those that have been granted or made, as the case may be, that are in full force
        and effect and (ii) as may be required under the U.S. federal or state securities or &#8220;blue sky&#8221; laws applicable to the purchase and sale of the Shares hereunder.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(t)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Material Actions or Proceedings</u></font>.&#160; Except as otherwise disclosed in the Prospectuses, there is no action, claim, suit, demand, hearing, notice of violation or deficiency, or
        proceeding pending or, to the knowledge of the Company or any of the Subsidiaries, threatened in writing by Governmental Authorities or threatened in writing by others that would, individually or in the aggregate, have a Material Adverse Effect or
        adversely affect the consummation of the transactions contemplated by this Agreement.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">9</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(u)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Intellectual Property Rights</u></font>.&#160; Except as disclosed in the Prospectus, to the Company&#8217;s knowledge: (i) the Company and the Subsidiaries own, or have obtained valid and enforceable
        licenses for, the inventions, patent applications, patents, trademarks, trade names, service names, copyrights, trade secrets and other intellectual property described in the Prospectus as being owned or licensed by them (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Intellectual Property</font>&#8221;) necessary for the conduct of its business in all material respects; and (ii) there is no U.S. or Canadian patent that to the
        knowledge of the Company contains claims that dominate or may dominate any Intellectual Property or that interferes with any such Intellectual Property except, in the case of clause (ii), as would not have a Material Adverse Effect. Except as
        disclosed in the Prospectus, the Company is not obligated to pay a material royalty grant or license, or provide other material consideration to any third party in connection with the Intellectual Property. Except as disclosed in the Prospectus and
        other than trademark oppositions which arise in the normal course of trademark prosecution, there is no pending or, to the Company&#8217;s knowledge, threatened action, suit, proceeding or claim by others: (A) challenging the Company&#8217;s rights in or to
        any Intellectual Property; (B) challenging the validity, enforceability or scope of any Intellectual Property; or (C) asserting that the Company or any of the Subsidiaries infringes or otherwise violates, or would, upon the commercialization of any
        product or service described in the Prospectus as under development, infringe or violate, any patent, trademark, trade name, service name, copyright, trade secret or other proprietary rights of others. The Company and the Subsidiaries have
        complied, in all material respects, with the terms of each agreement pursuant to which Intellectual Property has been licensed to the Company or any Subsidiary, and all such agreements are in full force and effect.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>All Necessary Permits, etc</u></font>.&#160; Except as otherwise disclosed in the Prospectus, the Company and each subsidiary possess such valid and current certificates, authorizations or
        permits required by state, federal or foreign regulatory agencies or bodies (including Health Canada) presently required or necessary to own or lease, as the case may be, and to operate its properties and to carry on its businesses as now conducted
        as described in the Registration Statement and the Prospectus (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Permits</font>&#8221;), except where the failure to possess such Permits would not,
        individually or in the aggregate, have a Material Adverse Effect; each of the Company and the Subsidiaries has fulfilled and performed all of its obligations with respect to any such Permits, except where the failure to have fulfilled or performed
        such Permits would not, individually or in the aggregate, have a Material Adverse Effect; no event has occurred which allows, or after notice or lapse of time would allow, revocation or termination of any such Permit or has resulted, or after
        notice or lapse of time would, except where such revocation, termination or impairment would not, individually or in the aggregate, have a Material Adverse Effect result, in any other material impairment of the rights of the holder of any Permit;
        and none of the Company or the Subsidiaries has received or has any reason to believe it will receive any notice of any proceeding relating to revocation or modification of any Permit, except, in each instance, as described in the Registration
        Statement and the Prospectus or except where such revocation or modification would not, individually or in the aggregate, have a Material Adverse Effect.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(w)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Title to Properties</u></font>.&#160; Each of the Company and the Subsidiaries has good, marketable and valid title to all real property owned by it and good title to all personal property owned
        by it and good and valid title to all leasehold estates in real and personal property being leased by it, free and clear of any security interests, mortgages, liens, encumbrances, equities, adverse claims and other defects, except as disclosed in
        the Prospectus or as would not reasonably be expected, individually or in the aggregate, to materially affect the value of such property or interfere with the use thereof. All Existing Instruments to which the Company or any of the Subsidiaries is
        a party or by which any of them is bound are valid and enforceable against each of the Company or such Subsidiary, as applicable, and are valid and enforceable against the other party or parties thereto and are in full force and effect (A) with
        only such exceptions as would not, individually or in the aggregate, have a Material Adverse Effect and (B) except that the enforcement thereof may be subject to (i) bankruptcy, insolvency, winding-up, arrangement, reorganization, receivership,
        moratorium, fraudulent conveyance, fraudulent transfer or other similar laws now or hereafter in effect relating to creditors&#8217; rights generally and (ii) general principles of equity (whether applied by a court of law or equity) and the discretion
        of the court before which any proceeding therefor may be brought.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">10</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(x)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Tax Law Compliance</u></font>.&#160; All Tax (as hereinafter defined) returns required to be filed by the Company and each of the Subsidiaries have been filed and all such returns are true,
        complete and correct in all material respects. All material Taxes that are due from the Company and the Subsidiaries have been paid other than those (i) currently payable without penalty or interest or (ii) being contested in good faith and by
        appropriate proceedings and for which adequate accruals have been established in accordance with generally accepted accounting principles in the United States applied on a consistent basis throughout the periods involved. To the knowledge of the
        Company, after due inquiry, there are no actual or proposed Tax assessments against the Company or any of the Subsidiaries that would, individually or in the aggregate, have a Material Adverse Effect. The accruals on the books and records of the
        Company and the Subsidiaries in respect of any material Tax liability for any period not finally determined are adequate to meet any assessments of Tax for any such period. For purposes of this Agreement, the term &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Tax</font>&#8221; and &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Taxes</font>&#8221; shall mean all U.S., Canadian and other non-U.S.
        federal, state, provincial, local and taxes, and other assessments of a similar nature (whether imposed directly or through withholding), including any interest, additions to tax or penalties applicable thereto.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(y)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Company Not an &#8220;Investment Company</u></font>.&#8221;&#160; The Company has been advised of the Investment Company Act of 1940, as amended, and the rules and regulations of the Commission thereunder
        (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Investment Company Act</font>&#8221;); as of the date hereof and, after giving effect to the sale of the Shares hereunder and the
        application of the proceeds therefrom as described under &#8220;Use of Proceeds&#8221; in the Prospectus, each of the Company and the Subsidiaries is not and will not be, individually or on a consolidated basis, an &#8220;investment company&#8221; that is required to be
        registered under the Investment Company Act.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(z)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Insurance</u></font>.&#160; Except as disclosed in the Prospectus, each of the Company and the Subsidiaries are insured against such losses and risks and in such amounts as are commercially
        reasonable, and customary in the businesses in which they are engaged. All policies of insurance insuring the Company or any of the Subsidiaries or their respective businesses, assets, employees, officers and directors are, in full force and
        effect. The Company and the Subsidiaries are in compliance with the terms of such policies and instruments in all material respects, and there are no claims by the Company or any of the Subsidiaries under any such policy or instrument as to which
        any insurance company is denying liability or defending under a reservation of rights clause. Neither the Company nor any such Subsidiary has any reason to believe that it will not be able to renew its existing insurance coverage as and when such
        coverage expires or to obtain similar coverage from similar insurers as may be necessary to continue its business at a cost that would not, individually or in the aggregate, have a Material Adverse Effect.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(aa)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Price Stabilization or Manipulation; Compliance with Regulation M</u></font>.&#160; Neither the Company nor any of its Subsidiaries has taken, directly or indirectly, any action designed to or
        that might cause or result in stabilization or manipulation of the price of the Common Shares or of any &#8220;reference security&#8221; (as defined in Rule 100 of Regulation M under the Exchange Act (<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#8220;Regulation M&#8221;</font>)) with respect to the Common Shares, whether to facilitate the sale or resale of the Shares or otherwise, and has taken no action which would directly or indirectly violate
        Regulation M.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">11</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(bb)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Related Party Transactions</u></font>.&#160; There are no business relationships or related-party transactions involving the Company or any of its Subsidiaries or any other person required to be
        described in the Registration Statement or the Prospectus which have not been described as required.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(cc)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>FINRA Matters</u></font>.&#160; All of the information provided by the Company to the Agents or to counsel for the Agents by the Company, its counsel, its officers and directors and the holders
        of any securities (debt or equity) or options to acquire any securities of the Company in connection with the offering of the Shares is true, complete, correct and compliant with <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Financial Industry Regulatory Authority, Inc.&#8217;s (&#8220;</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">FINRA</font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#8221;) rules and any </font>letters, filings or other supplemental information provided by the Company to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">FINRA </font>pursuant to FINRA Rules or NASD Conduct
        Rules is true, complete and correct in all material respect. The Company meets the requirements for use of Form S-3 under the Securities Act specified in FINRA Rule 5110(b)(7)(C)(i).</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(dd)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Unlawful Contributions or Other Payments</u></font>.&#160; Except as otherwise disclosed in the Prospectus, neither the Company nor any of the Subsidiaries nor, to the best of the Company&#8217;s
        knowledge, any employee or agent of the Company or any Subsidiary, has made any contribution or other payment to any official of, or candidate for, any federal, state or foreign office in violation of any law or of the character required to be
        disclosed in the Registration Statement and the Prospectus.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(ee)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Compliance with Environmental Laws</u>.&#160; </font>Each of the Company and the Subsidiaries is (i) in compliance with any and all applicable Canadian and Unites States federal, state and local
        laws and regulations relating to health and safety, or the pollution or the protection of the environment or hazardous or toxic substances of wastes, pollutants or contaminants (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Environmental Laws</font>&#8221;), (ii) has received and is in compliance with all permits, licenses or other approvals required of them under applicable Environmental Laws to conduct its respective businesses and (iii) has
        not received notice of, and is not aware of, any actual or potential liability for damages to natural resources or the investigation or remediation of any disposal, release or existence of hazardous or toxic substances or wastes, pollutants or
        contaminants, in each case except where such non-compliance with Environmental Laws, failure to receive and comply with required permits, licenses or other approvals, or liability would not, individually or in the aggregate, have a Material Adverse
        Effect. Neither the Company nor any of the Subsidiaries has been named as a potentially responsible party under Environmental Laws requiring the Company or any of the Subsidiaries to investigate or remediate any pollutants or contaminants, except
        where such requirements would not, individually or in the aggregate, have a Material Adverse Effect, whether or not arising from transactions in the ordinary course of business.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(ff)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Forward Looking Statements</u></font>.&#160; With respect to forward-looking information contained or incorporated by reference in the Registration Statement and the Prospectus: (i) the Company
        had a reasonable basis for the forward-looking information at the time the disclosure was made; (ii) all forward-looking information is identified as such, and all such documents caution users of forward-looking information that actual results may
        vary from the forward-looking information; (iii) all future-oriented financial information and each financial outlook: (A) presents fully, fairly and correctly in all material respects the then-expected results of the operations for the periods
        covered thereby; and (B) is based on assumptions that are reasonable in the circumstances; and (iv) is limited, in the Company&#8217;s reasonable judgment, to a period for which the information in the future-oriented financial information or financial
        outlook can be reasonably estimated.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">12</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(gg)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>ERISA Compliance; Employee Plans</u></font>.&#160; Neither the Company, nor the Subsidiaries is subject to the standards of Section 302 of the United States Employee Retirement Income Security
        Act of 1974, as amended (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ERISA</font>&#8221;) with respect to each &#8220;pension plan&#8221; (as defined in Section 3(2) of ERISA), which the Company, the Subsidiaries
        sponsors or maintains, or with respect to which it has (or within the last three years had) any obligation to make contributions. Each material plan for bonus, stock purchase, profit sharing, stock option, deferred compensation, severance or
        termination pay, insurance, medical, hospital, dental, vision care, drug, sick leave, disability, salary continuation, legal benefits, unemployment benefits, vacation, incentive or otherwise contributed to, or required to be contributed to, by the
        Company or the Subsidiaries for the benefit of any current or former director, officer or employee of the Company or any Subsidiary, as applicable (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Employee






          Plans</font>&#8221;), has been maintained in all material respects in accordance with its terms in all material respects and with the requirements prescribed by any and all statutes, orders, rules and regulations that are applicable to such Employee
        Plans.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(hh)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Broker</u><u>s</u></font>.&#160; Except as otherwise<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> disclosed in the </font>Prospectus, there is no broker, finder
        or other party that is entitled to receive from the Company any brokerage or finder&#8217;s fee or other fee or commission as a result of any transactions contemplated by this Agreement.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Outstanding Loans or Other Extensions of Credit; Rating Agencies</u></font>.&#160; The Company does not have any outstanding extension of credit, in the form of a personal loan, to or for any
        director or executive officer (or equivalent thereof) of the Company except for such extensions of credit as are expressly permitted by Section 13(k) of the Exchange Act.&#160; No &#8220;nationally recognized statistical rating organization&#8221; (as that term is
        used in Rule 15c3-1(c)(2)(vi)(F) under the Exchange Act) (i) has imposed (or has informed the Company that it is considering imposing) any condition (financial or otherwise) to retain any rating assigned to the Company or any of the wholly owned
        Subsidiaries or to any securities of the Company or any of the wholly owned Subsidiaries or (ii) has indicated to the Company that it is considering (A) the downgrading, suspension, or withdrawal of, or any review (or of any potential or intended
        review) for a possible change in, any rating so assigned (including, without limitation, the placing of any of the foregoing ratings on credit watch with negative or developing implications or under review with an uncertain direction) or (B) any
        change in the outlook for any rating of the Company or any of the wholly owned Subsidiaries or any securities of the Company or any of the wholly owned Subsidiaries.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(jj)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Compliance with Laws</u></font>.&#160; Except as disclosed in the Registration Statement and the Prospectus, each of the Company, the Subsidiaries and, to the knowledge of the Company, their
        respective directors, officers and employees: (A) is in full compliance with all applicable statutes, rules, regulations, ordinances, orders, decrees and guidances including, without limitation the Cannabis Act (Canada) (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Cannabis Act</font>&#8221;); (B) has not received any correspondence or notice from any Governmental Authority (including Health Canada) alleging or asserting
        material unrectified noncompliance with any Applicable Law or any licenses, certificates, approvals, clearances, authorizations, permits and supplements or amendments thereto required by any such Applicable Law (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Authorizations</font>&#8221;); (C) possesses all Authorizations required for the conduct of its business in the markets in which it operates, and such
        Authorizations are valid and in full force and effect, and the Company, the Subsidiaries and, to the knowledge of the Company, all directors, officers and employees of each are not in violation of any term of any such Authorization; (D) has not
        received notice of any pending or threatened claim, suit, proceeding, charge, hearing, enforcement, audit, investigation, arbitration or other action from any Governmental Authority (including Health Canada) alleging that any operation or activity
        of the Company, the Subsidiaries or, to the knowledge of the Company, any of their directors, officers and/or employees is in violation of any Applicable Law or Authorizations and has no reason to believe that any such Governmental Authority is
        considering any such claim, suit, proceeding, charge, hearing, enforcement, audit, investigation, arbitration or other action; (E) has not received notice that any Governmental Authority has taken, is taking, or intends to take action to limit,
        suspend, modify or revoke any material Authorizations and has no reason to believe that any such Governmental Authority is considering taking or would have reasonable grounds to take such action; and (F) has, or has had on its behalf, filed,
        declared, obtained, maintained or submitted all reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments as required by any Applicable Law or Authorizations and to keep its licenses that are
        described or referred to in the Registration Statement and the Prospectus in good standing and that all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were materially complete and
        correct on the date filed (or were corrected or supplemented by a subsequent submission). Other than as disclosed in the Prospectus and Registration Statement, neither the Company nor any Subsidiary has received any notice or communication from
        Health Canada (or similar Governmental Authority) alleging a material unrectified defect, an issue requiring an unrectified recall or quarantine of product (whether voluntary, required or otherwise) or claim in respect of any products supplied or
        sold by the Company or any Subsidiary and, to the Company&#8217;s knowledge, there are no circumstances that would give rise to any reports, recalls, public disclosure, announcements or customer communications that are required to be made by the Company
        or any Subsidiary in respect of any products supplied or sold by the Company or any Subsidiary. All product research and development activities, quality assurance, quality control, testing, and research and analysis activities, conducted by the
        Company and each Subsidiary in connection with their business is conducted in accordance Applicable Law. Each individual employed by or associated with Company and the Subsidiaries in a key position required to hold security clearance under the
        Cannabis Act (Canada) and Cannabis Regulations thereunder in order to maintain any material Authorizations holds, or is in the process of securing, such clearance, and in the event of any failure by any such individual to obtain a required security
        clearance, the Company will ensure the prompt removal of such individual from the applicable key position. The Company and each Subsidiary is not aware of any circumstance that would affect such security clearances.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">13</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(kk)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Dividend Restrictions</u></font>.&#160; Except as disclosed in the Prospectus, no subsidiary of the Company is prohibited or restricted, directly or indirectly, from paying dividends to the
        Company, or from making any other distribution with respect to such subsidiary&#8217;s equity securities or from repaying to the Company or any other subsidiary of the Company any amounts that may from time to time become due under any loans or advances
        to such subsidiary from the Company or from transferring any property or assets to the Company or to any other subsidiary.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(ll)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Anti-Corruption and Anti-Bribery Laws</u></font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">.</font>&#160; None of the Company or any
        Subsidiary or, to the knowledge of the Company, any director, officer, employee or any agent or other person acting on behalf of the Company or any Subsidiary has, in the course of its actions for, or on behalf of, the Company or any Subsidiary (i)
        used any corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; (ii) made any direct or indirect unlawful payment to any domestic government official, &#8220;foreign official&#8221; (as
        defined in the U.S. Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (collectively, the &#8220;FCPA&#8221;)) or employee from corporate funds; (iii) violated or is in violation, of any provision of the FCPA, the
        Corruption of Foreign Public Officials Act (Canada) (the &#8220;CFPOA&#8221;) or any other or any applicable non-U.S. anti-bribery statute or regulation; or (iv) made any unlawful bribe, rebate, payoff, influence payment, kickback or other unlawful payment to
        any domestic government official, such foreign official or employee; and the Company and the Subsidiaries, and, to the knowledge of the Company, its and their other affiliates have conducted their businesses in compliance with the FCPA and CFPOA
        and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to ensure, continued compliance therewith.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(mm)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Money Laundering Laws</u></font>.&#160; The operations of the Company and the Subsidiaries are, and have been conducted at all times, in compliance with applicable financial recordkeeping and
        reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the Proceeds of Crime (Money Laundering) and Terrorist Financing Act (Canada), the money laundering statutes of all applicable jurisdictions, the
        rules and regulations thereunder and any related or similar applicable rules, regulations or guidelines, issued, administered or enforced by any Governmental Authority (collectively, the &#8220;Money Laundering Laws&#8221;) and no action, suit or proceeding by
        or before any Governmental Authority or any arbitrator involving the Company or any of the Subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(nn)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Cannabis Licenses</u></font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">.</font>&#160; The Company has provided the Agents with copies of all
        material documents and correspondence relating to the licenses issued pursuant to the Cannabis Act, as applicable (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Cannabis Licenses</font>&#8221;), to
        the Company and any Subsidiary. The Company and the Subsidiaries are in compliance, in all material respects, with the terms and conditions of all such Cannabis Licenses and all other licenses, permits and authorizations required in connection with
        their respective businesses and the Company and each Subsidiary expects to obtain, maintain and/or renew, as applicable, such Cannabis Licenses or any other required license, authorization or permit. The transactions contemplated herein (including
        the proposed use of proceeds from the offering of the Shares) are not expected to have any adverse impact on the Cannabis Licenses or require the Company or any Subsidiary to obtain any new license under the Cannabis Act or any other Applicable
        Law. The Company and the Subsidiaries have obtained all material permits or licenses required in connection with their respective businesses as currently conducted, including the Cannabis Licenses.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(oo)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Sanctions.</u></font>&#160; Neither the Company nor any Subsidiary, nor, to the knowledge of the Company, after due inquiry, any director, officer, agent, employee or Affiliate of the Company or
        any of the Subsidiaries is currently subject to any sanctions administered or enforced by the U.S. government (including, without limitation the Office of Foreign Assets Control of the U.S. Department of the Treasury (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">OFAC</font>&#8221;) or the U.S. Department of State), the United Nations Security Council, the European Union, Her Majesty&#8217;s Treasury of the United Kingdom, or other relevant sanctions
        authority (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Sanctions</font>&#8221;); nor is the Company or any of its Subsidiaries located, organized or resident in a country or territory
        that is the subject or the target of Sanctions, including, without limitation, Crimea, Cuba, Iran, North Korea, and Syria (each a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Sanctioned Country</font>&#8221;);






        and the Company will not directly or indirectly use the proceeds from the sale of the Shares, or lend, contribute or otherwise make available such proceeds to any subsidiary, or any joint venture partner or other person or entity, for the purpose
        of financing the activities of or business with any person, or in any country or territory, that at the time of such financing, is the subject or the target of Sanctions or in any other manner that will result in a violation by any person
        (including any person participating in the transaction whether as underwriter, advisor, investor or otherwise) of applicable Sanctions.&#160; &#160; For the past five years, the Company and its Subsidiaries have not knowingly engaged in and are not now
        knowingly engaged in any dealings or transactions with any person that at the time of the dealing or transaction is or was the subject or the target of Sanctions or with any Sanctioned Country.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">14</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(pp)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Sarbanes-Oxley</u></font>.&#160; Except as otherwise disclosed in the Registration Statement and Prospectus, the Company is in compliance, in all material respects, with all applicable provisions
        of the Sarbanes-Oxley Act of 2002 and the rules and regulations promulgated thereunder.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(qq)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>[Intentionally
          Omitted]</u></font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(rr)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Cybersecurity</u></font>. The Company and the Subsidiaries&#8217; information technology assets and equipment, computers, systems, networks, hardware, software, websites, applications, and
        databases (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">IT Systems and Data</font>&#8221;) are adequate for, and operate and perform in all respects as required in connection with the
        operation of the business of the Company and the Subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants, except as would not reasonably be expected to have
        a Material Adverse Effect. The Company and the Subsidiaries have implemented and maintain commercially reasonable physical, technical and administrative controls, policies, procedures, and safeguards to maintain and protect their material
        confidential information and the integrity, continuous operation, redundancy and security of all IT Systems and Data, including &#8220;Personal Data,&#8221; used in connection with their businesses. &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Personal Data</font>&#8221; means (i) a natural person&#8217;s name, street address, telephone number, e-mail address, photograph, social security number or tax identification number, driver&#8217;s license number,
        passport number, credit card number, bank information, or customer or account number; (ii) any information which would qualify as &#8220;personally identifying information&#8221; under the Federal Trade Commission Act, as amended; (iii) &#8220;personal data&#8221; as
        defined by the European Union General Data Protection Regulation; (iv) any information which would qualify as &#8220;protected health information&#8221; under the Health Insurance Portability and Accountability Act of 1996, as amended by the Health Information
        Technology for Economic and Clinical Health Act; and (v) any other piece of information that allows the identification of such natural person, or his or her family, or permits the collection or analysis of any data related to an identified person&#8217;s
        health or sexual orientation. There have been no breaches, violations, outages or unauthorized uses of or accesses to same, except for those that have been remedied without material cost or liability or the duty to notify any other person, nor any
        incidents under internal review or investigations relating to the same. The Company and the Subsidiaries have been and are presently in compliance with all Applicable Law, internal policies and contractual obligations relating to the privacy and
        security of IT Systems and Data, including Personal Data, and to the protection of such IT Systems and Data, including Personal Data, from unauthorized use, access, misappropriation or modification, except as would not reasonably be expected to,
        individually or in the aggregate, result in a Material Adverse Change.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">15</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(ss)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Compliance with Data Privacy Laws</u></font>. The Company and its Subsidiaries are, and at all prior times were, in material compliance with all applicable state and federal data privacy and
        security laws and regulations, including without limitation HIPAA, and the Company and its Subsidiaries have taken commercially reasonable actions to prepare to comply with, and since May 25, 2018, have been and currently are in compliance with,
        the European Union General Data Protection Regulation (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">GDPR</font>&#8221;) (EU 2016/679) (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Privacy Laws</font>&#8221;). To ensure compliance with the Privacy Laws, the Company and its Subsidiaries have in place, comply with, and take appropriate steps reasonably designed to ensure
        compliance in all material respects with their policies and procedures relating to data privacy and security and the collection, storage, use, disclosure, handling, and analysis of Personal Data (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Policies</font>&#8221;). The Company and its Subsidiaries have at all times made all disclosures to users or customers required by applicable laws and regulatory rules or requirements, and none of
        such disclosures made or contained in any Policy have, to the knowledge of the Company, been inaccurate or in violation of any applicable laws and regulatory rules or requirements in any material respect. The Company further certifies that neither
        it nor any subsidiary: (i) has received notice of any actual or potential liability under or relating to, or actual or potential violation of, any of the Privacy Laws, and has no knowledge of any event or condition that would reasonably be expected
        to result in any such notice; (ii) is currently conducting or paying for, in whole or in part, any investigation, remediation, or other corrective action pursuant to any Privacy Law; or (iii) is a party to any order, decree, or agreement that
        imposes any obligation or liability under any Privacy Law.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(tt)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Other Underwriting Agreements</u></font>. The Company is not a party to any agreement&#160; with an agent or underwriter for any other &#8220;at the market&#8221; or continuous equity transaction that is in
        effect as of the date of this Agreement.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(uu)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>U.S. Criminal Laws</u></font>. Neither the Company nor any of the Subsidiaries has engaged in any direct or indirect dealings or transactions in violation of U.S. federal or state criminal
        laws, including, without limitation, the Controlled Substances Act, the Racketeering Influenced and Corrupt Practices Act or the Travel Act. No action, suit or proceeding by or before any Governmental Authority involving the Company or any of the
        Subsidiaries with respect to Applicable Law is pending or, to the knowledge of the Company, threatened.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(vv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Illegal Cannabis Activities</u></font>. Neither the Company nor any of the Subsidiaries nor, to the Company&#8217;s knowledge, any director, officer or employee acting on behalf of the Company
        or any Subsidiary (collectively, &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Covered Persons</font>&#8221;) nor, to the Company&#8217;s knowledge, any entity in which the Company holds an equity interest,
        has cultivated, produced, processed, imported or distributed any cannabis or cannabinoid product or has otherwise engaged in any direct or indirect dealings or transactions, in each case, involving the purchase or sale of cannabis or cannabinoid
        product by the Company or any of its controlled Subsidiaries in or to any jurisdiction where such activity is illegal (including the United States of America, its territories and possessions, any state of the United States and the District of
        Columbia). Neither the Company nor any of its Subsidiaries nor, to the Company&#8217;s knowledge, any director of officer of the Company has any current intention to engage in any of the foregoing. Neither the Company nor any of the Subsidiaries has
        operated in or exported any cannabis or cannabinoid product to any jurisdiction except as disclosed in the Registration Statement and the Prospectus. The Company and the Subsidiaries have instituted and maintained policies and procedures reasonably
        designed to ensure that the Company and the Subsidiaries do not carry on any activities in, or distribute any products to, any jurisdiction where such activities or products do not comply with Applicable Law in all material respects, and that the
        Company does not maintain investments in any entity that carries on any activities in, or distributes any products to, any jurisdiction where such activities or products do not comply with Applicable Law in all material respects.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">16</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(ww)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Regulatory Compliance</u></font>. The Company and the Subsidiaries are in compliance in all material respects with all applicable rules, regulations and policies of Health Canada or any
        Governmental Authority in Canada or any other country with similar authority, performing similar functions and having jurisdiction over Company, the Subsidiaries or any of their businesses or property (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Regulatory Agencies</font>&#8221;).</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(xx)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Research and Development</u></font>. All product research and development activities, quality assurance, quality control, testing, and research and analysis activities, conducted by the
        Company and each Subsidiary in connection with their business is conducted in accordance with industry practices and in compliance, in all material respects, with all industry, laboratory safety, management and training standards applicable to the
        Company&#8217;s current business, and all such processes, procedures and practices, required in connection with such activities are in place as necessary and are being complied with, in all material respects.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(yy)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Recalls</u></font>. Except as disclosed in the Prospectus and Registration Statement and as would not, individually or in the aggregate, have a Material Adverse Effect, neither the Company
        nor any Subsidiary has ever received any notice or communication from any customer or Government Authority (including Health Canada) alleging a material defect, an issue requiring a material recall or quarantine of product (whether voluntary,
        required or otherwise) or claim in respect of any products supplied or sold by the Company or any Subsidiary to a customer and, to the Company&#8217;s knowledge, there are no circumstances that would give rise to any reports, recalls, public disclosure,
        announcements or customer communications that are required to be made by the Company or any Subsidiary in respect of any products supplied or sold by the Company or any Subsidiary.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(zz)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Labor Matters</u></font>. (i) The Company is not party to or bound by any collective bargaining agreement with any labor organization; (ii) there is no union representation question existing
        with respect to the employees of the Company, and, to the knowledge of the Company, after due inquiry, no union organizing activities are taking place that, could, individually or in the aggregate, have a Material Adverse Effect; (iii) to the
        knowledge of the Company, after due inquiry, no union organizing or decertification efforts are underway or threatened against the Company; (iv) no labor strike, work stoppage, slowdown or other material labor dispute is pending against the
        Company, or, to the Company&#8217;s knowledge, after due inquiry, threatened against the Company; (v) there is no worker&#8217;s compensation liability, experience or matter that could be reasonably expected to have a Material Adverse Effect; (vi) except as
        disclosed in the Registration Statement and the Prospectus, there is no material human rights or employment-related charge, complaint, grievance, investigation, unfair labor practice claim or inquiry of any kind, pending before any Governmental
        Authority against the Company that could, individually or in the aggregate, have a Material Adverse Effect; and (vii) to the knowledge of the Company, after due inquiry, no employee or agent of the Company has committed any act or omission giving
        rise to liability for any violation identified in subsection (vi) above, other than such acts or omissions that would not, individually or in the aggregate, have a Material Adverse Effect.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">17</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(aaa)&#160; <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Material Transactions</u></font>. Except as
      disclosed in the Registration Statement and the Prospectus, neither the Company nor any Subsidiary is currently party to any agreement in respect of (i) the purchase of any material property or assets or the sale, transfer or other disposition of any
      material property or assets currently owned, directly or indirectly, by the Company or the Subsidiaries whether by asset sale, transfer of shares or otherwise or (ii) the change of control of the Company or the Subsidiaries (whether by sale or
      transfer of shares or sale of all or substantially all of the property and assets of the Company or the Subsidiaries or otherwise).</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(bbb)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Well-Known Seasoned Issuer</u></font>. (A) At the original time of effectiveness of the Registration Statement, (B) at the time of the most recent amendment thereto for any purpose,
        including for the purpose of complying with Section 10(a)(3) of the Securities Act (whether such amendment was by post-effective amendment or incorporated report filed pursuant to Section 13 or 15(d) of the Exchange Act or in the form of a
        prospectus), (C) at the time the Company or any person acting on its behalf (within the meaning, for this clause only, of Rule 163(c) under the Securities Act) made any offer relating to the Shares in reliance on the exemption of Rule 163 under the
        Securities Act, and (D) as of the Applicable Time, the Company was, is and will be a &#8220;well-known seasoned issuer&#8221; (as defined in Rule 405). As used herein, &#8220;Applicable Time&#8221; means the date of this Agreement, each Representation Date, the date on
        which an Issuance Notice is given, and any date on which Shares are sold hereunder.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Any certificate signed by any officer or representative of the Company or any of its Subsidiaries and delivered to the Agents or counsel
      for the Agents in connection with an issuance of Shares shall be deemed a representation and warranty by the Company to the Agents as to the matters covered thereby on the date of such certificate.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company acknowledges that the Agents and, for purposes of the opinions to be delivered pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 4(o)</u></font> hereof, counsel to the Company and counsel to the Agents, will rely upon the accuracy and truthfulness of the foregoing representations and hereby consents to such reliance.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Section 3.&#160; ISSUANCE AND SALE OF COMMON SHARES</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Sale of Securities</u></font>.&#160; On the basis of the representations, warranties and agreements herein contained, but subject to the terms and conditions herein set forth, the Company and the
        Agents agree that the Company may from time to time seek to sell Shares through an Agent named in the applicable Issuance Notice, acting as sales agent, or directly to an Agent acting as principal (either such Agent, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Designated Agent</font>&#8221;), as follows, with an aggregate Sales Price of up to the Maximum Program Amount, based on and in accordance with Issuance Notices as the Company may
        deliver, during the Agency Period.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Mechanics of Issuances</u></font>.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Issuance Notice</u></font>.&#160; Upon the terms and subject to the conditions set forth herein, on any Trading Day during the Agency Period on which the conditions set forth in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 5(a)</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 5(b)</u></font> shall have been satisfied, the Company
        may exercise its right to request an issuance of Shares by delivering to the Designated Agent an Issuance Notice; <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">provided, however</font>, that (A)
        in no event may the Company deliver an Issuance Notice to the extent that (I) the sum of (x) the aggregate Sales Price of the requested Issuance Amount, plus (y) the aggregate Sales Price of all Shares issued under all previous Issuance Notices
        effected pursuant to this Agreement, would exceed the Maximum Program Amount; (B) prior to delivery of any Issuance Notice, the period set forth for any previous Issuance Notice shall have expired or been terminated and (C) any sales of the Shares
        shall be effected by or through the Designated Agent on any single given day and the Company shall in no event request that more than one Agent offer or sell the Shares pursuant to this Agreement on the same day.&#160; An Issuance Notice shall be
        considered delivered on the Trading Day that it is received by e&#8209;mail to the persons set forth in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Schedule A</u></font> hereto and confirmed by the Company by
        telephone (including a voicemail message to the persons so identified), with the understanding that, with adequate prior written notice, the Agents may modify the list of such persons from time to time.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">18</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(ii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Agents Efforts</u></font>.&#160; Upon the terms and subject to the conditions set forth in this Agreement, upon the receipt of an Issuance Notice, the Designated Agent will use its commercially
        reasonable efforts consistent with their normal sales and trading practices to place the Shares with respect to which the Designated Agent has agreed to act as sales agent, subject to, and in accordance with the information specified in, the
        Issuance Notice, unless the sale of the Shares described therein has been suspended, cancelled or otherwise terminated in accordance with the terms of this Agreement.&#160; For the avoidance of doubt, the Company and the Designated Agent may modify an
        Issuance Notice at any time provided they both agree in writing to any such modification.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(iii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Method of Offer and Sale</u></font>.&#160; The Shares may be offered and sold (A) in privately negotiated transactions with the consent of the Company; (B) as block transactions; or (C) by any
        other method permitted by law deemed to be an &#8220;at the market offering&#8221; as defined in Rule 415(a)(4) under the Securities Act, including sales made directly on the Principal Market.&#160; Nothing in this Agreement shall be deemed to require either party
        to agree to the method of offer and sale specified in the preceding sentence, and (except as specified in clauses (A) and (B) above) the method of placement of any Shares by the Designated Agent shall be at the Designated Agent&#8217;s discretion.&#160; The
        Company and the Agents agree that all sales of Shares hereunder shall be made only outside Canada and no sales will be made on the Toronto Stock Exchange or on any other trading markets in Canada.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(iv)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Confirmation to the Company</u></font>.&#160; If acting as sales agents hereunder, the Designated Agent will provide written confirmation to the Company no later than the opening of the Trading
        Day next following the Trading Day on which it has placed Shares hereunder setting forth the number of shares sold on such Trading Day, the corresponding Sales Price and the Issuance Price payable to the Company in respect thereof.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Settlement</u></font>.&#160; Each issuance of Shares will be settled on the applicable Settlement Date for such issuance of Shares and, subject to the provisions of <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 5</u></font>, on or before each Settlement Date, the Company will, or will cause its transfer agent to, electronically transfer the Shares being sold by crediting the Designated Agent or
        its designee&#8217;s account at The Depository Trust Company through its Deposit/Withdrawal At Custodian (DWAC) System, or by such other means of delivery as may be mutually agreed upon by the parties hereto and, upon receipt of such Shares, which in all
        cases shall be freely tradable, transferable, registered shares in good deliverable form, the Designated Agent will deliver, by wire transfer of immediately available funds, the related Issuance Price in same day funds delivered to an account
        designated by the Company prior to the Settlement Date.&#160; The Company may sell Shares to the Designated Agent as principal at a price agreed upon at each relevant time Shares are sold pursuant to this Agreement (each, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Time of Sale</font>&#8221;).</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">19</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(vi)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Suspension or Termination of Sales</u></font>.&#160; Consistent with standard market settlement practices, the Company or the Designated Agent may, upon notice to the other party hereto in
        writing or by telephone (confirmed immediately by verifiable email), suspend any sale of Shares, and the period set forth in an Issuance Notice shall immediately terminate; <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">provided, however</font>, that (A) such suspension and termination shall not affect or impair either party&#8217;s obligations with respect to any Shares placed or sold hereunder prior to the receipt of such notice; (B) if
        the Company suspends or terminates any sale of Shares after the Designated Agent confirms such sale to the Company, the Company shall still be obligated to comply with <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section






            3(b)(v)</u></font> with respect to such Shares; and (C) if the Company defaults in its obligation to deliver Shares on a Settlement Date, the Company agrees that it will hold the Designated Agent harmless against any loss, claim, damage or
        expense (including, without limitation, penalties, interest and reasonable legal fees and expenses), as incurred, arising out of or in connection with such default by the Company. The parties hereto acknowledge and agree that, in performing its
        obligations under this Agreement, the Agents may borrow Common Shares from stock lenders in the event that the Company has not delivered Shares to settle sales as required by subsection (v) above, and may use the Shares to settle or close out such
        borrowings.&#160; The Company agrees that no such notice shall be effective against the Designated Agent unless it is made to the persons identified in writing by the Designated Agent pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 3(b)(i)</u></font>.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(vii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Guarantee of Placement, Etc.</u></font>&#160; The Company acknowledges and agrees that (A) there can be no assurance that the Designated Agent will be successful in placing Shares; (B) the
        Designated Agent will incur no liability or obligation to the Company or any other Person if it does not sell Shares; and (C) the Designated Agent shall be under no obligation to purchase Shares on a principal basis pursuant to this Agreement,
        except as otherwise specifically agreed by the Designated Agent and the Company.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(viii)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Material Non-Public Information.</u></font>&#160; Notwithstanding any other provision of this Agreement, the Company and the Agents agree that the Company shall not deliver any
        Issuance Notice to the Agents, and the Agents shall not be obligated to place any Shares, during any period in which the Company is in possession of material non-public information.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Fees</u></font>.&#160; As compensation for services rendered, the Company shall pay to the Designated Agent, on the applicable Settlement Date, the Selling Commission for the applicable Issuance
        Amount (including with respect to any suspended or terminated sale pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 3(b)(vi))</u></font> by the Designated Agent deducting the Selling Commission
        from the applicable Issuance Amount.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Expenses</u></font>.&#160; The Company agrees to pay all costs, fees and expenses incurred in connection with the performance of its obligations hereunder and in connection with the transactions
        contemplated hereby, including without limitation (i) all expenses incident to the issuance and delivery of the Shares (including all printing and engraving costs); (ii) all fees and expenses of the registrar and transfer agent of the Shares; (iii)
        all necessary issue, transfer and other stamp taxes in connection with the issuance and sale of the Shares; (iv) all fees and expenses of the Company&#8217;s counsel, independent public or certified public accountants and other advisors; (v) all costs
        and expenses incurred in connection with the preparation, printing, filing, shipping and distribution of the Registration Statement (including financial statements, exhibits, schedules, consents and certificates of experts), the Prospectus, any
        Free Writing Prospectus (as defined below) prepared by or on behalf of, used by, or referred to by the Company, and all amendments and supplements thereto, and this Agreement; (vi) all filing fees, attorneys&#8217; fees and expenses incurred by the
        Company or the Agents in connection with qualifying or registering (or obtaining exemptions from the qualification or registration of) all or any part of the Shares for offer and sale under the state securities or blue sky laws or the provincial
        securities laws of Canada, and, if requested by the Agents, preparing and printing a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Blue Sky Survey</font>&#8221; or memorandum and a &#8220;Canadian wrapper,&#8221;
        and any supplements thereto, advising the Agents of such qualifications, registrations, determinations and exemptions; (vii) the reasonable fees and disbursements of the Agents&#8217; counsel, including the reasonable fees and expenses of counsel for the
        Agents in connection with, FINRA review, if any, and approval of the Agents&#8217; participation in the offering and distribution of the Shares<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">;</font> (viii) the filing fees
        incident to FINRA review, if any; (ix) the costs and expenses of the Company relating to investor presentations on any &#8220;road show&#8221; undertaken in connection with the marketing of the offering of the Shares, including, without limitation, expenses
        associated with the preparation or dissemination of any electronic road show, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged in connection with the road show presentations with
        the prior approval of the Company, travel and lodging expenses of the representatives, employees and officers of the Company and of the Agents and any such consultants, and the cost of any aircraft chartered in connection with the road show; and
        (x) the fees and expenses associated with listing the Shares on the Principal Market. The fees and disbursements of Agents&#8217; counsel pursuant to subsections (vi) and (vii) above shall not exceed $100,000 in the aggregate.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">20</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Section 4.&#160; ADDITIONAL COVENANTS</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company covenants and agrees with the Agents as follows, in addition to any other covenants and agreements made elsewhere in this
      Agreement:</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Exchange Act Compliance</u></font>.&#160; During the Agency Period, the Company shall (i) file, on a timely basis, with the Commission all reports and documents required to be filed under Section
        13, 14 or 15 of the Exchange Act in the manner and within the time periods required by the Exchange Act; and (ii) either (A) include in its quarterly reports on Form 10-Q and its annual reports on Form 10-K, a summary detailing, for the relevant
        reporting period, (1) the number of Shares sold through the Agents pursuant to this Agreement and (2) the net proceeds received by the Company from such sales or (B) prepare a prospectus supplement containing, or include in such other filing
        permitted by the Securities Act or Exchange Act (each an &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Interim Prospectus Supplement</font>&#8221;), such summary information and, at least once a quarter
        and subject to this Section 4, file such Interim Prospectus Supplement pursuant to Rule 424(b) under the Securities Act (and within the time periods required by Rule 424(b) and Rule 430B under the Securities Act).</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Securities Act Compliance</u></font>.&#160; After the date of this Agreement, the Company shall promptly advise the Agents in writing (i) of the receipt of any comments of, or requests for
        additional or supplemental information from, the Commission; (ii) of the time and date of any filing of any post-effective amendment to the Registration Statement, any Rule 462(b) Registration Statement or any amendment or supplement to the
        Prospectus, any Free Writing Prospectus; (iii) of the time and date that any post-effective amendment to the Registration Statement or any Rule 462(b) Registration Statement becomes effective; (iv) if the Registration Statement ceases to be
        available for use as a result of the Company no longer qualifying as a &#8220;well-known seasoned issuer&#8221; (as defined in Rule 405 under the Securities Act); and (v) of the issuance by the Commission of any stop order suspending the effectiveness of the
        Registration Statement or any post-effective amendment thereto, any Rule 462(b) Registration Statement or any amendment or supplement to the Prospectus or of any order preventing or suspending the use of any Free Writing Prospectus or the
        Prospectus, or of any proceedings to remove, suspend or terminate from listing or quotation the Common Shares from any securities exchange upon which they are listed for trading or included or designated for quotation, or of the threatening or
        initiation of any proceedings for any of such purposes.&#160; If the Commission shall enter any such stop order at any time, the Company will use its best efforts to obtain the lifting of such order at the earliest possible moment.&#160; Additionally, the
        Company agrees that it shall comply with the provisions of Rule 424(b) and Rule 433, as applicable, under the Securities Act and will use its reasonable efforts to confirm that any filings made by the Company under such Rule 424(b) or Rule 433 were
        received in a timely manner by the Commission.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">21</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Amendments and Supplements to the Prospectus and Other Securities Act Matters</u></font>.&#160; If any event shall occur or condition exist as a result of which it is necessary to amend or
        supplement the Prospectus so that the Prospectus does not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is
        delivered to a purchaser, not misleading, or if in the opinion of the Agents or counsel for the Agents it is otherwise necessary to amend or supplement the Prospectus to comply with applicable law, including the Securities Act, the Company agrees
        (subject to Section 4(d) and 4(f)) to promptly prepare, file with the Commission and furnish at its own expense to the Agents, amendments or supplements to the Prospectus so that the statements in the Prospectus as so amended or supplemented will
        not include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances when the Prospectus is delivered to a purchaser, be misleading or so that the
        Prospectus, as amended or supplemented, will comply with applicable law including the Securities Act.&#160; Neither the Agents&#8217; consent to, or delivery of, any such amendment or supplement shall constitute a waiver of any of the Company&#8217;s obligations
        under Sections 4(d) and 4(f).</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Agents&#8217; Review of Proposed Amendments and Supplements</u></font>.<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">&#160; </font>Prior to amending
        or supplementing the Registration Statement (including any registration statement filed under Rule 462(b) under the Securities Act) or the Prospectus (excluding any amendment or supplement through incorporation of any report filed under the
        Exchange Act), the Company shall furnish to the Agents for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each such proposed amendment or supplement, insofar as such proposed amendment or
        supplement relates to the transactions contemplated hereby, and the Company shall not file or use any such proposed amendment or supplement without the Agents&#8217; prior consent, and to file with the Commission within the applicable period specified in
        Rule 424(b) under the Securities Act any prospectus required to be filed pursuant to such Rule.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">22</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Use of Free Writing Prospectus</u></font>. Neither the Company nor the Agents has prepared, used, referred to or distributed, or will prepare, use, refer to or distribute, without the other
        party&#8217;s prior written consent, any &#8220;written communication&#8221; <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">that</font> constitutes a &#8220;free writing prospectus&#8221; as such terms are defined in Rule 405 <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">under</font> the Securities Act <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">with respect to the offering contemplated by this Agreement</font>
        (any such free writing prospectus being referred to herein as a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Free Writing Prospectus</font>&#8221;).</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Free Writing Prospectuses</u></font>.&#160; The Company shall furnish to the Agents for review, a reasonable amount of time prior to the proposed time of filing or use thereof, a copy of each
        proposed free writing prospectus or any amendment or supplement thereto to be prepared by or on behalf of, used by, or referred to by the Company and the Company shall not file, use or refer to any proposed free writing prospectus or any amendment
        or supplement thereto without the Agents&#8217; consent.&#160; The Company shall furnish to the Agents, without charge, as many copies of any free writing prospectus prepared by or on behalf of, or used by the Company, as the Agents may reasonably request.&#160;
        If at any time when a prospectus is required by the Securities Act (including, without limitation, pursuant to Rule 173(d)) to be delivered in connection with sales of the Shares (but in any event if at any time through and including the date of
        this Agreement) there occurred or occurs an event or development as a result of which any free writing prospectus prepared by or on behalf of, used by, or referred to by the Company conflicted or would conflict with the information contained in the
        Registration Statement or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at that
        subsequent time, not misleading, the Company shall promptly amend or supplement such free writing prospectus to eliminate or correct such conflict or so that the statements in such free writing prospectus as so amended or supplemented will not
        include an untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances prevailing at such subsequent time, not misleading, as the case may be; <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">provided, however</font>, that prior to amending or supplementing any such free writing prospectus, the Company shall furnish to the Agents for review, a
        reasonable amount of time prior to the proposed time of filing or use thereof, a copy of such proposed amended or supplemented free writing prospectus and the Company shall not file, use or refer to any such amended or supplemented free writing
        prospectus without the Agents&#8217; consent, which consent shall not be unreasonably delayed, withheld, or conditioned.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Filing of Agents Free Writing Prospectuses</u></font>.&#160; The Company shall not take any action that would result in the Agents or the Company being required to file with the Commission
        pursuant to Rule 433(d) under the Securities Act a free writing prospectus prepared by or on behalf of the Agents that the Agents otherwise would not have been required to file thereunder.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Copies of Registration Statement and Prospectus</u></font>.&#160; After the date of this Agreement through the last time that a prospectus is required by the Securities Act (including, without
        limitation, pursuant to Rule 173(d)) to be delivered in connection with sales of the Shares, the Company agrees to furnish the Agents with copies (which may be electronic copies) of the Registration Statement and each amendment thereto, and with
        copies of the Prospectus and each amendment or supplement thereto in the form in which it is filed with the Commission pursuant to the Securities Act or Rule 424(b) under the Securities Act, both in such quantities as the Agents may reasonably
        request from time to time; and, if the delivery of a prospectus is required under the Securities Act or under the blue sky or securities laws of any jurisdiction at any time on or prior to the applicable Settlement Date for any period set forth in
        an Issuance Notice in connection with the offering or sale of the Shares and if at such time any event has occurred as a result of which the Prospectus as then amended or supplemented would include an untrue statement of a material fact or omit to
        state any material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made when such Prospectus is delivered, not misleading, or, if for any other reason it is necessary during such same
        period to amend or supplement the Prospectus or to file under the Exchange Act any document incorporated by reference in the Prospectus in order to comply with the Securities Act or the Exchange Act, to notify the Agents and to request that the
        Agents suspend offers to sell Shares (and, if so notified, the Agents shall cease such offers as soon as practicable); and if the Company decides to amend or supplement the Registration Statement or the Prospectus as then amended or supplemented,
        to advise the Agents promptly by telephone (with confirmation in writing) and to prepare and cause to be filed promptly with the Commission an amendment or supplement to the Registration Statement or the Prospectus as then amended or supplemented
        that will correct such statement or omission or effect such compliance; provided, however, that if during such same period the Agents are required to deliver a prospectus in respect of transactions in the Shares, the Company shall promptly prepare
        and file with the Commission such an amendment or supplement.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">23</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(i)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Blue Sky Compliance</u></font>.&#160; The Company shall cooperate with the Agents and counsel for the Agents to qualify or register the Shares for sale under (or obtain exemptions from the
        application of) the state securities or blue sky laws or Canadian provincial securities laws of those jurisdictions designated by the Agents, shall comply with such laws and shall continue such qualifications, registrations and exemptions in effect
        so long as required for the distribution of the Shares.&#160; The Company shall not be required to qualify as a foreign corporation or to take any action that would subject it to general service of process in any such jurisdiction where it is not
        presently qualified or where it would be subject to taxation as a foreign corporation.&#160; The Company will advise the Agents promptly of the suspension of the qualification or registration of (or any such exemption relating to) the Shares for
        offering, sale or trading in any jurisdiction or any initiation or threat of any proceeding for any such purpose, and in the event of the issuance of any order suspending such qualification, registration or exemption, the Company shall use its best
        efforts to obtain the withdrawal thereof at the earliest possible moment.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(j)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Earnings Statement</u></font>.&#160; As soon as practicable, the Company will make generally available to its security holders and to the Agents an earnings statement (which need not be audited)
        covering a period of at least twelve months beginning with the first fiscal quarter of the Company occurring after the date of this Agreement which shall satisfy the provisions of Section 11(a) of the Securities Act and Rule 158 under the
        Securities Act.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(k)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Listing; Reservation of Shares</u></font>.&#160; (a)&#160; The Company will maintain the listing of the Shares on the Principal Market; and (b) the Company will reserve and keep available at all
        times, free of preemptive rights, Shares for the purpose of enabling the Company to satisfy its obligations under this Agreement.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(l)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Transfer Agent</u></font>.&#160; The Company shall engage and maintain, at its expense, a registrar and transfer agent for the Shares.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">24</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(m)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Due Diligence</u></font>.&#160; During the term of this Agreement, the Company will reasonably cooperate with any reasonable due diligence review conducted by the Agents in connection with the
        transactions contemplated hereby, including, without limitation, providing information and making available documents and senior corporate officers, during normal business hours and at the Company&#8217;s principal offices, as the Agents may reasonably
        request from time to time.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(n)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Representations and Warranties</u></font>.&#160; The Company acknowledges that each delivery of an Issuance Notice and each delivery of Shares on a Settlement Date shall be deemed to be (i) an
        affirmation to the Agents that the representations and warranties of the Company contained in or made pursuant to this Agreement are true and correct as of the date of such Issuance Notice or of such Settlement Date, as the case may be, as though
        made at and as of each such date, except as may be disclosed in the Prospectus (including any documents incorporated by reference therein and any supplements thereto); and (ii) an undertaking that the Company will advise the Agents if any of such
        representations and warranties will not be true and correct as of the Settlement Date for the Shares relating to such Issuance Notice, as though made at and as of each such date (except that such representations and warranties shall be deemed to
        relate to the Registration Statement and the Prospectus as amended and supplemented relating to such Shares).</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(o)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Deliverables at Triggering Event Dates; Certificates.</u></font> The Company agrees that on or prior to the date of the first Issuance Notice and, during the term of this Agreement after the
        date of the first Issuance Notice, upon:</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(A)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">the filing of the
        Prospectus or the amendment or supplement of any Registration Statement or Prospectus (other than a prospectus supplement relating solely to an offering of securities other than the Shares or a prospectus filed pursuant to Section 4(a)(ii)(B)), by
        means of a post-effective amendment, sticker or supplement, but not by means of incorporation of documents by reference into the Registration Statement or Prospectus;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(B)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">the filing with the
        Commission of an annual report on Form 10-K or a quarterly report on Form 10-Q (including any Form 10-K/A or Form 10-Q/A containing amended financial information or a material amendment to the previously filed annual report on Form 10-K or
        quarterly report on Form 10-Q), in each case, of the Company; or</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(C)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">the filing with the
        Commission of a current report on Form 8-K of the Company containing amended financial information (other than information &#8220;furnished&#8221; pursuant to Item 2.02 or 7.01 of Form 8-K or to provide disclosure pursuant to Item 8.01 of Form 8-K relating to
        reclassification of certain properties as discontinued operations in accordance with Statement of Financial Accounting Standards No. 144) that is material to the offering of securities of the Company in the Agents&#8217; reasonable discretion;</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(any such event, a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Triggering Event Date</font>&#8221;), the
      Company shall furnish the Agents (but in the case of clause (C) above only if the Agents reasonably determines that the information contained in such current report on Form 8-K of the Company is material) with a certificate as of the Triggering Event
      Date, in the form and substance satisfactory to the Agents and their counsel, substantially similar to the form previously provided to the Agents and their counsel, modified, as necessary, to relate to the Registration Statement and the Prospectus as
      amended or supplemented, (A) confirming that the representations and warranties of the Company contained in this Agreement are true and correct, (B) that the Company has performed all of its obligations hereunder to be performed on or prior to the
      date of such certificate and as to the matters set forth in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 5(a)(iii)</u></font> hereof, and (C) containing any other certification that the Agents shall
      reasonably request. The requirement to provide a certificate under this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 4(o)</u></font> shall be waived for any Triggering Event Date occurring at a time when no
      Issuance Notice is pending or a suspension is in effect, which waiver shall continue until the earlier to occur of the date the Company delivers instructions for the sale of Shares hereunder (which for such calendar quarter shall be considered a
      Triggering Event Date) and the next occurring Triggering Event Date. Notwithstanding the foregoing, if the Company subsequently decides to sell Shares following a Triggering Event Date when a suspension was in effect and did not provide the Agents
      with a certificate under this Section 4(o), then before the Company delivers the instructions for the sale of Shares or the Designated Agent sells any Shares pursuant to such instructions, the Company shall provide the Agents with a certificate in
      conformity with this Section 4(o) dated as of the date that the instructions for the sale of Shares are issued.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">25</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(p)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Legal Opinions.</u></font>&#160; On or prior to the date of the first Issuance Notice and on or prior to each Triggering Event Date with respect to which the Company is obligated to deliver a
        certificate pursuant to Section 4(o) for which no waiver is applicable and excluding the date of this Agreement, a negative assurances letter and the written legal opinion of DLA Piper LLP (US), counsel to the Company, and Goodwin Procter LLP,
        counsel to the Agents, each dated the date of delivery, in form and substance reasonably satisfactory to Agents and their counsel, substantially similar to the form previously provided to the Agents and their counsel, modified, as necessary, to
        relate to the Registration Statement and the Prospectus as then amended or supplemented. In lieu of such opinions for subsequent periodic filings, in the discretion of the Agents, the Company may furnish a reliance letter from such counsel to the
        Agents, permitting the Agents to rely on a previously delivered opinion letter, modified as appropriate for any passage of time or Triggering Event Date <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(except that
          statements in such prior opinion shall be deemed to relate to the Registration Statement and the Prospectus as amended or supplemented as of such Triggering Event Date)</font>.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(q)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Comfort Letter</u></font>. On or prior to the date of the first Issuance Notice and on or prior to each Triggering Event Date with respect to which the Company is obligated to deliver a
        certificate pursuant to Section 4(o) for which no waiver is applicable and excluding the date of this Agreement, the Company shall cause PricewaterhouseCoopers LLP, the independent registered public accounting firm who has audited the financial
        statements included or incorporated by reference in the Registration Statement, to furnish the Agents a comfort letter, dated the date of delivery, in form and substance reasonably satisfactory to the Agents and their counsel, substantially similar
        to the form previously provided to the Agents and their counsel; provided, however, that any such comfort letter will only be required on the Triggering Event Date specified to the extent that it contains financial statements filed with the
        Commission under the Exchange Act and incorporated or deemed to be incorporated by reference into a Prospectus.&#160; If requested by the Agents, the Company shall also cause a comfort letter to be furnished to the Agents within ten (10) Trading Days of
        the date of occurrence of any material transaction or event requiring the filing of a current report on Form 8-K containing material amended financial information of the Company, including the restatement of the Company&#8217;s financial statements. The
        Company shall be required to furnish no more than one comfort letter hereunder per calendar quarter.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">26</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(r)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Secretary&#8217;s Certificate</u></font>. On or prior to the date of the first Issuance Notice and on or prior to each Triggering Event Date, the Company shall furnish the Agents a certificate
        executed by the Secretary of the Company, signing in such capacity, dated the date of delivery (i) certifying that attached thereto are true and complete copies of the resolutions duly adopted by the Board of Directors of the Company authorizing
        the execution and delivery of this Agreement and the consummation of the transactions contemplated hereby (including, without limitation, the issuance of the Shares pursuant to this Agreement), which authorization shall be in full force and effect
        on and as of the date of such certificate, (ii) certifying and attesting to the office, incumbency, due authority and specimen signatures of each Person who executed this Agreement for or on behalf of the Company, and (iii) containing any other
        certification that the Agents shall reasonably request.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(s)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Agents&#8217; Own Account; Clients&#8217; Account</u></font>.&#160; The Company consents to the Agents trading, in compliance with applicable law, in the Common Shares for the Agents&#8217; own accounts and for
        the accounts of their clients at the same time as sales of the Shares occur pursuant to this Agreement.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(t)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Investment Limitation</u></font>.&#160; The Company shall not invest, or otherwise use the proceeds received by the Company from its sale of the Shares in such a manner as would require the
        Company or any of its Subsidiaries to register as an investment company under the Investment Company Act.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(u)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Market Activities</u></font>.&#160; The Company will not take, directly or indirectly, any action designed to or that might be reasonably expected to cause or result in stabilization or
        manipulation of the price of the Shares or any other reference security, whether to facilitate the sale or resale of the Shares or otherwise, and the Company will, and shall cause each of its affiliates to, comply with all applicable provisions of
        Regulation M.&#160; If the limitations of Rule 102 of Regulation M (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Rule 102</font>&#8221;) do not apply with respect to the Shares or any other reference
        security pursuant to any exception set forth in Section (d) of Rule 102, then promptly upon notice from the Agents (or, if later, at the time stated in the notice), the Company will, and shall cause each of its affiliates to, comply with Rule 102
        as though such exception were not available but the other provisions of Rule 102 (as interpreted by the Commission) did apply. The Company shall promptly notify the Agents if it no longer meets the requirements set forth in Section (d) of Rule 102.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(v)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Notice of Other Sale</u></font>.&#160; Without the written consent of the Agents, the Company will not, directly or indirectly, offer to sell, sell, contract to sell, grant any option to sell or
        otherwise dispose of any Common Shares or securities convertible into or exchangeable for Common Shares (other than Shares hereunder), warrants or any rights to purchase or acquire Common Shares, during the period beginning on the third Trading Day
        immediately prior to the date on which any Issuance Notice is delivered to the Agents hereunder and ending on the third Trading Day immediately following the Settlement Date with respect to Shares sold pursuant to such Issuance Notice; and will not
        directly or indirectly enter into any other &#8220;at the market&#8221; or continuous equity transaction offer to sell, sell, contract to sell, grant any option to sell or otherwise dispose of any Common Shares (other than the Shares offered pursuant to this
        Agreement) or securities convertible into or exchangeable for Common Shares, warrants or any rights to purchase or acquire, Common Shares prior to the termination of this Agreement; provided, however, that such restrictions will not be required in
        connection with the Company&#8217;s (i) issuance or sale of Common Shares, options to purchase Common Shares or Common Shares issuable upon the exercise of options or other equity awards pursuant to any employee or director share option, incentive or
        benefit plan, share purchase or ownership plan, long-term incentive plan, dividend reinvestment plan, inducement award under Nasdaq rules or other compensation plan of the Company or its Subsidiaries, as in effect on the date of this Agreement,
        (ii) issuance or sale of Common Shares issuable upon exchange, conversion or redemption of securities or the exercise or vesting of warrants, options or other equity awards outstanding at the date of this Agreement, and (iii) modification of any
        outstanding options, warrants of any rights to purchase or acquire Common Shares.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">27</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Section 5.&#160; CONDITIONS TO DELIVERY OF ISSUANCE NOTICES AND TO SETTLEMENT</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Conditions Precedent to the Right of the Company to Deliver an Issuance Notice and the Obligation of the Agents to Sell Shares</u></font>.&#160; The right of the Company to deliver an Issuance
        Notice hereunder is subject to the satisfaction, on the date of delivery of such Issuance Notice, and the obligation of the Designated Agent to use its commercially reasonable efforts to place Shares during the applicable period set forth in the
        Issuance Notice is subject to the satisfaction, on each Trading Day during the applicable period set forth in the Issuance, of each of the following conditions:</font></div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zdd643cdac2644f14b01b46ce5cf31e3f" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Accuracy of the Company&#8217;s Representations and Warranties; Performance by the Company</u></font>.&#160;






              The Company shall have delivered the certificate required to be delivered pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 4(o)</u></font> on or before the date on which delivery of such
              certificate is required pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 4(o)</u></font>. The Company shall have performed, satisfied and complied with all covenants, agreements and
              conditions required by this Agreement to be performed, satisfied or complied with by the Company at or prior to such date, including, but not limited to, the covenants contained in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 4(p)</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 4(q)</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section






                  4(r)</u></font>.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z84aa05cd3a09486d91cc6370d1dc1d90" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Injunction</u></font>.&#160; No statute, rule, regulation, executive order, decree, ruling
              or injunction shall have been enacted, entered, promulgated or endorsed by any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority over the matters contemplated hereby that prohibits
              or directly and materially adversely affects any of the transactions contemplated by this Agreement, and no proceeding shall have been commenced that may have the effect of prohibiting or materially adversely affecting any of the transactions
              contemplated by this Agreement.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zff32fb6694ff4fed9f84a5bd7a239f23" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iii)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Material Adverse Changes</u></font>. Except as disclosed in the Prospectus and the Time
              of Sale Information, (a) in the judgment of the Agents there shall not have occurred any Material Adverse Change; and (b) <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">there shall not have occurred any
                downgrading, nor shall any notice have been given of any intended or potential downgrading or of any review for a possible change that does not indicate the direction of the possible change, in the rating accorded any securities of the
                Company or any of its Subsidiaries by any &#8220;nationally recognized statistical rating organization&#8221; as such term is defined for purposes of Section 3(a)(62) of the Exchange Act.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">28</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zb26867399100436096757e2ba7c4d95a" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 36pt;"><br>
          </td>
          <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(iv)</td>
          <td style="width: auto; vertical-align: top; text-align: justify;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Suspension of Trading in or Delisting of Common Shares; Other Events</u></font>.&#160; The
              trading of the Common Shares (including without limitation the Shares) shall not have been suspended by the Commission, the Principal Market or FINRA and the Common Shares (including without limitation the Shares) shall have been approved for
              listing or quotation on and shall not have been delisted from the Nasdaq Stock Market, the New York Stock Exchange or any of their constituent markets.&#160; There shall not have occurred (and be continuing in the case of occurrences under clauses
              (i) and (ii) below) any of the following:&#160; (<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">i) trading or quotation in any of the Company&#8217;s securities shall have been suspended or limited by the Commission or by
                the </font>Principal Market <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">or trading in securities generally on either the </font>Principal Market <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">shall have been suspended or limited, or minimum or maximum prices shall have been generally established on any of such stock exchanges by the Commission or the FINRA; (ii) a general banking moratorium shall have been
                declared by any of federal or New York, authorities; or (iii) there shall have occurred any outbreak or escalation of national or international hostilities or any crisis or calamity, or any change in the United States or international
                financial markets, or any substantial change or development involving a prospective substantial change in United States&#8217; or international political, financial or economic conditions, as in the judgment of the Agents is material and adverse
                and makes it impracticable to market the Shares in the manner and on the terms described in the Prospectus or to enforce contracts for the sale of securities.</font></div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Documents Required to be Delivered on each Issuance Notice Date</u></font>.&#160; The Designated Agent&#8217;s obligation to use its commercially reasonable efforts to place Shares hereunder shall
        additionally be conditioned upon the delivery to the Agents on or before the Issuance Notice Date of a certificate in form and substance reasonably satisfactory to the Designated Agent, executed by the <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Chief Executive </font>Officer<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">, President or Chief Financial Officer</font> of the Company, to the effect that all conditions to the
        delivery of such Issuance Notice shall have been satisfied as at the date of such certificate (which certificate shall not be required if the foregoing representations shall be set forth in the Issuance Notice).</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Misstatement or Material Omission</u></font>. Agents shall not have advised the Company that the Registration Statement, the Prospectus or the Times of Sales Information, or any amendment
        or supplement thereto, contains an untrue statement of fact that in the Agents&#8217; reasonable opinion is material, or omits to state a fact that in the Agents&#8217; reasonable opinion is material and is required to be stated therein or is necessary to make
        the statements therein not misleading.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">29</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Section 6.&#160; INDEMNIFICATION AND CONTRIBUTION</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Indemnification of the Agents</u></font>.&#160; The Company agrees to indemnify and hold harmless the Agents, their respective officers and employees, and each person, if any, who controls an
        Agent within the meaning of the Securities Act or the Exchange Act against any loss, claim, damage, liability or expense, as incurred, to which such Agent or such officer, employee or controlling person may become subject, under the Securities Act,
        the Exchange Act, other federal or state statutory law or regulation, or the laws or regulations of foreign jurisdictions where Shares have been offered or sold or at common law or otherwise (including in settlement of any litigation), insofar as
        such loss, claim, damage, liability or expense (or actions in respect thereof as contemplated below) arises out of or is based upon (i) any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement, or
        any amendment thereto, including any information deemed to be a part thereof pursuant to Rule 430B under the Securities Act, or the omission or alleged omission therefrom of a material fact required to be stated therein or necessary to make the
        statements therein not misleading; (ii) any untrue statement or alleged untrue statement of a material fact contained in any Free Writing Prospectus that the Company has used, referred to or filed, or is required to file, pursuant to Rule 433(d) of
        the Securities Act or the Prospectus (or any amendment or supplement thereto), or the omission or alleged omission therefrom of a material fact necessary in order to make the statements therein, in the light of the circumstances under which they
        were made, not misleading;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">&#160;</font>or (iii) any act or failure to act or any alleged act or failure to act by the Agents in connection with, or relating in any manner to,
        the Common Shares or the offering contemplated hereby, and which is included as part of or referred to in any loss, claim, damage, liability or action arising out of or based upon any matter covered by clause (i) or (ii) above, provided that the
        Company shall not be liable under this clause (iii) to the extent that a court of competent jurisdiction shall have determined by a final judgment that such loss, claim, damage, liability or action resulted directly from any such acts or failures
        to act undertaken or omitted to be taken by the Agents through their bad faith or willful misconduct, and to reimburse the Agents and each such officer, employee and controlling person for any and all expenses (including the fees and disbursements
        of counsel chosen by the Agents) as such expenses are reasonably incurred by the Agents or such officer, employee or controlling person in connection with investigating, defending, settling, compromising or paying any such loss, claim, damage,
        liability, expense or action; provided, however, that the foregoing indemnity agreement shall not apply to any loss, claim, damage, liability or expense to the extent, but only to the extent, arising out of or based upon any untrue statement or
        alleged untrue statement or omission or alleged omission made in reliance upon and in conformity with written information furnished to the Company by the Agents expressly for use in the Registration Statement, any such Free Writing Prospectus or
        the Prospectus (or any amendment or supplement thereto), it being understood and agreed that the only such information furnished by the Agents to the Company consists of the information set forth in the first sentence of the ninth paragraph under
        the caption &#8220;Plan of Distribution&#8221; in the Prospectus.&#160; The indemnity agreement set forth in this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(a)</u></font>&#160; shall be in addition to any liabilities that
        the Company may otherwise have.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Notifications and Other Indemnification Procedures</u></font>.&#160; Promptly after receipt by an indemnified party under this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font> of notice of the commencement of any action, such indemnified party will, if a claim in respect thereof is to be made against an indemnifying party under this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font>, notify the indemnifying party in writing of the commencement thereof, but the omission so to notify the indemnifying party will not relieve it from any liability which it may have to any
        indemnified party for contribution or otherwise than under the indemnity agreement contained in this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font> or to the extent it is not prejudiced as a
        proximate result of such failure.&#160; In case any such action is brought against any indemnified party and such indemnified party seeks or intends to seek indemnity from an indemnifying party, the indemnifying party will be entitled to participate in,
        and, to the extent that it shall elect, jointly with all other indemnifying parties similarly notified, by written notice delivered to the indemnified party promptly after receiving the aforesaid notice from such indemnified party, to assume the
        defense thereof with counsel reasonably satisfactory to such indemnified party; provided, however, if the defendants in any such action include both the indemnified party and the indemnifying party and the indemnified party shall have reasonably
        concluded that a conflict may arise between the positions of the indemnifying party and the indemnified party in conducting the defense of any such action or that there may be legal defenses available to it and/or other indemnified parties which
        are different from or additional to those available to the indemnifying party, the indemnified party or parties shall have the right to select separate counsel to assume such legal defenses and to otherwise participate in the defense of such action
        on behalf of such indemnified party or parties.&#160; Upon receipt of notice from the indemnifying party to such indemnified party of such indemnifying party&#8217;s election so to assume the defense of such action and approval by the indemnified party of
        counsel, the indemnifying party will not be liable to such indemnified party under this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font> for any legal or other expenses subsequently incurred by
        such indemnified party in connection with the defense thereof unless (i) the indemnified party shall have employed separate counsel in accordance with the proviso to the preceding sentence (it being understood, however, that the indemnifying party
        shall not be liable for the fees and expenses of more than one separate counsel (together with local counsel), representing the indemnified parties who are parties to such action), which counsel (together with any local counsel) for the indemnified
        parties shall be selected by the Agents (in the case of counsel for the indemnified parties referred to in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(a)</u></font><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160;</font>above), (ii) the indemnifying party shall not have employed counsel satisfactory to the indemnified party to represent the indemnified party within a reasonable time after
        notice of commencement of the action or (iii) the indemnifying party has authorized in writing the employment of counsel for the indemnified party at the expense of the indemnifying party, in each of which cases the fees and expenses of counsel
        shall be at the expense of the indemnifying party and shall be paid as they are incurred.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">30</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Settlements</u></font>.&#160; The indemnifying party under this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font> shall not be liable for any
        settlement of any proceeding effected without its written consent, but if settled with such consent or if there be a final judgment for the plaintiff, the indemnifying party agrees to indemnify the indemnified party against any loss, claim, damage,
        liability or expense by reason of such settlement or judgment.&#160; Notwithstanding the foregoing sentence, if at any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of
        counsel as contemplated by <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(b)</u></font> hereof, the indemnifying party agrees that it shall be liable for any settlement of any proceeding effected without
        its written consent if (i) such settlement is entered into more than 30 days after receipt by such indemnifying party of the aforesaid request; and (ii) such indemnifying party shall not have reimbursed the indemnified party in accordance with such
        request prior to the date of such settlement.&#160; No indemnifying party shall, without the prior written consent of the indemnified party, effect any settlement, compromise or consent to the entry of judgment in any pending or threatened action, suit
        or proceeding in respect of which any indemnified party is or could have been a party and indemnity was or could have been sought hereunder by such indemnified party, unless such settlement, compromise or consent includes an unconditional release
        of such indemnified party from all liability on claims that are the subject matter of such action, suit or proceeding.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Contribution</u></font>.&#160; If the indemnification provided for in this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font> is for any reason
        held to be unavailable to or otherwise insufficient to hold harmless an indemnified party in respect of any losses, claims, damages, liabilities or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount
        paid or payable by such indemnified party, as incurred, as a result of any losses, claims, damages, liabilities or expenses referred to therein (i) in such proportion as is appropriate to reflect the relative benefits received by the Company, on
        the one hand, and the applicable Agent(s), on the other hand, from the offering of the Shares pursuant to this Agreement; or (ii) if the allocation provided by clause (i) above is not permitted by applicable law, in such proportion as is
        appropriate to reflect not only the relative benefits referred to in clause (i) above but also the relative fault of the Company, on the one hand, and the applicable Agent(s), on the other hand, in connection with the statements or omissions which
        resulted in such losses, claims, damages, liabilities or expenses, as well as any other relevant equitable considerations.&#160; The relative benefits received by the Company, on the one hand, and the applicable Agent(s), on the other hand, in
        connection with the offering of the Shares pursuant to this Agreement shall be deemed to be in the same respective proportions as the total gross proceeds from the offering of the Shares (before deducting expenses) received by the Company bear to
        the total commissions received by the applicable Agent(s).&#160; The relative fault of the Company, on the one hand, and the applicable Agent(s), on the other hand, shall be determined by reference to, among other things, whether any such untrue or
        alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company, on the one hand, or the applicable Agent(s), on the other hand, and the parties&#8217; relative intent,
        knowledge, access to information and opportunity to correct or prevent such statement or omission.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">31</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The amount paid or payable by a party as a result of the losses, claims, damages, liabilities and expenses referred to above shall be
      deemed to include, subject to the limitations set forth in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(b)</u></font>, any legal or other fees or expenses reasonably incurred by such party in connection
      with investigating or defending any action or claim.&#160; The provisions set forth in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(b)</u></font> with respect to notice of commencement of any action shall
      apply if a claim for contribution is to be made under this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(d)</u></font>; <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-style: italic;">provided, however,</font> that no additional notice shall be required with respect to any action for which notice has been given under <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section
          6(b)</u></font> for purposes of indemnification.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company and the Agents agree that it would not be just and equitable if contribution pursuant to this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(d)</u></font> were determined by pro rata allocation or by any other method of allocation which does not take account of the equitable considerations referred to in this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(d)</u></font>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Notwithstanding the provisions of this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(d)</u></font>,
      an Agent shall not be required to contribute any amount in excess of the agent fees received by such Agent in connection with the offering contemplated hereby.&#160; No person guilty of fraudulent misrepresentation (within the meaning of Section 11(f) of
      the Securities Act) shall be entitled to contribution from any person who was not guilty of such fraudulent misrepresentation.&#160; For purposes of this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6(d)</u></font>,
      each officer and employee of the Agents and each person, if any, who controls the Agents within the meaning of the Securities Act or the Exchange Act shall have the same rights to contribution as the Agents, and each director of the Company, each
      officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company with the meaning of the Securities Act and the Exchange Act shall have the same rights to contribution as the Company.</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">32</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: left;"><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Section 7.&#160; TERMINATION &amp; SURVIVAL</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Term</u></font>.&#160; Subject to the provisions of this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 7</u></font>, the term of this Agreement shall
        continue from the date of this Agreement until the end of the Agency Period, unless earlier terminated by the parties to this Agreement pursuant to this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 7</u></font>.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Termination; Survival Following Termination</u></font>.</font></div>
    <div style="text-align: justify; text-indent: 36pt;">
      <div><br>
      </div>
      <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

          <tr>
            <td style="width: 36pt;"><br>
            </td>
            <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(i)</td>
            <td style="width: auto; vertical-align: top; text-align: justify;">
              <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Each Agent may terminate this Agreement, solely with respect to its rights and obligations hereunder, and the Company may terminate this Agreement, with respect to
                one or both Agents, prior to the end of the Agency Period, by giving written notice as required by this Agreement, upon ten (10) Trading Days&#8217; notice to the other parties to this Agreement; provided that, (A) if the Company terminates this
                Agreement after an Agent confirms to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">the Company any sale of Shares</font>, the Company shall remain obligated to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">comply with <u>Section 3(b)(v)</u> with respect to such Shares</font> and (B) <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 2</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font>, <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 7</u></font> and <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 8</u></font> shall survive termination of this Agreement.&#160; If termination shall occur prior to the Settlement Date for any sale of Shares, such sale shall nevertheless settle in
                accordance with the terms of this Agreement.&#160; For the avoidance of doubt, the termination by one Agent of its rights and obligations under this Agreement pursuant to this Section 7(b)(i) shall not affect the rights and obligations of the
                other Agent under this Agreement.</div>
            </td>
          </tr>

      </table>
      <div><br>
      </div>
      <div>
        <div><br>
        </div>
        <table cellspacing="0" cellpadding="0" class="DSPFListTable" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

            <tr>
              <td style="width: 36pt;"><br>
              </td>
              <td style="width: 36pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">(ii)</td>
              <td style="width: auto; vertical-align: top; text-align: justify;">
                <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In addition to the survival provision of <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 7(b)(i)</u></font>, the respective
                  indemnities, agreements, representations, warranties and other statements of the Company, of its officers and of the Agents set forth in or made pursuant to this Agreement will remain in full force and effect, regardless of any
                  investigation made by or on behalf of the Agents or the Company or any of its or their partners, officers or directors or any controlling person, as the case may be, and, anything herein to the contrary notwithstanding, will survive
                  delivery of and payment for the Shares sold hereunder and any termination of this Agreement.</div>
              </td>
            </tr>

        </table>
        <div><br>
        </div>
      </div>
      <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"> </font></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Section 8.&#160; MISCELLANEOUS</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(a)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Press Releases and Disclosure</u></font>.&#160; The Company may issue a press release describing the material terms of the transactions contemplated hereby as soon as practicable following the
        date of this Agreement, and may file with the Commission a Current Report on Form 8&#8209;K, with this Agreement attached as an exhibit thereto, describing the material terms of the transactions contemplated hereby, and the Company shall consult with the
        Agents prior to making such disclosures, and the parties hereto shall use all commercially reasonable efforts, acting in good faith, to agree upon a text for such disclosures that is reasonably satisfactory to all parties hereto. No party hereto
        shall issue thereafter any press release or like public statement (including, without limitation, any disclosure required in reports filed with the Commission pursuant to the Exchange Act) related to this Agreement or any of the transactions
        contemplated hereby without the prior written approval of the other party hereto, except as may be necessary or appropriate in the reasonable opinion of the party seeking to make disclosure to comply with the requirements of applicable law or stock
        exchange rules. If any such press release or like public statement is so required, the party making such disclosure shall consult with the other party prior to making such disclosure, and the parties shall use all commercially reasonable efforts,
        acting in good faith, to agree upon a text for such disclosure that is reasonably satisfactory to all parties hereto.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">33</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(b)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>No Advisory or Fiduciary Relationship</u></font>.<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">&#160; </font>The Company acknowledges and agrees
        that (i) the transactions contemplated by this Agreement, including the determination of any fees, are arm&#8217;s-length commercial transactions between the Company and the Agents, (ii) when acting as principals under this Agreement, the Agents are and
        have been acting solely as principals and are not the agents or fiduciaries of the Company, or its stockholders, creditors, employees or any other party, (iii) the Agents have not assumed nor will assume an advisory or fiduciary responsibility in
        favor of the Company with respect to the transactions contemplated hereby or the process leading thereto (irrespective of whether the Agents have advised or are currently advising the Company on other matters) and the Agents do not have any
        obligation to the Company with respect to the transactions contemplated hereby except the obligations expressly set forth in this Agreement, (iv) the Agents and their respective affiliates may be engaged in a broad range of transactions that
        involve interests that differ from those of the Company, and (v) the Agents have not provided any legal, accounting, regulatory or tax advice with respect to the transactions contemplated hereby and the Company has consulted its own legal,
        accounting, regulatory and tax advisors to the extent it deemed appropriate.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(c)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Research Analyst Independence</u></font>.&#160; The Company acknowledges that the Agents&#8217; research analysts and research departments are required to and should be independent from their
        respective investment banking divisions and are subject to certain regulations and internal policies, and as such the Agents&#8217; research analysts may hold views and make statements or investment recommendations and/or publish research reports with
        respect to the Company or the offering that differ from the views of their respective investment banking divisions.&#160; The Company understands that the Agents are full service securities firms and as such from time to time, subject to applicable
        securities laws, may effect transactions for their own accounts or the accounts of their customers and hold long or short positions in debt or equity securities of the companies that may be the subject of the transactions contemplated by this
        Agreement.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(d)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Notices</u></font>.&#160; All communications hereunder shall be in writing and shall be mailed, hand delivered or telecopied and confirmed to the parties hereto as follows:</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">If to the </font>Agents<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">:</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Jefferies LLC</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">520 Madison Avenue</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">New York, NY 10022</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attention:&#160; General Counsel</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Canaccord Genuity LLC</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">99 High Street, 12<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Boston, MA 02110</div>
    <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attention:&#160; General Counsel</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">34</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">with a copy (which shall not constitute notice) to:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Goodwin Procter LLP</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The New York Times Building</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">620 Eighth Avenue</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">New York, NY 10018</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attention: <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Thomas S. Levato</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If to the Company:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Brands, Inc.</div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">265 Talbot Street West</div>
    <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Leamington, Ontario, Canada</div>
    <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attention: <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Chief Financial Officer</font></div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">with a copy (which shall not constitute notice) to:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -36pt; margin-left: 54pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">DLA Piper LLP (US)</div>
    <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1251 Avenue of the Americas</div>
    <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">New York, NY 10020</div>
    <div style="text-align: left; margin-left: 18pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attention: <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Stephen P. Alicanti</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Any party hereto may change the address for receipt of communications by giving written notice to the others in accordance with this <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 8(d)</u></font>.</div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(e)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Successors</u></font>.&#160; This Agreement will inure to the benefit of and be binding upon the parties hereto, and to the benefit of the employees, officers and directors and controlling
        persons referred to in <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 6</u></font>, and in each case their respective successors, and no other person will have any right or obligation hereunder.&#160; The term
        &#8220;successors&#8221; shall not include any purchaser of the Shares as such from the Agents merely by reason of such purchase.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(f)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Partial Unenforceability</u></font>.&#160; The invalidity or unenforceability of any Article, Section, paragraph or provision of this Agreement shall not affect the validity or enforceability of
        any other Article, Section, paragraph or provision hereof.&#160; If any Article, Section, paragraph or provision of this Agreement is for any reason determined to be invalid or unenforceable, there shall be deemed to be made such minor changes (and only
        such minor changes) as are necessary to make it valid and enforceable.</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(g)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Governing Law Provisions</u></font>.&#160; This Agreement shall be governed by and construed in accordance with the internal laws of the State of New York applicable to agreements made and to be
        performed in such state.&#160; Any legal suit, action or proceeding arising out of or based upon this Agreement or the transactions contemplated hereby (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Related






          Proceedings</font>&#8221;) may be instituted in the federal courts of the United States of America located in the Borough of Manhattan in the City of New York or the courts of the State of New York in each case located in the Borough of Manhattan in
        the City of New York (collectively, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Specified Courts</font>&#8221;), and each party irrevocably submits to the exclusive jurisdiction (except for
        proceedings instituted in regard to the enforcement of a judgment of any such court (a &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Related Judgment</font>&#8221;), as to which such jurisdiction is
        non-exclusive) of such courts in any such suit, action or proceeding.&#160; Service of any process, summons, notice or document by mail to such party&#8217;s address set forth above shall be effective service of process for any suit, action or other
        proceeding brought in any such court.&#160; The parties irrevocably and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to
        plead or claim in any such court that any such suit, action or other proceeding brought in any such court has been brought in an inconvenient forum.</font></div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">35</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">(h)</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>General Provisions</u></font>.&#160; This Agreement constitutes the entire agreement of the parties to this Agreement and supersedes all prior written or oral and all contemporaneous oral
        agreements, understandings and negotiations with respect to the subject matter hereof.&#160; This Agreement may be executed in two or more counterparts, each one of which shall be an original, with the same effect as if the signatures thereto and hereto
        were upon the same instrument, and may be delivered by facsimile transmission or by electronic delivery of a portable document format (PDF) file.&#160; Any signature to this Agreement may be delivered by facsimile, electronic mail (including pdf) or any
        electronic signature complying with the U.S. federal ESIGN Act of 2000 or the New York Electronic Signature and Records Act or other transmission method and any counterpart so delivered shall be deemed to have been duly and validly delivered and be
        valid and effective for all purposes to the fullest extent permitted by applicable law.&#160; This Agreement may not be amended or modified unless in writing by all of the parties hereto, and no condition herein (express or implied) may be waived unless
        waived in writing by each party whom the condition is meant to benefit.&#160; The Article and Section headings herein are for the convenience of the parties only and shall not affect the construction or interpretation of this Agreement.</font></div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">[Signature Page Immediately Follows]</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div style="text-align: center;" id="DSPFPageNumberArea"><font style="font-family: 'Times New Roman'; font-size: 10pt; color: #000000; font-weight: normal; font-style: normal;" id="DSPFPageNumber">36</font></div>
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">If the foregoing is in accordance with your understanding of our agreement, kindly sign and return to the Company the enclosed copies
      hereof, whereupon this instrument, along with all counterparts hereof, shall become a binding agreement in accordance with its terms</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z389049ececaf422e9c90df9bcd6958ee" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="3">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Very truly yours,</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="vertical-align: top;" colspan="3">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">TILRAY BRANDS, INC.</div>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 6%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
          </td>
          <td style="width: 6%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">/s/ Carl Merton<br>
          </td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name:</div>
          </td>
          <td style="width: 38%; vertical-align: top;">Carl Merton</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title:</div>
          </td>
          <td style="width: 38%; vertical-align: top;">Chief Financial Officer<br>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The foregoing Agreement is hereby confirmed and accepted by the Agents in New York, New York as of the date first above written.</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zc97a4a913e574a4c816c121d9bbc3a6e" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="vertical-align: top;" colspan="3">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">JEFFERIES LLC</div>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
          </td>
          <td style="width: 6%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">/s/ Ariella Tolkin<br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name:</div>
          </td>
          <td style="width: 38%; vertical-align: top;">Ariella Tolkin<br>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title:</div>
          </td>
          <td style="width: 38%; vertical-align: top;">Managing Director<br>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="vertical-align: top;" colspan="3">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">CANACCORD GENUITY LLC</div>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
          </td>
          <td style="width: 6%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" rowspan="1" colspan="2">/s/ Jennifer Pardi<br>
          </td>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name:</div>
          </td>
          <td style="width: 38%; vertical-align: top;">Jennifer Pardi</td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title:</div>
          </td>
          <td style="width: 38%; vertical-align: top;">Managing Director<br>
          </td>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">EXHIBIT A</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ISSUANCE NOTICE</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">[Date]</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Jefferies LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">520 Madison Avenue</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">New York, New York 10022</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Canaccord Genuity LLC</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">99 High Street, 12<sup style="vertical-align: text-top; line-height: 1; font-size: smaller;">th</sup> Floor</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Boston, MA 02110</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Attn: [__________]</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Reference is made to the Sales Agreement between Tilray Brands, Inc. (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Company</font>&#8221;) and Jefferies LLC and Canaccord Genuity LLC (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Agents</font>&#8221;) dated as of March 3, 2022.&#160; The Company confirms
      that all conditions to the delivery of this Issuance Notice are satisfied as of the date hereof.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Date of Delivery of Issuance Notice (determined pursuant to <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;"><u>Section 3(b)(i)</u></font>):






      _______________________</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Issuance Amount (equal to the total Sales Price for such Shares):</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z8a7b51753ead4aea889a5c83ce577944" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 37.48%; vertical-align: top; text-align: right; padding-bottom: 2px;">&#160;$</td>
          <td style="width: 27.1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><br>
            </div>
          </td>
          <td style="width: 35.42%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top;">&#160;</td>
          <td style="width: 27.1%; vertical-align: top;">&#160;</td>
          <td style="width: 35.42%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Number of days in selling period:</div>
          </td>
          <td style="width: 27.1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 35.42%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top;">&#160;</td>
          <td style="width: 27.1%; vertical-align: top;">&#160;</td>
          <td style="width: 35.42%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">First date of selling period:</div>
          </td>
          <td style="width: 27.1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 35.42%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top;">&#160;</td>
          <td style="width: 27.1%; vertical-align: top;">&#160;</td>
          <td style="width: 35.42%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Last date of selling period:</div>
          </td>
          <td style="width: 27.1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 35.42%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top;">&#160;</td>
          <td style="width: 27.1%; vertical-align: top;">&#160;</td>
          <td style="width: 35.42%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 64.58%; vertical-align: top;" colspan="2">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Settlement Date(s) if other than standard T+2 settlement:</div>
          </td>
          <td style="width: 35.42%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 27.1%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
          <td style="width: 35.42%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 37.48%; vertical-align: top;">&#160;</td>
          <td style="width: 27.1%; vertical-align: top;">&#160;</td>
          <td style="width: 35.42%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Floor Price Limitation (in no event less than $1.00 without the prior written consent of the Agents, which consent may be withheld in the Agents&#8217; sole
      discretion): $ ____ per share</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="z8e707d51730341fd986572d451115270" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 12%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Comments:</div>
          </td>
          <td style="width: 88%; vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" id="zdce8e3c8af814580b0c18bcd72ad280f" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;">

        <tr>
          <td style="width: 50%; vertical-align: top; padding-bottom: 2px;">&#160;</td>
          <td style="width: 6%; vertical-align: top; padding-bottom: 2px;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">By:</div>
          </td>
          <td style="vertical-align: top; border-bottom: 2px solid rgb(0, 0, 0);" colspan="2">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Name:</div>
          </td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
        </tr>
        <tr>
          <td style="width: 50%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">&#160;</td>
          <td style="width: 6%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Title:</div>
          </td>
          <td style="width: 38%; vertical-align: top;">&#160;</td>
        </tr>

    </table>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Schedule A</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Notice Parties</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>The Company</u></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Carl Merton (Carl.Merton@tilray.com)</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Mitchell Gendel (Mitchell.Gendel@tilray.com)</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>Jefferies LLC</u></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Michael Magarro (mmagarro@jefferies.com)</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Donald Lynaugh (dlynaugh@jefferies.com)</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Jack Fabbri (jfabbri@jefferies.com)</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>Canaccord Genuity LLC</u></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Jen Pardi&#160; (jpardi@cgf.com)</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tom Pollard&#160;&#160; (tpollard@cgf.com)</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Michael Wright&#160;&#160; (mwright@cgf.com)</div>
    <div><br>
    </div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Schedule B</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Subsidiaries</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">[See attached]</div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt;"> <br>
    </div>
    <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
      <div style="page-break-after: always;" id="DSPFPageBreak">
        <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
    </div>
    <div>
      <div>
        <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><u>Subsidiaries List</u></div>
        <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;"><u> <br>
          </u></div>
        <div style="text-align: center; font-family: 'Times New Roman',Times,serif; font-size: 10pt; font-weight: bold;">
          <table cellspacing="0" cellpadding="0" border="0" id="z7b980daeee6d4c4b822ec210699d861e" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

              <tr>
                <td style="width: 50%; vertical-align: bottom; background-color: rgb(222, 235, 246); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                  <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Name of entity</div>
                </td>
                <td style="width: 50%; vertical-align: bottom; background-color: rgb(222, 235, 246); border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                  <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold; text-align: left;">Place of incorporation or formation</div>
                </td>
              </tr>

          </table>
          <u> </u></div>
      </div>
      <div>
        <table cellspacing="0" cellpadding="0" border="0" id="z77d173c27e894b1a85249dce983f9a55" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Natura Naturals Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray, Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Delaware, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Manitoba Harvest USA LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Delaware, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Canada Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Dorada Ventures Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">FHF Holdings Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">High Park Farms Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Deutschland GmbH</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Germany</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Pardal Holdings, Lda.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Portugal</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Portugal Unipessoal, Lda.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Portugal</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Australia New Zealand Pty. Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Australia</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Ventures Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ireland</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Manitoba Harvest Japan K.K.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Japan</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">High Park Holdings Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Fresh Hemp Foods Ltd. (dba Manitoba Harvest)</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Natura Naturals Holdings Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">NC Clinics Pty Ltd (formerly National Cannabinoid Clinics Pty Ltd.)</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Australia</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Latin America SpA</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Chile</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Portugal II, Lda.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Portugal</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">High Park Gardens Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">High Park Shops Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Privateer Evolution, LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Delaware, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1197879 B.C. Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray France SAS</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">France</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">High Park Holdings B.V.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Netherlands</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">High Park Botanicals B.V</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Netherlands</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Aphria Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ontario, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">LATAM Holdings Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Broken Coast Cannabis Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1974568 Ontario Limited (dba Aphria Diamond)</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ontario, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Nuuvera Holdings Limited</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ontario, Canada</div>
              </td>
            </tr>

        </table>
        <div style="clear: both; margin-top: 10pt; margin-bottom: 10pt;" id="DSPFPageBreakArea">
          <div style="page-break-after: always;" id="DSPFPageBreak">
            <hr noshade="noshade" style="border-width: 0px; clear: both; margin: 4px 0px; width: 100%; height: 2px; color: #000000; background-color: #000000;"></div>
        </div>
        <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman',Times,serif; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: rgb(0, 0, 0);">

            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Aphria Terra S.R.L.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Italy</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Goodfields Supply Co. Ltd</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">United Kingdom</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Nuuvera Malta Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Malta</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Four Twenty Corporation</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Delaware, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ottley Drive Corporation</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Delaware, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Marigold Acquisitions Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">British Columbia, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">MMJ Colombia Partners Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ontario, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">MMJ International Investments Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ontario, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Hampstead International (Barbados) Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Barbados</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Colcanna S.A.S</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Colombia</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ABP, S.A</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Argentina</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">FL Group S.R.L.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Italy</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Aphria Germany GmbH (formerly Nuuvera Deutschland GmbH)</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Germany</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Aphria RX GmbH (formerly Aphria Deutschland GmbH)</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Germany</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">CC Pharma GmbH</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Germany</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Aphria Wellbeing GmbH</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Germany</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">CC Pharma Research &amp; Development GmbH</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Germany</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">CC Pharma Nordic APS</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Denmark</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Canninvest Africa Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">South Africa</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Verve Dynamics Incorporated (PTY) Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Lesotho</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">2787643 Ontario Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ontario, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ARA - Avanti RX Analytics Inc.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ontario, Canada</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Nuuvera Israel Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Israel</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">ASG Pharma Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Malta</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">QSG Health Ltd.</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Malta</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Aphria Malta Limited</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Malta</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">SW Brewing Company, LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Delaware, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">SweetWater Colorado Brewing Company, LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Delaware, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">SweetWater Brewing Company, LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Georgia, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Cheese Grits, LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-right: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Georgia, United States</div>
              </td>
            </tr>
            <tr>
              <td style="width: 50%; vertical-align: top; border-top: 1px solid rgb(0, 0, 0); border-left: 1px solid rgb(0, 0, 0); border-bottom: 1px solid rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Double Diamond Distillery, LLC</div>
              </td>
              <td style="width: 50%; vertical-align: top; border-width: 1px; border-style: solid; border-color: rgb(0, 0, 0);">
                <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Colorado, United States</div>
              </td>
            </tr>

        </table>
      </div>
      <div><br>
      </div>
    </div>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>3
<FILENAME>ny20002883x2_ex5-1.htm
<DESCRIPTION>EXHIBIT 5.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman'; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">
      <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;">Exhibit 5.1</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" border="0" style="font-family: 'Times New Roman'; font-size: 10pt; width: 100%; border-collapse: collapse; text-align: left; color: #000000;" id="zd632e8b11315433183ccb3e343e61205">

        <tr>
          <td style="width: 75%; vertical-align: bottom;">
            <div style="text-align: left;"><img width="150" height="96" src="ny20002883x2_ex5-1logo.jpg"></div>
          </td>
          <td style="width: 25%; vertical-align: top;">
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">DLA Piper LLP (US)</div>
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">1251 Avenue of the Americas</div>
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">27th Floor</div>
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">New York, New York 10020-1104</div>
            <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">www.dlapiper.com</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">March 3, 2022</div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Brands, Inc.</div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">265 Talbot Street West</div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Leamington, Ontario, Canada</div>
    <div><br>
    </div>
    <div style="text-align: left; margin-left: 0.5pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">Re:</font>&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;<font style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><u>Tilray Brands, Inc.
          Registration Statement on Form S-3ASR (Reg. No. 333-233703)</u></font></div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Ladies and Gentlemen:</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">We have acted as counsel to Tilray Brands, Inc., a Delaware corporation (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Company</font>&#8221;), in connection with the issuance and sale by the Company from time to time of shares of the Company&#8217;s Class 2 common stock, par value $0.0001 per share, having an aggregate offering price of up to
      $400 million (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Common Shares</font>&#8221;), pursuant to the Registration Statement on Form S-3ASR (Reg. No. 333-233703), filed with the Securities and
      Exchange Commission (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">SEC</font>&#8221;) under the Securities Act of 1933, as amended (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Act</font>&#8221;), on September 11, 2019, which became automatically effective upon filing (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Registration Statement</font>&#8221;),



      the related base prospectus, dated September 10, 2019 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Base Prospectus</font>&#8221;), and the prospectus supplement, dated March 3, 2022 (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Prospectus Supplement</font>&#8221; and together with the Base Prospectus, the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Prospectus</font>&#8221;), filed with the SEC pursuant to Rule 424(b) under the Act, and the sales agreement, dated March 3, 2022, by and between the Company, on the one hand, and Jefferies LLC and Canaccord Genuity LLC, as sales
      agents and/or principals, on the other hand (the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Sales Agreement</font>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In connection with this opinion letter, we have examined the Registration Statement, the Prospectus, the Sales Agreement, and originals, or
      copies certified or otherwise identified to our satisfaction, of the Certificate of Incorporation, as amended, of the Company, and the Bylaws, as amended, of the Company, and such other documents, records and other instruments as we have deemed
      appropriate for purposes of the opinion set forth herein.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">We have assumed the genuineness of all signatures, the legal capacity of all natural persons, the authenticity of the documents submitted
      to us as originals, the conformity with the originals of all documents submitted to us as certified, facsimile or photostatic copies and the authenticity of the originals of all documents submitted to us as copies.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Based upon the foregoing, we are of the opinion that the Common Shares have been duly authorized by the Company and, when issued and sold
      by the Company and delivered by the Company against receipt of the purchase price therefor, in the manner contemplated by the Sales Agreement, will be validly issued, fully paid and non-assessable.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The opinions expressed herein are limited to the Delaware General Corporation Law.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: 36pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">We hereby consent to the use of this opinion as Exhibit 5.1 to the Registration Statement and to the reference to us under the caption
      &#8220;Legal Matters&#8221; in the Prospectus Supplement. In giving such consent, we do not hereby admit that we are acting within the category of persons whose consent is required under Section 7 of the Act or the rules or regulations of the SEC thereunder.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Very truly yours,</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">/s/ DLA Piper LLP (US)</div>
    <br>
    <div>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>4
<FILENAME>ny20002883x2_ex99-1.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html>
  <head>
    <title></title>
    <!-- Licensed to: Broadridge Financial Solutions, Inc.
         Document created using EDGARfilings PROfile 8.1.1.0
         Copyright 1995 - 2022 Broadridge -->
  </head>
<body bgcolor="#ffffff" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; text-align: left; color: #000000;">
  <div>
    <div style="text-align: left;">
      <div style="text-align: right;">
        <hr noshade="noshade" align="center" style="height: 4px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"><font style="font-weight: bold;">Exhibit 99.1</font><br>
      </div>
      <div style="text-align: center;"> <img width="290" border="0" height="88" src="ny20002883x2_ex99-1logo.jpg"> </div>
      <div><br>
      </div>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">TILRAY BRANDS ANNOUNCES PROPOSED AGREEMENT FOR STRATEGIC ALLIANCE WITH HEXO CORP.</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">TILRAY TO ACQUIRE HEXO CORP.&#8217;S SENIOR SECURED CONVERTIBLE NOTES</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Commercial and financial alliance would bring together Canada&#8217;s top two cannabis market share leaders to strengthen operational
      efficiencies and product innovation to benefit consumers, shareholders, and the cannabis industry</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Provides Tilray Brands with approximately C$20 million in interest payments in the first year, adding approximately 4 cents per share to
      future earnings per share, and an equity conversion option into HEXO; well-positions Tilray Brands to benefit from HEXO&#8217;s accelerated growth potential</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Both companies expected to realize significant commercial benefits with production efficiencies and support services savings of up to
      C$50 million</div>
    <div><br>
    </div>
    <div style="text-align: center; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-style: italic;">Joint conference call to discuss announcement at 8:30 a.m. ET today</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">LEAMINGTON, ON &#8211; March 3, 2022 &#8212; Tilray Brands, Inc. (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Tilray
        Brands</font>&#8221; or the &#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Company</font>&#8221;) (Nasdaq | TSX: TLRY), a leading global cannabis-lifestyle and consumer packaged goods company inspiring and
      empowering the worldwide community to live their very best life, today announced proposed agreements for a commercial and financial partnership with HEXO Corp. (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">HEXO</font>&#8221;) (Nasdaq | TSX: HEXO) that would bring together Canada&#8217;s top two cannabis market share leaders, strengthening their respective positions and setting the stage for increased production efficiencies amid competitive market
      dynamics.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Under the terms of the proposed agreement, Tilray Brands would acquire up to US$211 million of senior secured convertible notes (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Notes</font>&#8221;) that were issued by HEXO and are currently held by funds affiliated with HT Investments MA LLC (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">HTI</font>&#8221;) (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Transaction</font>&#8221;). The Notes would be amended to permit Tilray Brands to exercise conversion rights
      at a price of C$0.90 per HEXO Share and acquire a significant equity ownership position in HEXO, driving meaningful, additional upside and direct participation in HEXO&#8217;s considerable growth opportunities.</div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Irwin D. Simon, Tilray Brands&#8217; Chairman and CEO, said, &#8220;We believe this proposed Transaction would be a win-win for Tilray Brands and HEXO as it would
      launch a strategic partnership between two leading Canadian cannabis producers with complementary brand portfolios. For us, it provides a path for meaningful future equity ownership of HEXO, and enables us to participate in HEXO&#8217;s share price
      appreciation as it continues to execute on its growth initiatives. We also expect to realize further commercial and production efficiency savings of up to C$50 million within two years, which would be shared equally and would allow us to continue
      being the leading, low-cost Canadian producer. I look forward to working with HEXO&#8217;s management team and Board to create additional brand and shareholder value.&#8221;</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The strategic alliance between Tilray Brands and HEXO would provide several financial and strategic benefits, including:</div>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="zb7276f3a0cff484ea82e92767fdefc13" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 17.75pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Accretion and Flexibility:</font> the acquisition of the Notes by Tilray
              Brands would be immediately accretive to Tilray Brands. As amended, the terms of the Notes will provide that the Notes shall bear interest at a rate of 10% per annum from the date of closing. During the first year, the interest will be paid
              in cash and during the remainder of the term, the Notes will be paid half in cash in each year and the remaining half will be added to the principal amount as a payment-in kind (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">PIK</font>&#8221;) when the payments are due and any payments of such PIK will be made in cash at the time of maturity or paid in additional HEXO Shares upon conversion (if converted prior to maturity). In
              addition, Tilray Brands shall have the flexibility to either be paid the principal amount plus any accrued interest and PIK upon the maturity of the Notes or, prior to maturity, convert the principal amount plus any accrued interest and PIK
              into a substantial ownership position in HEXO.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z87c8530d18fb4d71b6058e15462bac9c" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 17.75pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Substantial Synergies: </font>the proposed alliance between Tilray
              Brands and HEXO is further expected to deliver up to C$50 million of pre-tax cost synergies, to be shared equally, within two years of the completion of the Transaction. Both companies have been working together to evaluate cost saving
              synergies as well as other production efficiencies, including with respect to cultivation and processing services, certain Cannabis 2.0 products, including pre-rolls, beverages and edibles, as well as shared services and procurement.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <table cellspacing="0" cellpadding="0" id="z530667df49dc4e2ab234bd753711d224" class="DSPFListTable" style="font-family: 'Times New Roman', Times, serif; font-size: 10pt; width: 100%; text-align: left; color: #000000;">

        <tr>
          <td style="width: 17.75pt;"><br>
          </td>
          <td style="width: 18pt; vertical-align: top; align: right; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">&#8226;</td>
          <td style="width: auto; vertical-align: top; text-align: left;">
            <div style="font-family: 'Times New Roman', Times, serif; font-size: 10pt;"><font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Increases Product Breadth and Commitment to Innovation:</font> Tilray
              Brands and HEXO bring together industry leading expertise in the global cannabis industry, including cannabis cultivation, product innovation, brand building, and distribution. Leveraging both companies&#8217; commitment to innovation and
              operational efficiencies, both companies would share their respective expertise and know-how to strengthen market positioning and capitalize on opportunities for growth through a broadened product offering and accelerated CPG innovation.</div>
          </td>
        </tr>

    </table>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Upon closing, Tilray Brands will nominate Denise Faltischek to the HEXO Board of Directors (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Board</font>&#8221;), in addition to appointing one Board observer.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Transaction Details</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Under the terms of the Transaction, and subject to negotiation of the definitive documents and the satisfaction of specific conditions, Tilray Brands would
      acquire 100% of the remaining US$211 million outstanding principal balance of the Notes, all of which were originally issued by HEXO to HTI. As consideration for Tilray Brands&#8217; interest in the Notes, Tilray Brands would pay 95% of the then
      outstanding principal balance for the Notes (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Purchase Price</font>&#8221;), which includes accrued and unpaid interest on the Notes, as well as other agreed
      direct and indirect costs incurred by Tilray Brands in connection with the Transaction. Until closing, HTI may continue to redeem the Notes pursuant to their terms; however, in no event shall the outstanding principal balance of the Notes, when
      ultimately purchased by Tilray Brands, be less than US$182 million.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Among the various amendments to be made to the Notes, the initial conversion price would be C$0.90 (subject to adjustments as set forth in the certificates
      for the Notes and the indenture governing the Notes) (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Conversion Price</font>&#8221;), implies that, as at March 2, 2022, Tilray Brands has the right to
      convert into approximately 37% of HEXO Shares (on a basic basis). The Purchase Price would be satisfied in cash, common shares of Tilray Brands (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Tilray
        Shares</font>&#8221;), or a combination thereof, at Tilray Brands&#8217; sole discretion.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">HEXO will not receive any proceeds as a result of Tilray Brands&#8217; proposed purchase of the Notes from HTI.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">In connection with the proposed Transaction, the parties would amend and restate the indenture governing the Notes to, among other things, (i) extend the
      maturity date by three (3) years, to May 1, 2026; (ii) provide for the revised interest amounts previously identified; and (iii) amend or eliminate certain affirmative and negative covenants, including as it relates to minimum liquidity and minimum
      EBITDA covenants. The Notes will also provide Tilray Brands with subscription rights and top-up rights in respect of all future equity and debt issuances by HEXO following closing, other than in respect of certain customary exceptions.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Commercial Transactions</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">As part of the proposed Transaction, HEXO and Tilray Brands would work together, in good faith, to evaluate cost saving synergies as well as other production
      efficiencies and enter into definitive agreements related to certain mutually agreed commercial transactions. These mutually beneficial commercial transactions are expected to include (i) cultivation and processing services, (ii) certain Cannabis 2.0
      products (including pre-rolls), each with a view to achieving optimal profitability between Tilray Brands and HEXO, and (iii) establishing a joint venture company that will provide shared services to both companies. Total savings, which will be
      shared equally between Tilray Brands and HEXO, are expected to be a minimum of C$50 million within two years.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Transaction Conditions</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The proposed Transaction will be subject to a number of conditions, including (i) execution of definitive documentation relating to the Notes; (ii) completion
      of all required amendments to the terms of the Notes; (iii) receipt of approvals from the Toronto Stock Exchange and the Nasdaq Stock Market LLC, satisfactory to both Tilray Brands and HEXO, as applicable; (iv) Tilray Brands&#8217; satisfactory completion
      of confirmatory financial due diligence; (v) receipt of all consents and approvals required by any regulatory authorities; (vi) final approval of the boards of directors of each of Tilray Brands and HEXO; (vii) receipt of shareholder approval from
      the HEXO shareholders; (viii) no material adverse effect having occurred in respect of HEXO; and (ix) a committed equity line being made available to HEXO for up to C$180 million on terms acceptable to both HEXO and Tilray Brands.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Conference Call</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Brands and HEXO will host a conference call to discuss today&#8217;s announcement at 8:30 a.m. ET, details of which are provided below.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Call-in Number: (877) 407-0792 from Canada and the U.S. or (201) 689-8263 from international locations. Please dial in at least 10 minutes prior to the start
      time.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">There will be a simultaneous, live webcast available on the Investors section of Tilray&#8217;s website at <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">www.Tilray.com</font>. The webcast will also be archived.</div>
    <div><br>
    </div>
    <div style="text-align: left; text-indent: -0.5pt; margin-left: 0.5pt; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For further details, investors and other security holders may also obtain a copy of the presentation associated with
      the transaction on the Investors section of Tilray Brands&#8217; website at <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">www.Tilray.com</font>.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Transaction Advisors</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Canaccord Genuity Corp. is serving as financial advisor, and DLA Piper LLP is serving as legal counsel, to Tilray Brands.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Lazard is serving as financial advisor, and Norton Rose Fulbright Canada LLP is serving as legal counsel, to HEXO.</div>
    <div><br>
    </div>
    <div style="text-align: left; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Tilray Brands Update; Prospectus Supplement Filing</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Brands also announced today that it has filed a prospectus supplement with the U.S. Securities and Exchange Commission (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">SEC</font>&#8221;), under which it may offer and sell shares of its common stock (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Common Stock</font>&#8221;) having an aggregate offering value of up to US$400,000,000 from time to time through an at-the-market equity program (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">ATM Program</font>&#8221;).</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company intends to use the net proceeds from sales of its Common Stock under the ATM Program offering to strengthen its balance sheet
      (including through debt repayments) and to fund accretive acquisitions, including potential acquisitions of cannabis assets upon federal permissibility.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">The Company has entered into an at-the-market issuance sales agreement with Jefferies LLC (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Jefferies</font>&#8221;) and Canaccord Genuity LLC (&#8220;<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; font-weight: bold;">Canaccord Genuity</font>&#8221;). Pursuant to the sales
      agreement, Jefferies and Canaccord Genuity may sell the Company&#8217;s Common Stock in transactions that are deemed an &#8220;at-the-market offering&#8221; defined in Rule 415 under the Securities Act of 1933, as amended, including sales made directly on or through
      the Nasdaq Global Select Market. The timing and amount of any such sales will be determined by a variety of factors considered by the Company. Sales may be made at market prices prevailing at the time of a sale or at prices related to prevailing
      market prices. As a result, sales prices may vary.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">A registration statement on Form S-3 (File No. 333-233703) utilizing a shelf registration process, including a base prospectus relating to
      Tilray Brands&#8217; securities was filed with the SEC on September 11, 2019 and became effective automatically upon filing, and a prospectus supplement and accompanying prospectus relating to the ATM Program was filed with the SEC on March 3, 2022.
      Prospective investors should read the prospectus supplement and accompanying prospectus, together with the documents incorporated by reference therein. Prospective investors may obtain these documents for free by visiting EDGAR on the SEC&#8217;s website
      at www.sec.gov. Alternatively, a copy of the prospectus supplement and accompanying prospectus relating to the offering may be obtained from Jefferies LLC, 520 Madison Avenue, New York, NY 10022 or by telephone at (877) 821-7388 or by email at
      Prospectus_Department@Jefferies.com.</div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;"><font style="background-color: #FEFEFE;">About Tilray Brands</font></div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Brands, Inc. (Nasdaq: TLRY; TSX: TLRY), is a leading global cannabis-lifestyle and consumer packaged goods company with operations
      in Canada, the United States, Europe, Australia, and Latin America that is changing people&#8217;s lives for the better &#8211; one person at a time. Tilray Brands delivers on this mission by inspiring and empowering the worldwide community to live their very
      best life and providing access to products that meet the needs of their mind, body, and soul while invoking wellbeing. Patients and consumers trust Tilray Brands to deliver a cultivated experience and health and wellbeing through high-quality,
      differentiated brands and innovative products. A pioneer in cannabis research, cultivation, and distribution, Tilray Brands&#8217; unprecedented production platform supports over 20 brands in over 20 countries, including comprehensive cannabis offerings,
      hemp-based foods, and craft beverages.</div>
    <div id="DSPFPageBreakArea" style="clear: both; margin-top: 10pt; margin-bottom: 10pt;">
      <div id="DSPFPageBreak" style="page-break-after:always;">
        <hr noshade="noshade" style="margin: 4px 0px; width: 100%; border-width: 0; height: 2px; color: #000000; background-color: #000000; clear: both;"></div>
    </div>
    <div><br>
    </div>
    <div style="text-align: justify; color: #000000; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For more information on how we open a world of wellbeing, visit www.Tilray.com<font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif;">.</font></div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt; font-weight: bold;">Cautionary Statement Concerning Forward-Looking Statements</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Certain statements in this communication that are not historical facts constitute forward-looking information or forward-looking statements (together,
      &#8220;forward-looking statements&#8221;) under Canadian securities laws and within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, that are intended to be subject to the
      &#8220;safe harbor&#8221; created by those sections and other applicable laws. Forward-looking statements can be identified by words such as &#8220;forecast,&#8221; &#8220;future,&#8221; &#8220;should,&#8221; &#8220;could,&#8221; &#8220;enable,&#8221; &#8220;potential,&#8221; &#8220;contemplate,&#8221; &#8220;believe,&#8221; &#8220;anticipate,&#8221; &#8220;estimate,&#8221;
      &#8220;plan,&#8221; &#8220;expect,&#8221; &#8220;intend,&#8221; &#8220;may,&#8221; &#8220;project,&#8221; &#8220;will,&#8221; &#8220;would&#8221; and the negative of these terms or similar expressions, although not all forward-looking statements contain these identifying words. Certain material factors, estimates, goals, projections
      or assumptions were used in drawing the conclusions contained in the forward-looking statements throughout this communication. Forward-looking statements include statements regarding our intentions, beliefs, projections, outlook, analyses or current
      expectations concerning, among other things: the Company successfully negotiating and executing definitive agreements in connection with the proposed Transaction; expected production efficiencies and potential cost saving synergies resulting from the
      Transaction or other proposed commercial arrangements; the Company&#8217;s ability to sell Common Stock under the ATM Program;; and the Company&#8217;s ability to commercialize new and innovative products. Many factors could cause actual results, performance or
      achievement to be materially different from any forward-looking statements, and other risks and uncertainties not presently known to the Company or that the Company deems immaterial could also cause actual results or events to differ materially from
      those expressed in the forward-looking statements contained herein. For a more detailed discussion of these risks and other factors, see the most recently filed annual information form of Tilray and the Annual Report on Form 10-K (and other periodic
      reports filed with the SEC) of Tilray made with the SEC and available on EDGAR. The forward-looking statements included in this communication are made as of the date of this communication and the Company does not undertake any obligation to publicly
      update such forward-looking statements to reflect new information, subsequent events or otherwise unless required by applicable securities laws.</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">For further information:</div>
    <div><br>
    </div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Tilray Brands</div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Media: Berrin Noorata, <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">news@tilray.com</font></div>
    <div style="text-align: left; font-family: 'Times New Roman', Times, serif; font-size: 10pt;">Investors: Raphael Gross, +1-203-682-8253, <font style="font-size: 10pt; font-family: 'Times New Roman', Times, serif; color: #000000;">Raphael.Gross@icrinc.com</font>
      <hr noshade="noshade" align="center" style="height: 2px; color: #000000; background-color: #000000; text-align: center; margin-left: auto; margin-right: auto; border: none;"></div>
  </div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>5
<FILENAME>tlry-20220303.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<xs:schema targetNamespace="http://tilray.com/20220303" elementFormDefault="qualified" xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:tlry="http://tilray.com/20220303" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:us-types="http://fasb.org/us-types/2021-01-31" xmlns:srt-types="http://fasb.org/srt-types/2021-01-31" xmlns:dei="http://xbrl.sec.gov/dei/2021" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xlink:type="simple" xlink:href="tlry-20220303_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tlry-20220303_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="tlry-20220303_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:roleType roleURI="http://tilray.com/role/DocumentAndEntityInformation" id="DocumentAndEntityInformation">
        <link:definition>000100 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
  <xs:import namespace="http://fasb.org/us-gaap/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/dei/2021" schemaLocation="https://xbrl.sec.gov/dei/2021/dei-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/country/2021" schemaLocation="https://xbrl.sec.gov/country/2021/country-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/currency/2021" schemaLocation="https://xbrl.sec.gov/currency/2021/currency-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/exch/2021" schemaLocation="https://xbrl.sec.gov/exch/2021/exch-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/naics/2021" schemaLocation="https://xbrl.sec.gov/naics/2021/naics-2021.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/sic/2021" schemaLocation="https://xbrl.sec.gov/sic/2021/sic-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <xs:import namespace="http://xbrl.sec.gov/stpr/2021" schemaLocation="https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd" />
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2004/ref" schemaLocation="http://www.xbrl.org/2004/ref-2004-08-10.xsd" />
  <xs:import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <xs:import namespace="http://fasb.org/us-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <xs:import namespace="http://fasb.org/srt/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd" />
  <xs:import namespace="http://fasb.org/srt-types/2021-01-31" schemaLocation="https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd" />
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>6
<FILENAME>tlry-20220303_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:t1="http://xbrl.org/2005/xbrldt">
  <link:roleRef roleURI="http://tilray.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="tlry-20220303.xsd#DocumentAndEntityInformation" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" />
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" />
  <link:definitionLink xlink:type="extended" xlink:role="http://tilray.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesLineItems" xlink:label="EntityAddressesLineItems" xlink:title="EntityAddressesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="DocumentType" xlink:title="definition: EntityAddressesLineItems to DocumentType" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="AmendmentFlag" xlink:title="definition: EntityAddressesLineItems to AmendmentFlag" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="definition: EntityAddressesLineItems to DocumentPeriodEndDate" order="3.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityRegistrantName" xlink:title="definition: EntityAddressesLineItems to EntityRegistrantName" order="4.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="definition: EntityAddressesLineItems to EntityIncorporationStateCountryCode" order="5.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityFileNumber" xlink:title="definition: EntityAddressesLineItems to EntityFileNumber" order="6.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="definition: EntityAddressesLineItems to EntityTaxIdentificationNumber" order="7.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="definition: EntityAddressesLineItems to EntityAddressAddressLine1" order="8.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="definition: EntityAddressesLineItems to EntityAddressAddressLine2" order="9.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="definition: EntityAddressesLineItems to EntityAddressAddressLine3" order="10.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="definition: EntityAddressesLineItems to EntityAddressCityOrTown" order="11.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="definition: EntityAddressesLineItems to EntityAddressStateOrProvince" order="12.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressCountry" xlink:title="definition: EntityAddressesLineItems to EntityAddressCountry" order="13.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="definition: EntityAddressesLineItems to EntityAddressPostalZipCode" order="14.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="CityAreaCode" xlink:title="definition: EntityAddressesLineItems to CityAreaCode" order="15.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="LocalPhoneNumber" xlink:title="definition: EntityAddressesLineItems to LocalPhoneNumber" order="16.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="WrittenCommunications" xlink:title="definition: EntityAddressesLineItems to WrittenCommunications" order="17.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="SolicitingMaterial" xlink:title="definition: EntityAddressesLineItems to SolicitingMaterial" order="18.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="definition: EntityAddressesLineItems to PreCommencementTenderOffer" order="19.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="definition: EntityAddressesLineItems to PreCommencementIssuerTenderOffer" order="20.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="definition: EntityAddressesLineItems to NoTradingSymbolFlag" order="21.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="definition: EntityAddressesLineItems to EntityEmergingGrowthCompany" order="22.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="definition: EntityAddressesLineItems to DocumentFiscalYearFocus" order="23.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="definition: EntityAddressesLineItems to DocumentFiscalPeriodFocus" order="24.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="EntityCentralIndexKey" xlink:title="definition: EntityAddressesLineItems to EntityCentralIndexKey" order="25.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="Security12bTitle" xlink:title="definition: EntityAddressesLineItems to Security12bTitle" order="26.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="TradingSymbol" xlink:title="definition: EntityAddressesLineItems to TradingSymbol" order="27.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="EntityAddressesLineItems" xlink:to="SecurityExchangeName" xlink:title="definition: EntityAddressesLineItems to SecurityExchangeName" order="28.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesTable" xlink:label="EntityAddressesTable" xlink:title="EntityAddressesTable" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/all" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressesTable" xlink:title="definition: EntityAddressesLineItems to EntityAddressesTable" order="29.0" t1:closed="true" t1:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="EntityAddressesAddressTypeAxis" xlink:title="EntityAddressesAddressTypeAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="EntityAddressesTable" xlink:to="EntityAddressesAddressTypeAxis" xlink:title="definition: EntityAddressesTable to EntityAddressesAddressTypeAxis" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain" xlink:title="AddressTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="AddressTypeDomain" xlink:title="definition: EntityAddressesAddressTypeAxis to AddressTypeDomain" order="1.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain_2" xlink:title="AddressTypeDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="AddressTypeDomain_2" xlink:title="definition: EntityAddressesAddressTypeAxis to AddressTypeDomain_2" order="2.0" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_FormerAddressMember" xlink:label="FormerAddressMember" xlink:title="FormerAddressMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="AddressTypeDomain" xlink:to="FormerAddressMember" xlink:title="definition: AddressTypeDomain to FormerAddressMember" order="1.0" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>7
<FILENAME>tlry-20220303_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:label xlink:type="resource" xlink:label="dei_CoverAbstract_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CoverAbstract_lbl" xml:lang="en-US" id="dei_CoverAbstract_lbl">Cover [Abstract]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:title="label: CoverAbstract to dei_CoverAbstract_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentType_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentType_lbl" xml:lang="en-US" id="dei_DocumentType_lbl">Document Type</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentType" xlink:to="dei_DocumentType_lbl" xlink:title="label: DocumentType to dei_DocumentType_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:label xlink:type="resource" xlink:label="dei_WrittenCommunications_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_WrittenCommunications_lbl" xml:lang="en-US" id="dei_WrittenCommunications_lbl">Written Communications</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:title="label: WrittenCommunications to dei_WrittenCommunications_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:label xlink:type="resource" xlink:label="dei_SolicitingMaterial_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SolicitingMaterial_lbl" xml:lang="en-US" id="dei_SolicitingMaterial_lbl">Soliciting Material</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:title="label: SolicitingMaterial to dei_SolicitingMaterial_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementTenderOffer_lbl">Pre-commencement Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:title="label: PreCommencementTenderOffer to dei_PreCommencementTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:label xlink:type="resource" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US" id="dei_PreCommencementIssuerTenderOffer_lbl">Pre-commencement Issuer Tender Offer</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:title="label: PreCommencementIssuerTenderOffer to dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:label xlink:type="resource" xlink:label="dei_AmendmentFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AmendmentFlag_lbl" xml:lang="en-US" id="dei_AmendmentFlag_lbl">Amendment Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:title="label: AmendmentFlag to dei_AmendmentFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalYearFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalYearFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalYearFocus_lbl">Document Fiscal Year Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalYearFocus" xlink:to="dei_DocumentFiscalYearFocus_lbl" xlink:title="label: DocumentFiscalYearFocus to dei_DocumentFiscalYearFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentFiscalPeriodFocus_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentFiscalPeriodFocus_lbl" xml:lang="en-US" id="dei_DocumentFiscalPeriodFocus_lbl">Document Fiscal Period Focus</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentFiscalPeriodFocus" xlink:to="dei_DocumentFiscalPeriodFocus_lbl" xlink:title="label: DocumentFiscalPeriodFocus to dei_DocumentFiscalPeriodFocus_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:label xlink:type="resource" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US" id="dei_DocumentPeriodEndDate_lbl">Document Period End Date</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:title="label: DocumentPeriodEndDate to dei_DocumentPeriodEndDate_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:label xlink:type="resource" xlink:label="dei_EntityRegistrantName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityRegistrantName_lbl" xml:lang="en-US" id="dei_EntityRegistrantName_lbl">Entity Registrant Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:title="label: EntityRegistrantName to dei_EntityRegistrantName_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:label xlink:type="resource" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityCentralIndexKey_lbl" xml:lang="en-US" id="dei_EntityCentralIndexKey_lbl">Entity Central Index Key</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:title="label: EntityCentralIndexKey to dei_EntityCentralIndexKey_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityFileNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityFileNumber_lbl" xml:lang="en-US" id="dei_EntityFileNumber_lbl">Entity File Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:title="label: EntityFileNumber to dei_EntityFileNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:label xlink:type="resource" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US" id="dei_EntityTaxIdentificationNumber_lbl">Entity Tax Identification Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:title="label: EntityTaxIdentificationNumber to dei_EntityTaxIdentificationNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US" id="dei_EntityIncorporationStateCountryCode_lbl">Entity Incorporation, State or Country Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:title="label: EntityIncorporationStateCountryCode to dei_EntityIncorporationStateCountryCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:label xlink:type="resource" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US" id="dei_EntityEmergingGrowthCompany_lbl">Entity Emerging Growth Company</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:title="label: EntityEmergingGrowthCompany to dei_EntityEmergingGrowthCompany_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesTable" xlink:label="EntityAddressesTable" xlink:title="EntityAddressesTable" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressesTable_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressesTable_lbl" xml:lang="en-US" id="dei_EntityAddressesTable_lbl">Entity Addresses [Table]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressesTable" xlink:to="dei_EntityAddressesTable_lbl" xlink:title="label: EntityAddressesTable to dei_EntityAddressesTable_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="EntityAddressesAddressTypeAxis" xlink:title="EntityAddressesAddressTypeAxis" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressesAddressTypeAxis_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressesAddressTypeAxis_lbl" xml:lang="en-US" id="dei_EntityAddressesAddressTypeAxis_lbl">Entity Addresses, Address Type [Axis]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="dei_EntityAddressesAddressTypeAxis_lbl" xlink:title="label: EntityAddressesAddressTypeAxis to dei_EntityAddressesAddressTypeAxis_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain" xlink:title="AddressTypeDomain" />
    <link:label xlink:type="resource" xlink:label="dei_AddressTypeDomain_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_AddressTypeDomain_lbl" xml:lang="en-US" id="dei_AddressTypeDomain_lbl">Address Type [Domain]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="AddressTypeDomain" xlink:to="dei_AddressTypeDomain_lbl" xlink:title="label: AddressTypeDomain to dei_AddressTypeDomain_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_FormerAddressMember" xlink:label="FormerAddressMember" xlink:title="FormerAddressMember" />
    <link:label xlink:type="resource" xlink:label="dei_FormerAddressMember_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_FormerAddressMember_lbl" xml:lang="en-US" id="dei_FormerAddressMember_lbl">Former Address [Member]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="FormerAddressMember" xlink:to="dei_FormerAddressMember_lbl" xlink:title="label: FormerAddressMember to dei_FormerAddressMember_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesLineItems" xlink:label="EntityAddressesLineItems" xlink:title="EntityAddressesLineItems" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressesLineItems_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressesLineItems_lbl" xml:lang="en-US" id="dei_EntityAddressesLineItems_lbl">Entity Addresses [Line Items]</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressesLineItems" xlink:to="dei_EntityAddressesLineItems_lbl" xlink:title="label: EntityAddressesLineItems to dei_EntityAddressesLineItems_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine1_lbl">Entity Address, Address Line One</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:title="label: EntityAddressAddressLine1 to dei_EntityAddressAddressLine1_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine2_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine2_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine2_lbl">Entity Address, Address Line Two</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine2" xlink:to="dei_EntityAddressAddressLine2_lbl" xlink:title="label: EntityAddressAddressLine2 to dei_EntityAddressAddressLine2_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressAddressLine3_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressAddressLine3_lbl" xml:lang="en-US" id="dei_EntityAddressAddressLine3_lbl">Entity Address, Address Line Three</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressAddressLine3" xlink:to="dei_EntityAddressAddressLine3_lbl" xlink:title="label: EntityAddressAddressLine3 to dei_EntityAddressAddressLine3_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US" id="dei_EntityAddressCityOrTown_lbl">Entity Address, City or Town</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:title="label: EntityAddressCityOrTown to dei_EntityAddressCityOrTown_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US" id="dei_EntityAddressStateOrProvince_lbl">Entity Address, State or Province</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:title="label: EntityAddressStateOrProvince to dei_EntityAddressStateOrProvince_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressCountry_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressCountry_lbl" xml:lang="en-US" id="dei_EntityAddressCountry_lbl">Entity Address, Country</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:title="label: EntityAddressCountry to dei_EntityAddressCountry_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:label xlink:type="resource" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US" id="dei_EntityAddressPostalZipCode_lbl">Entity Address, Postal Zip Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:title="label: EntityAddressPostalZipCode to dei_EntityAddressPostalZipCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:label xlink:type="resource" xlink:label="dei_CityAreaCode_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_CityAreaCode_lbl" xml:lang="en-US" id="dei_CityAreaCode_lbl">City Area Code</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:title="label: CityAreaCode to dei_CityAreaCode_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:label xlink:type="resource" xlink:label="dei_LocalPhoneNumber_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_LocalPhoneNumber_lbl" xml:lang="en-US" id="dei_LocalPhoneNumber_lbl">Local Phone Number</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:title="label: LocalPhoneNumber to dei_LocalPhoneNumber_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:label xlink:type="resource" xlink:label="dei_Security12bTitle_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_Security12bTitle_lbl" xml:lang="en-US" id="dei_Security12bTitle_lbl">Title of 12(b) Security</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:title="label: Security12bTitle to dei_Security12bTitle_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:label xlink:type="resource" xlink:label="dei_NoTradingSymbolFlag_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_NoTradingSymbolFlag_lbl" xml:lang="en-US" id="dei_NoTradingSymbolFlag_lbl">No Trading Symbol Flag</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="NoTradingSymbolFlag" xlink:to="dei_NoTradingSymbolFlag_lbl" xlink:title="label: NoTradingSymbolFlag to dei_NoTradingSymbolFlag_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:label xlink:type="resource" xlink:label="dei_TradingSymbol_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_TradingSymbol_lbl" xml:lang="en-US" id="dei_TradingSymbol_lbl">Trading Symbol</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:title="label: TradingSymbol to dei_TradingSymbol_lbl" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:label xlink:type="resource" xlink:label="dei_SecurityExchangeName_lbl" xlink:role="http://www.xbrl.org/2003/role/label" xlink:title="dei_SecurityExchangeName_lbl" xml:lang="en-US" id="dei_SecurityExchangeName_lbl">Security Exchange Name</link:label>
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:title="label: SecurityExchangeName to dei_SecurityExchangeName_lbl" />
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>8
<FILENAME>tlry-20220303_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!--Generated by EDGARfilings PROfile 8.0.0.0 Broadridge-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" />
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" />
  <link:roleRef roleURI="http://tilray.com/role/DocumentAndEntityInformation" xlink:type="simple" xlink:href="tlry-20220303.xsd#DocumentAndEntityInformation" />
  <link:presentationLink xlink:type="extended" xlink:role="http://tilray.com/role/DocumentAndEntityInformation">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CoverAbstract" xlink:label="CoverAbstract" xlink:title="CoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesTable" xlink:label="EntityAddressesTable" xlink:title="EntityAddressesTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesAddressTypeAxis" xlink:label="EntityAddressesAddressTypeAxis" xlink:title="EntityAddressesAddressTypeAxis" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AddressTypeDomain" xlink:label="AddressTypeDomain" xlink:title="AddressTypeDomain" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_FormerAddressMember" xlink:label="FormerAddressMember" xlink:title="FormerAddressMember" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="AddressTypeDomain" xlink:to="FormerAddressMember" xlink:title="presentation: AddressTypeDomain to FormerAddressMember" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesAddressTypeAxis" xlink:to="AddressTypeDomain" xlink:title="presentation: EntityAddressesAddressTypeAxis to AddressTypeDomain" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesTable" xlink:to="EntityAddressesAddressTypeAxis" xlink:title="presentation: EntityAddressesTable to EntityAddressesAddressTypeAxis" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressesLineItems" xlink:label="EntityAddressesLineItems" xlink:title="EntityAddressesLineItems" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentType" xlink:label="DocumentType" xlink:title="DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="DocumentType" xlink:title="presentation: EntityAddressesLineItems to DocumentType" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_AmendmentFlag" xlink:label="AmendmentFlag" xlink:title="AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="AmendmentFlag" xlink:title="presentation: EntityAddressesLineItems to AmendmentFlag" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentPeriodEndDate" xlink:label="DocumentPeriodEndDate" xlink:title="DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="DocumentPeriodEndDate" xlink:title="presentation: EntityAddressesLineItems to DocumentPeriodEndDate" order="2.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityRegistrantName" xlink:label="EntityRegistrantName" xlink:title="EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityRegistrantName" xlink:title="presentation: EntityAddressesLineItems to EntityRegistrantName" order="3.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="EntityIncorporationStateCountryCode" xlink:title="EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityIncorporationStateCountryCode" xlink:title="presentation: EntityAddressesLineItems to EntityIncorporationStateCountryCode" order="4.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityFileNumber" xlink:label="EntityFileNumber" xlink:title="EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityFileNumber" xlink:title="presentation: EntityAddressesLineItems to EntityFileNumber" order="5.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityTaxIdentificationNumber" xlink:label="EntityTaxIdentificationNumber" xlink:title="EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityTaxIdentificationNumber" xlink:title="presentation: EntityAddressesLineItems to EntityTaxIdentificationNumber" order="6.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine1" xlink:label="EntityAddressAddressLine1" xlink:title="EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine1" xlink:title="presentation: EntityAddressesLineItems to EntityAddressAddressLine1" order="7.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine2" xlink:label="EntityAddressAddressLine2" xlink:title="EntityAddressAddressLine2" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine2" xlink:title="presentation: EntityAddressesLineItems to EntityAddressAddressLine2" order="8.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressAddressLine3" xlink:label="EntityAddressAddressLine3" xlink:title="EntityAddressAddressLine3" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressAddressLine3" xlink:title="presentation: EntityAddressesLineItems to EntityAddressAddressLine3" order="9.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCityOrTown" xlink:label="EntityAddressCityOrTown" xlink:title="EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressCityOrTown" xlink:title="presentation: EntityAddressesLineItems to EntityAddressCityOrTown" order="10.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressStateOrProvince" xlink:label="EntityAddressStateOrProvince" xlink:title="EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressStateOrProvince" xlink:title="presentation: EntityAddressesLineItems to EntityAddressStateOrProvince" order="11.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressCountry" xlink:label="EntityAddressCountry" xlink:title="EntityAddressCountry" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressCountry" xlink:title="presentation: EntityAddressesLineItems to EntityAddressCountry" order="12.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityAddressPostalZipCode" xlink:label="EntityAddressPostalZipCode" xlink:title="EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityAddressPostalZipCode" xlink:title="presentation: EntityAddressesLineItems to EntityAddressPostalZipCode" order="13.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_CityAreaCode" xlink:label="CityAreaCode" xlink:title="CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="CityAreaCode" xlink:title="presentation: EntityAddressesLineItems to CityAreaCode" order="14.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_LocalPhoneNumber" xlink:label="LocalPhoneNumber" xlink:title="LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="LocalPhoneNumber" xlink:title="presentation: EntityAddressesLineItems to LocalPhoneNumber" order="15.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_WrittenCommunications" xlink:label="WrittenCommunications" xlink:title="WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="WrittenCommunications" xlink:title="presentation: EntityAddressesLineItems to WrittenCommunications" order="16.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SolicitingMaterial" xlink:label="SolicitingMaterial" xlink:title="SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="SolicitingMaterial" xlink:title="presentation: EntityAddressesLineItems to SolicitingMaterial" order="17.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementTenderOffer" xlink:label="PreCommencementTenderOffer" xlink:title="PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="PreCommencementTenderOffer" xlink:title="presentation: EntityAddressesLineItems to PreCommencementTenderOffer" order="18.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="PreCommencementIssuerTenderOffer" xlink:title="PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="PreCommencementIssuerTenderOffer" xlink:title="presentation: EntityAddressesLineItems to PreCommencementIssuerTenderOffer" order="19.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_NoTradingSymbolFlag" xlink:label="NoTradingSymbolFlag" xlink:title="NoTradingSymbolFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="NoTradingSymbolFlag" xlink:title="presentation: EntityAddressesLineItems to NoTradingSymbolFlag" order="20.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityEmergingGrowthCompany" xlink:label="EntityEmergingGrowthCompany" xlink:title="EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityEmergingGrowthCompany" xlink:title="presentation: EntityAddressesLineItems to EntityEmergingGrowthCompany" order="21.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalYearFocus" xlink:label="DocumentFiscalYearFocus" xlink:title="DocumentFiscalYearFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="DocumentFiscalYearFocus" xlink:title="presentation: EntityAddressesLineItems to DocumentFiscalYearFocus" order="22.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_DocumentFiscalPeriodFocus" xlink:label="DocumentFiscalPeriodFocus" xlink:title="DocumentFiscalPeriodFocus" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="DocumentFiscalPeriodFocus" xlink:title="presentation: EntityAddressesLineItems to DocumentFiscalPeriodFocus" order="23.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_EntityCentralIndexKey" xlink:label="EntityCentralIndexKey" xlink:title="EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="EntityCentralIndexKey" xlink:title="presentation: EntityAddressesLineItems to EntityCentralIndexKey" order="24.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_Security12bTitle" xlink:label="Security12bTitle" xlink:title="Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="Security12bTitle" xlink:title="presentation: EntityAddressesLineItems to Security12bTitle" order="25.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_TradingSymbol" xlink:label="TradingSymbol" xlink:title="TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="TradingSymbol" xlink:title="presentation: EntityAddressesLineItems to TradingSymbol" order="26.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2021/dei-2021.xsd#dei_SecurityExchangeName" xlink:label="SecurityExchangeName" xlink:title="SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesLineItems" xlink:to="SecurityExchangeName" xlink:title="presentation: EntityAddressesLineItems to SecurityExchangeName" order="27.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="EntityAddressesTable" xlink:to="EntityAddressesLineItems" xlink:title="presentation: EntityAddressesTable to EntityAddressesLineItems" order="1.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="CoverAbstract" xlink:to="EntityAddressesTable" xlink:title="presentation: CoverAbstract to EntityAddressesTable" order="0.0" preferredLabel="http://www.xbrl.org/2003/role/label" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>ny20002883x2_ex5-1logo.jpg
<TEXT>
begin 644 ny20002883x2_ex5-1logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" 0B!V8# 2(  A$! Q$!_\0
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1124FP%HI*6DF 444
M50!1110 4444 %)124"8M+244 %%)2TQ7%HHHI%!1110 E%%)3)N.HI*6D4%
M%%% !1110 444E !124M,FXM)124AMBTM)2T @HHHH&%%%% !1110 4444 %
M%%% !1110 4444 %%%)0 44E+3$F+1112&%%%% !1110 4444 %%%% "444E
M,FXZBDI:104444 )1124R;CJ*2EI%!1110 4E%)3$V+2TE+2!!1110,****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "DI:2DP"EI**5P"BBBD,
M**** "EI**:8A:***H HHHH *2EHH 2EHHH 2BEHH **** "BBB@!**6B@ H
MHHH **** "BBB@ HHHH 2EHHH *2EHH 2EHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@!*6BB@ HHHH **** "BBB@ HHHH **** $HI:* "
MBBB@ HHHH *2EHH **** "BBB@ I*6B@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *2EHI6 2BEHHL E%+24F@"BBBD
M,*6DHIIB%HHHJ@"BBB@ HHHH **** "BBB@ HI**38"T444( HHHI@%%%)2;
M 6BDI:$ 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HI**38"T444T 4444 %%%
M)2; 6BDI:$ 4444P"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBDS0 M%)FEH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****3 2EI**0"T4450!111
M0 4444 %%&:3(]: %HI,BDR/6@5Q:*3(]:3(]:8KCJ*;N'K2;AZT"N/HINX4
M;AZT6'S#J*;N'K1N'K0*XZEIFX>M+N'K18I,=129%)N'K2L%Q:2C</6C(]:+
M"N+2TW</6DW"BP7'T4S<*-PIV#F0ZBF[A2Y'K0%Q:6FY'K2;A0%Q]%,W"C<*
M+!S(?24W<*7(]: N+129'K2;AZTK!<?13-PHW"G8.9#Z2F[A2Y'K18+BT4F1
MZT;AZT6"XZBF;A1N%*P<R'TE-W"EW#UIV"XM%)D>M&1ZT!<=13-PHW"BP<R'
MT4S<*-PHL',.HI,CUHR/6@!U%,W"C<*+!S(?13-PHW"BP<R'T4F1ZT9%(=Q:
M*;N%)N%.P<R'T4S<*-PHL+F0^BF[AZTN12'<6BF[AZTFX4[!<?13-PHW"BPN
M9#J*;N'K2Y'K0%Q:6FY'K2;A0%Q]%,W"C<*+!S(?24W</6C</6BP.0ZBF[AZ
MT;AZT6!2'T4S<*-PHL',A])3=PI<CUH"XM%)D>M)N%*P7'T4S<*-PIV#F0^D
MINX4NX>M%@N+129'K1N'K0%QU%,W"C<*+!S(?24W<*-P]:+!S#J*3(]:,CUH
M =129'K1D4BA:*3(]:,B@!:*3(I<T %%%% !1110 4E+25("T444P$I:3%+2
M0!24M)0P%HI**:8"T444P$-1DU(13"M "*:D%,"T\4 +1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !32:4U&U #]U+FHAFI!0 ZBBB@ HHHH *2EHI- )2TE%+
M8!:8SXIU5YR<52$V(]P%[U7?4%7O5*Y=@#6)=W$@S5J-S)U#??5T7^(56?7T
M7^(5QEY>RC/)K!NM3F!/)K14C.5:QZ8?$<?]X4T^)(_[XKR1]6F'<U ^LS#N
M?SJU1.>6*L>P?\)+'_?%'_"2Q_WQ7C+:W-_>/YT@UN;^\:M8<AXP]F_X22/^
M^*/^$DC_ +XKQS^VIO[Q_.C^VIO[Q_.J^KF;QA['_P )+'_>%'_"2Q_WA7C?
M]LS>I_.E_MJ;U/YTUAB?KI['_P )+'_?%)_PDL?]\5XX=9F]3^=)_;,_]X_G
M5?527CSV7_A)8_[X_.E'B6/^^*\9_MF;U/YTO]M3?WC5?4Q?V@>R_P#"31_W
MQ2'Q+'_?%>-_VU/_ 'C1_;,_]X_G1]3&\P/9!XEC_OBE_P"$EC_OBO&O[9G_
M +Q_.E_MF?\ O'\Z/J8+,#V3_A)8_P"^*3_A)(_[XKQW^VIO[Q_.D.M3?WC^
M=5]3']>N>Q?\)+'_ 'Q1_P )+'_?%>-G69O4_G2C6IO[Q_.CZF/ZZ>R_\))'
M_?%'_"31_P!X5XX=:F_O&F'6IO[Q_.E]2&L<>S?\)+&?XQ1_PD<?]X5XVNM3
M?WC3_P"VIL?>/YT?4QO&GKY\2Q_WQ1_PDL?]\5XXVLS9^\?SI!K4WJ?SI_4Q
M?73V;_A)(_[XH_X26/\ OBO'/[:FQ]X_G3#K4W]X_G1]2$L<>S?\)+'_ 'Q1
M_P ))'_>%>-#6YO[QJ3^VIO[Q_.E]3*>-/8#XDC'\8I/^$EC_OBO'6UF;^\?
MSIO]LS9^\?SH^IB^NGLO_"21_P!\4O\ PDL?]\5XV-:F_O'\Z0ZU-_>/YTOJ
M@ECCV7_A)H_[XH_X22/^^*\9_MJ?^\?SIPUJ;^\::P8WCCV/_A)(_P"^*3_A
M)8_[XKQTZU-_>/YTS^V9_4_G3^IB6-/9O^$EC_OBE_X26/\ OBO&AK4W]X_G
M2G6IO[Q_.I^IA]>/9/\ A)H_[XH_X26/^^*\9_MJ?U/YTX:U-_>/YTU@BGCC
MV/\ X22/^^*3_A)8_P"^*\>.M3?WC3#K,WJ?SI_4R5C3V3_A)8_[XIW_  DD
M?]\5XTNM3>I_.G?VU-_>-'U,/KQ['_PDL?\ ?%'_  DL?]\5XR=:G_O'\Z4:
MU-_>/YTOJ17U[0]E_P"$DC_OBF_\)+'_ 'Q7CW]M3?WC3#K4WJ?SI_4R5C3V
M3_A)8_[XI?\ A)(_[XKQH:S-_>/YT[^VIO[Q_.E]3#ZZ>R?\)+'_ 'Q1_P )
M-'_?%>,G6IO[Q_.@:U/ZG\Z/J97UX]F_X22/^^*;_P )+'_?%>/#6IO[QIIU
MJ;^\?SI_4R?KQ['_ ,)+'_?%+_PDD?\ ?%>,_P!LS>I_.GC6IO[Q_.CZF#QI
M[)_PDL?]\4?\)-'_ 'Q7C9UJ;^\?SIO]M3^I_.E]2*6./9O^$EC_ +XI/^$D
MC_OBO'!K4W]X_G0=:F_O&G]2)>./8O\ A)8_[XI?^$EC_OBO&?[9G]3^=.&M
M3?WC^=+ZF'UT]E_X26/^^*/^$FC_ +XKQLZU-_>/YTW^VI_4_G2^IC6./9O^
M$EC_ +XI/^$DC_OBO&QK4W]X_G3O[:F_O&J^I">./8?^$EC_ +XH'B6/^^*\
M;.LS9ZG\Z4:U-ZG\Z/J8?73V3_A)(_[XI/\ A)8_[XKQ[^VIO[QIAUJ;^\?S
MH^I@L:>R?\)+'_?%+_PDD?\ ?'YUXT-:F_O'\Z?_ &U-_>-'U,'C3V$^)8_[
MXH_X26/^^*\<.M3>I_.D&LS>I_.CZF'UT]E_X22/^^*7_A)8_P"^*\<_MJ;'
MWC33K4W]X_G1]2!8X]E_X2:/^\*/^$DC_OBO&1K4_P#>/YTX:U-_>/YTOJ0W
MCCV/_A)(_P"^*3_A)8_[XKQTZU-_>/YTS^V9O4_G3^IB6-/9O^$DC_OBE_X2
M6/\ OBO&QK4W]XT'6IO[Q_.CZF'UX]D_X2:/^^*/^$EC_OBO&?[:G_O'\Z<-
M:F_O'\Z7U,IXX]C_ .$DC_OBD_X26/\ O"O'3K4W]X_G3/[:F_O'\Z?U,E8T
M]E_X26/^^*=_PDD?]\5XT-:F_O'\Z=_;4W]XT?4P^O:GL?\ PDL?]\4X>)(S
M_$*\8_MN;^\?SIZ:W-_>/YUF\(:K&'LO_"1Q_P!\4T^)8Q_$*\@.MRX^\?SJ
M!M;FS]X_G2>%-(XJY[./$L9_C%/7Q%&?XA7B\>LSD]3^=78-5G)ZG\ZS>'L:
MK$'L2:XC?Q"K,>J*_<5Y7:ZC,V.36_8W<IQDU'L!^W/0([L-WJ=9<US=G,Q
MS6O Y(J94[%QJW-$-2YJ)3Q3LUC8T4Q^:*;FES2L6I#J*2BD.X4M-I: 3%HH
MHH&)12T5+0"4M)10F M%%%4 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MK)TC:%86&WK3MK89'%5(SBK<=P$K.5(Z%7-RSMEXKH+.%1BN.CU01]ZN1>(
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M4[ I*IA<,4PK4@IX I(FY"%I<5*0*8>M,5R(@TH%28%&!3*&TTBGTN!20D1
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M4_-9'0F(:94AI,4T.XBT\4@IU)C04444AA1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MMWW+7G5(6/6H5>8NBGBHUJ05@ST(A2T45)H%%%)2; 6BDI:$P"BBBF 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MUY<]SU(;!24M)4%,*6DI: 04444#"BBB@ HHHH **** "BBB@ HHHH ****
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M_2K55+8\5;KRI[GK0V$I*=25!3"EI*6@$%%%% PHHHH **** "BBB@ HHHH
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M8J4S9(44ZD IU2V.PRE!H(I*+E#Q2U&#3P:!6 BF[:?11<+B 4M%% @HHHH
M*2EHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH 3%+110
M 4E+10 4444 )BDQ3J* $Q28IU%%PN)BEI**5P%HI*6BX!24M)3$QN*:RY%2
M4F*=R'$H3V@D[5DW6CJP)VBND(J&1-PJXR:,ITTS@KW15Y^6N8U#2MN<+7JT
M]H'SQ6->:0) ?EKJIUK'GU</<\>NK-E8_*:J&%AVKTR]\/\ 4[:YZ\T?R\_+
M7;"NCSJF'9RJ@BI@0*L7%L8\\5FRR%3BNA5+G)*BT6"^*57R:IB0FI5:MHW9
MDZ=B\J@BF.H%1K+@4IDS73%&;1&11BE--+8JT"$84SO3LYHQ5%7 "EQ3<XI0
MV:PD N*,4M)G%0A) 5IM+NHQ5IV--@ IV.*3I1NJTQ,:3@T]#3,9IZBK,Y,E
M'2FFG#I014,S6Y7<4ZV'[T42C%-MV_>BN>9WT6=MHIQMKNM/;Y5K@]$.=M=Y
MIX^5:\ZOL>SAT=%;=*MU4MN@JW7D3W/7AL%%%)47+%HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MZ^'>IOVW05;%5+;I5L5YD]SW*>PM%%%0:A1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** &YI:3%+3)0M%%%(H****0!2&EI#30F9VH_ZEOI7E_B
M9L%J]0U'_4M]*\N\3+RU=N&W//Q6QY_.W[T_6E2FSK^]/UI4KWZ.Q\_6+"FG
M4Q:?72<;&D4WI3B:3K0)7$W4\4W92]*AEV%--W4I.:;MH06' TM- Q3Q3T,V
M)2$4_;1BD@N1XQ1G%.--VUHD-,3.:2EQBDIFB%W8HSFC&:7;2;)8@%3I48%2
MK65R6*QXJK(U3R'BJK\G%93D7!%:20YK1TG,DH'O59+0RGI70Z+IA$BG'>N.
MK*R/2H0N=GH=AYBJ<5V%K8A .*S]"MMB+Q73H@ KR:E1W/8I4589&FT8J4"C
M%.KG;.J,0Q2T44KFEA:6DI:12"BBB@84444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M3NSTX::#L4E.HQ6;-K""EHQ2TD-(****8PHHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** $HHHH$A:***!A24M)4L I#3J0U2$S/U#_4M
M]*\O\3+RU>H:A_J6^E>8>)3RU=N&W//Q6QY[.O[T_6A!2SM^]/UI$KWZ.Q\_
M6)UIQZ4U:>:ZD<;(6I5&:4BE7BAC3%VTT\5)NXJ-N:R9HA.M*%IHXIX:I%(4
M#%.%(#FG"FD0QVVFD8I^ZF,:T1#&4;<TM&ZJ0T-VXIIIQ---,T0F*53BDI#4
M2V&2&3BJTC9-/-,V9-<DV7%%JQMO-8<5U^EZ/N*G;6+HT.77BO2-'M1L7BN&
MK,ZZ4&V6M)T_R@O%=3 N$ JI;Q!0.*OITKRZCNSW,.K(=BE I12UBV=:B+12
M45#9H+124M"8!1115 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1112 *2EHH0$96HVCS4^:2K3
M)<;F7>V^8SQ7 :]8;BW%>F7"Y0URFJVP;=Q711GJ<.)A9'DUU8[')Q5)CY9Q
M77ZI:[2W%<C>KM<UZE.1X%6.H!\TO:JT;<U8!XKOIR.5I#&I *5J0&NA,!P6
MG8Q0#2U+9!&U/MO]:*8]+;']Z*YJB+BCM]$_AKNK#[JUPFB'[M=W8?=6O.K[
M'I8;<W[;H*M"JMMTJT*\F>Y]%2^$6BBBH-0HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MDJ&B@HHI:$@"BBBK$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M*"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M\$5#(&8J-JF:H7KGFRX[D)^]6UI<&]EXK$W?/74:" SK7'4E8[Z,+G5Z5I_
M.*[#3[;8!Q5'2;<>6#BN@B4*!Q7FU9W/9P\&BT@PM/J-6%2 UQL])(*6BDI%
M!1244R;CJ*2EI%!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MA#3:=28IF;0E.%)BEH!:"TM)2TBT%%%% PHHHH **** "BBB@ HHHH ****
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M6EJ?08:&A/"NU:FIJCBG5QL]..P4444B@I*6B@ HHHH **** "BBB@ HHHH
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M7$^&Q\B5W$7W!7@5_B/IL-%<H\4M%%<YUA1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M* "BBB@ HHHH **** "BBB@ HHHH **** "DI:2@!*6BDIDCJ*2EI#N%%%%
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M HHHH 8U1D&IL4F* &J*>*.E&: %HHHH **** "BBB@ HHHH **** "BBB@
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M7ZZCTW^UH_44]=01NAKRQ-=<M]XULV6KEL9:D\(T2\6F=^MP#WJ=9 :YBVU
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MS%K1_O5H0ZQG^*LWAC2.,.Y%TI[U*LX-<C#JJG^*M"'45/\ %6;HFL<2=$)
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M9#T%;MC:"7'%;]MHP<#Y:RG.QT039PG]GS8Z4QM/F]#7J$?A]2/N4V3P\O\
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M0NF]1;%\7 KU#PPV56O*;'/VD?6O4_"^=JUY6)C8]G#'HUO_ *L?2IJ@M_\
M5BIZ\N3/5B+2TE%9.1JAU%)134@%HHHJP"BBB@!N*6BBF*PM%%%(84E+25+
M*0TM!JD)HSM0_P!2WTKR_P 3+RU>HZA_J6^E>8>)3RU=N&W//Q6QYY.O[T_6
ME2EG(\T_6A*]^CL?/UB0"EVTJT\UUHY&1YQ2]::1S3EI,$@*TTBI<C%1MUJ#
M0:!2[:!3P102QFVC;4E&*I,SN,V4N*DI#3&QM+BBC-*UR4(>*:33F-1U$H&L
M4+0'VT5%(<5RSB=5,U=/N,2CFO2/#TN0O->3V3D3#FO2/#L^ O->?B(:'HT)
M)'I5NWR"K -9EK< H.:OH^:\N4;'JTYW)J6F@TM9G2F+1110,***2DV M%)2
MT)@%%%%, HHHH *2EHI, HHHH0"5&U2&HVJD9U-C'U3_ %35Y=XC^\U>HZI_
MJFKR[Q']YJ]+"/4\;%'$O_K*<.E-?[YJ15XKW(/0\:>XTBK-JOS5#BK5MU%5
M*Q=,Z'3OO+7<Z-_#7"Z>?F6NXT8_=KR\5L>OA7J=I:_ZL59JM:_ZL59KQ);G
MM1V&$4W;S4E%*Y0T"G4447 :5J)TXJ;(I&QMH3!HY/7TQ&WTKR77#B5OK7KW
MB'_5M]*\>UX_O6^M>M@I'BXZ)F0OS5K.5K/A/-7A]VO;A+0\&2U(S]ZM73Y=
MA%99ZU9@?!%*<4T;TSN]+O>@S79:?+O05YEI<QWCFO0='?,:UY&,BD>OA-27
M5QE&KSS5D^<UZ+JO^K->?ZL/G-<E#<Z,0M#E+I.36<RX-:UUU-9K]:]BE+0\
M2KN-C^]6S9<D5C)]ZMJQZBBL]"J$4V=9I*\K7?:4/E6N$TDC*UWFE?=6O%KL
M]W#QL;J]*6FCI2UQ':A:***!A129I: "BBB@ HHHH **3-&:+A81AD56>.K=
M,?&*+ S.?Y*R=1N<1,,U>U"<1@UR.IZB.1FNFC3NSS\14L<SK[[V:N/9#O\
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ML.14#22)T)KGK4N8WHU.5GJ$?BH ??\ UJP/%0_O_K7DZW4H_B-2K=R_WC7
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MHC]\U40V*^AI2T/FZL=2QUIK+Q35:GYXK24C..Y 1\U=)H'^L7ZUSC?>KH]
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MQ,48HS1FG8.844M)FEHL.X4444 %%%% !1110 4444 %%%% !1110 44446
M**** "BBBE8!**6BBR ****+ %%%%, HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !24M% K"4M%% PHHHH **** "BBB@!*:13J*9+1"RY%4IX V>*T34;*#5QE
M8PG"YRVH6&Y3Q7&:II));Y:]2N( R]*P;W3P^?EKKIUC@JT#R:;2RIZ53DM"
MG:O1[K2,YPM8EWHS<X6NR-9'#.BSAI5*U "2:Z*[T=P3\IK-.G,AY%;*H8.B
MRHL>:F6&IA'LZT%P*M5"/9L8$Q2^9MI&E%5W;-;1G<B5-EC[3CO33<Y[U4VL
M:41MFM.<2IDY?=2"A8S3MM4IF<HBAJD%0XJ0&M.<S<204[-1[J3=3YR' D)I
MN*3=1NHYQJ(M*!FFTX'%/G%8=MHSBC>*831SBL/ZTA6FJ:?N%*]PL,(Q24X\
MTVD.P449HS0.PA%-VT_-&13N"0T#%+NI"::::9HD*32@XIF:,T^89+NIC&FY
MI:.="L)BEVTH%/%)R$QNRG!*>,4[(J',BXT+1Y>:>*D4BE<+E<P4PQ8J[D5&
MV*FR'S,J&*D\NK6!00*7*@YV5P,4[-/*TS%+D12F)DTA!-.I10J:*51D)4TP
M[AWJR<4PKFJ]F:JHR#S"O>E6Y(/6AHB:C^SM6<J9K&H7$O".]64U(K_%65Y#
MBF/&X]:RE2-8U#HX=8VG[U:UKKN"/FK@<R*>IJ>&X=6ZFN>4#HC,]<TW5_,*
M_-7665SO4<UY)H=RQ9>:](TF0F,<UQ58'33F=,C9J8&J<)JT#Q7%)'=3D2 T
M[-1BG"H:-XR'T4E+4F@4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4TTZ
MB@"/%.%+BEIW'<813-O-2XHQ2$-44^DQ2T )12T4K )2T44) %%%%, HHHH
M**** "BBB@ HHHH **** "BBB@ I*6BE8!**6BE8!**6DI<HPHHI:$@$HI:*
M=A"4E.I*3B,2C%+1240&,*9MYJ;%&T4^01&JT\4N*6CE 2BEHIV 2EHHII %
M%%%, HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
<H **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>ny20002883x2_ex99-1logo.jpg
<TEXT>
begin 644 ny20002883x2_ex99-1logo.jpg
M_]C_X  02D9)1@ !  $ 8 !@  #_VP"$  4%!0@%" P'!PP,"0D)# T,# P,
M#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T!
M!0@("@<*# <'# T,"@P-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-#0T-
M#0T-#0T-#0T-#0T-#0T-#0T-#?_" !$( '8!@P,!$0 "$0$#$0'_Q  U  $
M @(# 0              !P@%!@$"! ,! 0 " P$!               %!@$#
M! ('_]H # ,!  (0 Q    "Y8                          &!AG(
M                  'E]>/#ED<9^_GT                    ./+KEJ7=
MQ17/0V*]^=UAYFM%LB95AN^Q%<D,WHW]V&0                  ZD<2D7#
MUDA>,XF>N3>_1,E3NZPL?2G%G.;=<:CS>T\_0 8!D  P9    !@R   8,@
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M QK-:8=$;EV52B/HDBK)E*.XPWMM*YN%^P,"4I!V%E8$ <,0'UP/PXY<+4+
M!9LS&$PB)LH<*+- 7JIB@8!*.QJJ-9DS>[ROV%Y6G)7;*K6=M:F97;8.W'GG
M/S<_D\^'/Y'/Y5BEBPS0ZXJJF7.*BG"DS?Q%KX=3+Y62VB-4;@JD9 YDSYKZ
MT'K,F0QDS <H&+AR^T AETD[!6))1J8+Q.YUQ.YUQ.YUQ.AA+M/',!2R 24!
M4%G#CKB=S3\R]F6[L[[<,X_AS-? ]<3N5!PH[AF2Z^#FX9M]#^$\"%XG<ZXG
M<ZXG<)>YU,>81&W)N.. N*M:6=J:@Y9XZ=)LTCKK3.Q)AZ\66;]<SN:KMJM@
M9';/-I_&8%8LC']<SG?*):26B.(L8,.(%]1O^R';A^+>(86JQ2+@C5O7X]:-
M8I(.@X;&?"HY3:!Q@Y4\,[(Y(W6(Y3*LF.;>JH1;P)1OG;-=S(S,(W6.'"3@
M(^9$HO\ H:"#US:L8UB9D&[-L4#*D*9O1H,R1!,E2X1N<JB>RPY5M[PT9_%>
M\MY_N9<*/]A8<=Z=F6!E+JD0\A6BR_1,)DSKN%D&QT4UDA04,F.FY([69%H
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MAB=,M#2YDL*9AO705)-(GS+.'$R]R;%;U"N<6VT>V?J' 0Q>;,LTIG8FI+%
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MQ!@#]>*JHA/&6\D18V.H5%4&0"$G,>B'&_DIIA3L)=Y*20RN+CQ5K(=M$_+
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MA6H-O(0QA01!QMR.FC*?IF-:2. M)JQ(\P'@<*["D;N;2+=AI<K2'D(<E<=
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9LN8+0TT(_P $(FM]K0!_T@*X_(77XK__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.22.0.1</span><table class="report" border="0" cellspacing="2" id="idm140220333268808">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Mar. 03, 2022</div></th>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar.  03,  2022<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Tilray Brands, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-38594<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">82-4310622<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">265 Talbot Street West<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Leamington<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Ontario<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address, Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">N8H 4H3<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">845-7291<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001731348<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Class 2 Common Stock, $0.0001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TLRY<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember', window );">Former Address [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressesLineItems', window );"><strong>Entity Addresses [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">655 Madison Avenue<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 1900<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">New York<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">NY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl " style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="top.Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">10065<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation 12B<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="top.Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="top.Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressesAddressTypeAxis=dei_FormerAddressMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>ny20002883x2_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2021"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tlry-20220303.xsd" xlink:type="simple"/>
    <context id="c20220303to20220303">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001731348</identifier>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-03</endDate>
        </period>
    </context>
    <context id="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001731348</identifier>
            <segment>
                <xbrldi:explicitMember dimension="dei:EntityAddressesAddressTypeAxis">dei:FormerAddressMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2022-03-03</startDate>
            <endDate>2022-03-03</endDate>
        </period>
    </context>
    <dei:AmendmentFlag
      contextRef="c20220303to20220303"
      id="Fact_6ffd309601274ab8aa155eb1733b495e">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="c20220303to20220303"
      id="Fact_a6a6767e2b8e4fb98948294112de7cb7">0001731348</dei:EntityCentralIndexKey>
    <dei:DocumentType
      contextRef="c20220303to20220303"
      id="Fact_b169bdf0e346499483436fc6861b4b6a">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="c20220303to20220303"
      id="Fact_bc67854aa40a4b23842b4757ef6e7863">2022-03-03</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="c20220303to20220303"
      id="Fact_3c4309d60a1a496f83eee87fafc49f83">Tilray Brands, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="c20220303to20220303"
      id="Fact_4ee961c296974272a4f1fc6f45882f99">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="c20220303to20220303"
      id="Fact_edebf49b778d4c908cc0eac28c37c0c8">001-38594</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="c20220303to20220303"
      id="Fact_28a4c3f3ce05415fb835c65efb75eef7">82-4310622</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220303to20220303"
      id="Fact_f9c0b47103794d508d3dc4c4100deaa2">265 Talbot Street West</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20220303to20220303"
      id="Fact_3574e43cd2924ac68ac0ef71c93f3b11">Leamington</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20220303to20220303"
      id="Fact_6dfa9db41b1247e980e4c4a659848890">Ontario</dei:EntityAddressCityOrTown>
    <dei:EntityAddressCountry
      contextRef="c20220303to20220303"
      id="Fact_100b5cdfc7354e429d0be4f24b39f3ac">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220303to20220303"
      id="Fact_41b8a960db14480fa905d4cf0648005f">N8H 4H3</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="c20220303to20220303"
      id="Fact_f106d235470244f399f30ce5ddc2b521">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="c20220303to20220303"
      id="Fact_9c4e207dbe914d1fb2163c3e56745c06">845-7291</dei:LocalPhoneNumber>
    <dei:EntityAddressAddressLine1
      contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_ac1e538e40fd40c5b7baa7137f934d2f">655 Madison Avenue</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2
      contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_a6a87fe1f7634e4babbc933a30515bb0">Suite 1900</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown
      contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_908df462bd194fb583da432c1eb5a413">New York</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_190b4e48729549cc96d4f36fd4871c37">NY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="c20220303to20220303_EntityAddressesAddressTypeAxis_FormerAddressMember"
      id="Fact_ccc9ab7784d94e5b92471a2fe69aac10">10065</dei:EntityAddressPostalZipCode>
    <dei:WrittenCommunications
      contextRef="c20220303to20220303"
      id="Fact_f7e0bc5180b54fc4bdf5508604ba23db">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="c20220303to20220303"
      id="Fact_9527d22fd06840d1ae777da73eaf9685">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="c20220303to20220303"
      id="Fact_f94a94d822fa47969cfa1078ef13a106">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="c20220303to20220303"
      id="Fact_1dd3e074d4ef4a25a6465a035460a6a3">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="c20220303to20220303"
      id="Fact_3e1fdb5d042b4036947adb7d3829f485">Class 2 Common Stock, $0.0001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="c20220303to20220303"
      id="Fact_fdee6b91c9284a3b974e57d000c3ace2">TLRY</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="c20220303to20220303"
      id="Fact_6ffabf326396417b8069dfef8428d6ea">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="c20220303to20220303"
      id="Fact_1106681606044242854e5153c4e1d5fe">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>13
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5
MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$%     @
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M.__+UI,6WDQ/*LK/JC$K)-NM%OA\(#3,T,$;CU-T%A:N34\JU\^J+RLDIZF
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MPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE
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M%S?W1:[-XPFNWPQP>'3^ 5!+ P04    "  %/&-499!YDAD!  #/ P  $P
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MKP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @ !3QC5)E<G",0!@
MG"<  !,              ( !RP$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"
M% ,4    "  %/&-4CH?"*.$$  #7%   &               @($,"   >&PO
M=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @ !3QC5)^@&_"Q @
MX@P   T              ( !(PT  'AL+W-T>6QE<RYX;6Q02P$"% ,4
M"  %/&-4EXJ[',     3 @  "P              @ '_#P  7W)E;',O+G)E
M;'-02P$"% ,4    "  %/&-4'#AEZC\!   \ @  #P              @ 'H
M$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ !3QC5"0>FZ*M    ^ $
M !H              ( !5!(  'AL+U]R96QS+W=O<FMB;V]K+GAM;"YR96QS
M4$L! A0#%     @ !3QC5&60>9(9 0  SP,  !,              ( !.1,
J %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^ @  @Q0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.22.0.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>2</ContextCount>
  <ElementCount>118</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>1</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="ny20002883x2_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000100 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://tilray.com/role/DocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="ny20002883x2_8k.htm">ny20002883x2_8k.htm</File>
    <File>ny20002883x2_ex1-1.htm</File>
    <File>ny20002883x2_ex5-1.htm</File>
    <File>ny20002883x2_ex99-1.htm</File>
    <File>tlry-20220303.xsd</File>
    <File>tlry-20220303_def.xml</File>
    <File>tlry-20220303_lab.xml</File>
    <File>tlry-20220303_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="28">http://xbrl.sec.gov/dei/2021</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "ny20002883x2_8k.htm": {
   "axisCustom": 0,
   "axisStandard": 1,
   "contextCount": 2,
   "dts": {
    "definitionLink": {
     "local": [
      "tlry-20220303_def.xml"
     ]
    },
    "inline": {
     "local": [
      "ny20002883x2_8k.htm"
     ]
    },
    "labelLink": {
     "local": [
      "tlry-20220303_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tlry-20220303_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "tlry-20220303.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2004/ref-2004-08-10.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/srt/2021/elts/srt-types-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-gaap-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-roles-2021-01-31.xsd",
      "https://xbrl.fasb.org/us-gaap/2021/elts/us-types-2021-01-31.xsd",
      "https://xbrl.sec.gov/country/2021/country-2021.xsd",
      "https://xbrl.sec.gov/currency/2021/currency-2021.xsd",
      "https://xbrl.sec.gov/dei/2021/dei-2021.xsd",
      "https://xbrl.sec.gov/exch/2021/exch-2021.xsd",
      "https://xbrl.sec.gov/naics/2021/naics-2021.xsd",
      "https://xbrl.sec.gov/sic/2021/sic-2021.xsd",
      "https://xbrl.sec.gov/stpr/2021/stpr-2021.xsd"
     ]
    }
   },
   "elementCount": 34,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2021": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 118,
   "memberCustom": 0,
   "memberStandard": 1,
   "nsprefix": "tlry",
   "nsuri": "http://tilray.com/20220303",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20002883x2_8k.htm",
      "contextRef": "c20220303to20220303",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "000100 - Document - Document and Entity Information",
     "role": "http://tilray.com/role/DocumentAndEntityInformation",
     "shortName": "Document and Entity Information",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "div",
       "div",
       "body",
       "html"
      ],
      "baseRef": "ny20002883x2_8k.htm",
      "contextRef": "c20220303to20220303",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 1,
   "tag": {
    "dei_AddressTypeDomain": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types.",
        "label": "Address Type [Domain]"
       }
      }
     },
     "localname": "AddressTypeDomain",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentFiscalPeriodFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3.  1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.",
        "label": "Document Fiscal Period Focus"
       }
      }
     },
     "localname": "DocumentFiscalPeriodFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fiscalPeriodItemType"
    },
    "dei_DocumentFiscalYearFocus": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.",
        "label": "Document Fiscal Year Focus"
       }
      }
     },
     "localname": "DocumentFiscalYearFocus",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "gYearItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine2": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 2 such as Street or Suite number",
        "label": "Entity Address, Address Line Two"
       }
      }
     },
     "localname": "EntityAddressAddressLine2",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressAddressLine3": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 3 such as an Office Park",
        "label": "Entity Address, Address Line Three"
       }
      }
     },
     "localname": "EntityAddressAddressLine3",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCountry": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "ISO 3166-1 alpha-2 country code.",
        "label": "Entity Address, Country"
       }
      }
     },
     "localname": "EntityAddressCountry",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "countryCodeItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table.",
        "label": "Entity Addresses, Address Type [Axis]"
       }
      }
     },
     "localname": "EntityAddressesAddressTypeAxis",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesLineItems": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.",
        "label": "Entity Addresses [Line Items]"
       }
      }
     },
     "localname": "EntityAddressesLineItems",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityAddressesTable": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container of address information for the entity",
        "label": "Entity Addresses [Table]"
       }
      }
     },
     "localname": "EntityAddressesTable",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "stringItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r7"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_FormerAddressMember": {
     "auth_ref": [
      "r5",
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Former address for entity",
        "label": "Former Address [Member]"
       }
      }
     },
     "localname": "FormerAddressMember",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "domainItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_NoTradingSymbolFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true only for a security having no trading symbol.",
        "label": "No Trading Symbol Flag"
       }
      }
     },
     "localname": "NoTradingSymbolFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r8"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2021",
     "presentation": [
      "http://tilray.com/role/DocumentAndEntityInformation"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "Name": "Form 10-Q",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308",
   "Subsection": "a"
  },
  "r6": {
   "Name": "Form 8-K",
   "Number": "249",
   "Publisher": "SEC",
   "Section": "308"
  },
  "r7": {
   "Name": "Regulation 12B",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r8": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425"
  }
 },
 "version": "2.1"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001140361-22-007581-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001140361-22-007581-xbrl.zip
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M0="3 XJ,BC3XLD_^HO7Q\"69T8S<T+CD9(;G-2?/7Y3\[!IRV\FM%*+41.T
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M4#.58V^@!25^UWP:G^(@_&'JG41=LF-T&R8FKJDQ=@9SU7Q4)HM:J8<E";%
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M)D?.Q_H$I_E2.8D%[BPCOAY[R$8K/[=<N7</?[Z)E#?7:1S=NMNDNO.WB2_
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MVW$I @7:]9N<Q26S_=R,"5==#@L3HOKUUG9H_(<@5Z'Q"M]M"=&6#-_PK=9
MLQ=49D53:"IFIJ*@CMG\<\IS@\]P$00$X]*&^6ZA>H6UV#N:77G*^XHSW7"(
MGL["W5?#80APP/]QC]O8DB1*29H6!Y.WXUCO QC#,UXHTA:"\<OPWEUDP6C"
M;\&']I[S%]'3[5:K  Z\"_M*.?X1[$AO'X/#[>  L+-T;Q\^P3'\D5" %S3,
M*X "W*>MMJ>M_GJ?MKJM::OUG3= K99_,&1Z))YGI^$N;!@$E[G#ES'04Z]%
M]Y/R90MZ%*^$)D3#G2/&L.)B9Z3L7L(KX 99!$F*O>\._C)SU8M%PE [2109
MS+<"1HDD'BZ&(F_8S;YZ!DT)]T5/S<*"K]PF^(=(XIPWV<?7[G9?\PLPGY9X
MY/[O%<67E<'MZF;Z??-XX+P\RR3F*BA)!O/[KDY.O)28WAJKR1)]ZS'4)'W?
MV-]JT'!]:,@T>CE: !N^OW4^\S_NO,IZQIA<+>+"36/1E3_ AB)8%PP>[#<]
M$8ZUU7RF&*OJ6N<3];"_H0#FY, -2)POSS<1[57^W'$YB*L44$NTB:5%:AR4
M?&%]2;7),%5<9DL,@19).>)5AC181*2,O\X^@0K-.:5BYUVM!7I=*U]U$W:D
MO:S?.C;M62\VOL(OBGWMH?_>ZIYIX'8KTP'!#6AP:P9E23.$03IJF*##+HW&
M 1B1AW"4TV6!^+U^U1W1F&'EG8FZCY;@2:;4=?+@H8Q@]*B==I92O)<<%:+.
M,O<<AD-\/K1T7LSTE*BIA'OA65X5'M1W5=5]AIIHJLPON*R#4S=:&V96'I\S
M%.38B/'GS,%7E.D(R86<KBH#:3M#MUUBX10SR 0^2GML>S;+*:3?+[$]"YDO
MVU2/+[09Y(\J>X57ES^I$XEK<Z3Z6^*[\?!0UVP<\D_SJNQL@T[^+6LINP:T
M/2>:M76I6:^'@HTXP;U4. W%!>++*N(@DB99MH)#'[M"^7UHSRDRXO3S&!R&
MPGG&O<GII.!5)O- $[M]MD9]YVT--B4<]OLU!Z/':)>-'N5LI4$J^RM;2?4/
MJ=,"2#;\X\2%X,)>R6C]UIGQ3UAPE4")6>G\<;'6.47KO'RAEEQHQP ED(HY
M3JSL*73GD%D@8<AE3*#_O!2X]VD//FT0#W[J$QU<24D6$LD??LNUJ/"S6\GL
M2BE LS-$WAABB>.ZP];#SY7F;HP9V&-SPA74^DJNUJ4!FFD/@=ZT:DU I3->
MTN9Z:\72-'WB%C>9.EVB,3[1_KCO0W57'ZK[VWVH[K:&ZIH[?Q>!$;]//(F@
MJ4M5P2\T/_JJ! W%#,V$?WS9U60T!8PG9$P=(2"#X!G2.C(=\9'?7++$6ZJO
M^GX#6JC$VL<8.4,X6 ;!Q/EFG].W:NO9A"T")AW[]$V&RYZ=,B698<8/8F9/
M7 75P%GZ[<'Q@SAZEI0)K% I"6_*KHK39BK0R763[MV4H..KN5H(>*EKJ7K\
MW'C&XZW5%WRKPD?)MN"Z:*U'QU']WJ4GG /3HG+$CL1XP4DMEJD[S\O?A2RP
MWYOMAI;?D(B\3L[[W=C,0G,M?KE/_];U'5M67E,G9$'=/=5]T3)4]<8C .*M
MG^+&OO#+>95N8J[H1Y-_GJ.YP'YMDQ7+??\E$[(T,FZC'O^9)078!B0\B6X=
M [#83=09VJG);%==F9.58":KDA=,! 8LE*SA>X3N )%@]:87]R&3)816G/5T
MQ$@Y^XPSIC>8Z_S%3O1(=W)0_F@A4I71;*LH4'1Y;;DZ?$[^"262<]$ :  P
MJI.,W66"A>UL#A/?<E6FYLBGV1Q&U]7,!X['NTH,F4U&)?V+C!&=GCR X 7Z
MQ17XNR<)FI<I=AW#P=9PWRH*)=C/Q%7JTL'6JP+GS7%X._M<"XY8LC<C'^%M
M'ET9BHW.T0(9:>GH5^"&1&'L?AP(@@&"6)RYK^&WY?N>L\<I?81GT/9S>DEV
M7PBOI[$A]C;L@T2F.1,$/C*1SW] @<RQ69,SB>CV#B.'")%@()=O,$S>)KP?
M= ?%+^F7\UR":1ZE$=LXTPBOS&>$@Q](3(_@7HUTDA/@"JYB[ &0ZZ1I$FE8
M3&T*#)@EEM5&6 =W0([V$BP<#NYGVKS!W2ZFD;EQX@B=]&3\:./Q4B%^C@'
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MO2DOCEX'?!B>+_U%Z*_S#"?#"R9@R>DUNWUZ8K/Y$^@):N$2J(4+\;!'TSV
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M'?-D';HJ\#0%S'!CAMQ9/@O<NZE[!,8I73O'5\;/GO'"$W6*O#2W[P"F=_X
MOA"_= (SU?=]*CIA>-(658.:?N#@.M]V@LQ<O4]-8H:! 9N)=[SEPV=84%50
M:- BYQ[)+U>V[VC%CD14.!D[>'*]5(FX=*MAA-CTH)06U\\]Z$O&2>"JE"<U
M=T^@]9H) RI^;KARKF"'R71J!:;:=&CP:B$*-6S!>,TZ.G.JUC$,5/@X-A;
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MRH04*I]*P9UT"B*;"X'<8 PMN+O.;R]W&;Q[Z^;02OS4F#>GI:/+F4Q=SS7
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M.T?SBZ(0_I!ATR '/Y0SMI#I%[((U:"&[G7!BD(U(;,.?#=HGV,DD'P3W8E
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M.-JAV)&FF2R2 D"T^38*[W*.(GTK RU8 \Y":M4+S#B^QS8"J2#SH7F#BA&
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M>!O&Z1C"XZUPML+YRL)Y(<<7^=[!91M_G+4 (QF)[%LKAS/)H4B2"+.%WL$
M$4O;>LF9%[.73HHAKV,KCK.LX*]A=AMZ1_>)?(2/N6NN3X-.P\OKWU=;\9RC
M\SW,TV*8MI(YR^)M[.[M[FQMZO[7-F?=EE6\JIM]=>!]YQW<BJ2(("9YD(CX
MOF"EV4IF*YFOWGYSFF<BC-L+>XZ\(JY@*X4SZ<?>9^5AMQ+8=H"]_-+]/RF
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MP0\Y_+EM>XPN+]:L0#B&P;=KD,]CSTZ,C@9HX$@F 4,D4&^;6('AGL?8+[*
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MX_BICAJ.;:**I8)$$%V"]^?D,2#OK'P$&W!,'TF)T62G9.LD>MV<LD18I<2
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MD>2)C]RX7O,;],;D$!(CAC/6 EBMQ_VXS:H_ M\GPEJCR!>J[<0V$U-Q0FK
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M4=)K2#=76R'N,963C?X"4$L#!!0    (  4\8U3=\<S3G08  /="   5
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M ;Q"P;I@Q&V"X2M[7:U>W76GZJW_M;FX9)_X_Q53'8K+_ULE^ ]02P,$%
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M,C P,#(X.#-X,E\X:RYH=&U02P$"% ,4    "  %/&-4W]V< >VN  "CK00
M%@              @ 'Y&@  ;GDR,# P,C@X,W@R7V5X,2TQ+FAT;5!+ 0(4
M Q0    (  4\8U1>Q1[41 @  )D@   6              "  1K*  !N>3(P
M,# R.#@S>#)?97@U+3$N:'1M4$L! A0#%     @ !3QC5$#6COW7'   (W4
M !<              ( !DM(  &YY,C P,#(X.#-X,E]E>#DY+3$N:'1M4$L!
M A0#%     @ !3QC5'0\5FM= P  0A   !$              ( !GN\  '1L
M<GDM,C R,C S,#,N>'-D4$L! A0#%     @ !3QC5-WQS-.=!@  ]T(  !4
M             ( !*O,  '1L<GDM,C R,C S,#-?9&5F+GAM;%!+ 0(4 Q0
M   (  4\8U302^,9F@D  *1F   5              "  ?KY  !T;')Y+3(P
M,C(P,S S7VQA8BYX;6Q02P$"% ,4    "  %/&-4HQW:@ZP&  !82P  %0
M            @ '' P$ =&QR>2TR,#(R,#,P,U]P<F4N>&UL4$L%!@     (
-  @ %@(  *8* 0    $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
